
<html lang="en"     class="pb-page"  data-request-id="e17922ff-9e96-4bf1-bbf7-fbb7fadac2f4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2009.52.issue-17;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/jm900447q;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Phosphoramidate Prodrugs of 2′-C-Methylcytidine for Therapy of Hepatitis C Virus Infection" /></meta><meta name="dc.Creator" content="Cristina  Gardelli" /></meta><meta name="dc.Creator" content="Barbara  Attenni" /></meta><meta name="dc.Creator" content="Monica  Donghi" /></meta><meta name="dc.Creator" content="Malte  Meppen" /></meta><meta name="dc.Creator" content="Barbara  Pacini" /></meta><meta name="dc.Creator" content="Steven  Harper" /></meta><meta name="dc.Creator" content="Annalise  Di Marco" /></meta><meta name="dc.Creator" content="Fabrizio  Fiore" /></meta><meta name="dc.Creator" content="Claudio  Giuliano" /></meta><meta name="dc.Creator" content="Vincenzo  Pucci" /></meta><meta name="dc.Creator" content="Ralph  Laufer" /></meta><meta name="dc.Creator" content="Nadia  Gennari" /></meta><meta name="dc.Creator" content="Isabella  Marcucci" /></meta><meta name="dc.Creator" content="Joseph F.  Leone" /></meta><meta name="dc.Creator" content="David B.  Olsen" /></meta><meta name="dc.Creator" content="Malcolm  MacCoss" /></meta><meta name="dc.Creator" content="Michael  Rowley" /></meta><meta name="dc.Creator" content="Frank  Narjes" /></meta><meta name="dc.Description" content="The application of a phosphoramidate prodrug approach to 2′-C-methylcytidine (NM107), the first nucleoside inhibitor of the hepatitis C virus (HCV) NS5B polymerase, is reported. 2′-C-Methylcytidine..." /></meta><meta name="Description" content="The application of a phosphoramidate prodrug approach to 2′-C-methylcytidine (NM107), the first nucleoside inhibitor of the hepatitis C virus (HCV) NS5B polymerase, is reported. 2′-C-Methylcytidine..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 6, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm900447q" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm900447q" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm900447q" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm900447q" /></link>
        
    
    

<title>Phosphoramidate Prodrugs of 2′-C-Methylcytidine for Therapy of Hepatitis C Virus Infection | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm900447q" /></meta><meta property="og:title" content="Phosphoramidate Prodrugs of 2′-C-Methylcytidine for Therapy of Hepatitis C Virus Infection" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0004.jpeg" /></meta><meta property="og:description" content="The application of a phosphoramidate prodrug approach to 2′-C-methylcytidine (NM107), the first nucleoside inhibitor of the hepatitis C virus (HCV) NS5B polymerase, is reported. 2′-C-Methylcytidine, as its valyl ester prodrug (NM283), was efficacious in reducing the viral load in patients infected with HCV. Several of the phosphoramidates prepared demonstrated a 10- to 200-fold superior potency with respect to the parent nucleoside in the cell-based replicon assay. This is due to higher levels of 2′-C-methylcytidine triphosphate in the cells. These prodrugs are efficiently activated and converted to the triphosphate in hepatocytes of several species. Our SAR studies ultimately led to compounds that gave high levels of NTP in hamster and rat liver after subcutaneous dosing and that were devoid of the toxic phenol moiety usually found in ProTides." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm900447q"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm900447q">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm900447q&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm900447q&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm900447q&amp;href=/doi/10.1021/jm900447q" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 5394-5407</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm900366z" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm900809r" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Phosphoramidate Prodrugs of 2′-<i>C</i>-Methylcytidine for Therapy of Hepatitis C Virus Infection</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cristina++Gardelli">Cristina Gardelli</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barbara++Attenni">Barbara Attenni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Monica++Donghi">Monica Donghi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Malte++Meppen">Malte Meppen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barbara++Pacini">Barbara Pacini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Harper">Steven Harper</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Annalise++Di+Marco">Annalise Di Marco</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabrizio++Fiore">Fabrizio Fiore</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claudio++Giuliano">Claudio Giuliano</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vincenzo++Pucci">Vincenzo Pucci</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ralph++Laufer">Ralph Laufer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nadia++Gennari">Nadia Gennari</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Isabella++Marcucci">Isabella Marcucci</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+F.++Leone">Joseph F. Leone</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+B.++Olsen">David B. Olsen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Malcolm++MacCoss">Malcolm MacCoss</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Rowley">Michael Rowley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frank++Narjes">Frank Narjes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">§</span> <span class="aff-text">Departments of Medicinal Chemistry and Pharmacology, Istituto di Ricerche di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">†</span> <span class="aff-text">Department of Medicinal Chemistry, Merck Research Laboratories, Rahway, New Jersey 07065</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania 19486</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +39-0691093279. Fax: +39-0691093654. E-mail: <a href="/cdn-cgi/l/email-protection#adcedfc4ded9c4c3ccf2caccdfc9c8c1c1c4edc0c8dfcec683cec2c0"><span class="__cf_email__" data-cfemail="197a6b706a6d707778467e786b7d7c75757059747c6b7a72377a7674">[email protected]</span></a></div><div class="corresp-fn" id="fn1">∥Current address: Schering Plough Corp., Kenilworth, NJ 07033.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm900447q&amp;href=/doi/10.1021%2Fjm900447q" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 5394–5407</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 6, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 April 2009</li><li><span class="item_label"><b>Published</b> online</span>6 August 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 September 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm900447q" title="DOI URL">https://doi.org/10.1021/jm900447q</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5394%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DCristina%2BGardelli%252C%2BBarbara%2BAttenni%252C%2BMonica%2BDonghi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D17%26contentID%3Djm900447q%26title%3DPhosphoramidate%2BProdrugs%2Bof%2B2%25E2%2580%25B2-C-Methylcytidine%2Bfor%2BTherapy%2Bof%2BHepatitis%2BC%2BVirus%2BInfection%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5407%26publicationDate%3DSeptember%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm900447q"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2888</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">40</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm900447q" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Phosphoramidate Prodrugs of 2′-C-Methylcytidine for Therapy of Hepatitis C Virus Infection&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Cristina&quot;,&quot;last_name&quot;:&quot;Gardelli&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;Attenni&quot;},{&quot;first_name&quot;:&quot;Monica&quot;,&quot;last_name&quot;:&quot;Donghi&quot;},{&quot;first_name&quot;:&quot;Malte&quot;,&quot;last_name&quot;:&quot;Meppen&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;Pacini&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Harper&quot;},{&quot;first_name&quot;:&quot;Annalise&quot;,&quot;last_name&quot;:&quot;Di Marco&quot;},{&quot;first_name&quot;:&quot;Fabrizio&quot;,&quot;last_name&quot;:&quot;Fiore&quot;},{&quot;first_name&quot;:&quot;Claudio&quot;,&quot;last_name&quot;:&quot;Giuliano&quot;},{&quot;first_name&quot;:&quot;Vincenzo&quot;,&quot;last_name&quot;:&quot;Pucci&quot;},{&quot;first_name&quot;:&quot;Ralph&quot;,&quot;last_name&quot;:&quot;Laufer&quot;},{&quot;first_name&quot;:&quot;Nadia&quot;,&quot;last_name&quot;:&quot;Gennari&quot;},{&quot;first_name&quot;:&quot;Isabella&quot;,&quot;last_name&quot;:&quot;Marcucci&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;F. Leone&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;B. Olsen&quot;},{&quot;first_name&quot;:&quot;Malcolm&quot;,&quot;last_name&quot;:&quot;MacCoss&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Rowley&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;Narjes&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;5394-5407&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm900447q&quot;},&quot;abstract&quot;:&quot;The application of a phosphoramidate prodrug approach to 2′-C-methylcytidine (NM107), the first nucleoside inhibitor of the hepatitis C virus (HCV) NS5B polymerase, is reported. 2′-C-Methylcytidine, as its valyl ester prodrug (NM283), was efficacious in reducing the viral load in patients infected with HCV. Several of the phosphoramidates prepared demonstrated a 10- to 200-fold superior potency with respect to the parent nucleoside in the cell-based replicon assay. This is due to higher levels of 2′-C-methylcytidine triphosphate in the cells. These prodrugs are efficiently activated and converted to the triphosphate in hepatocytes of several species. Our SAR studies ultimately led to compounds that gave high levels of NTP in hamster and rat liver after subcutaneous dosing and that were devoid of the toxic phenol moiety usually found in ProTides.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900447q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900447q" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900447q&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900447q" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900447q&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900447q" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm900447q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900447q&amp;href=/doi/10.1021/jm900447q" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm900447q" /></input><a href="/doi/pdf/10.1021/jm900447q" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm900447q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm900447q%26sid%3Dliteratum%253Aachs%26pmid%3D19725579%26genre%3Darticle%26aulast%3DGardelli%26date%3D2009%26atitle%3DPhosphoramidate%2BProdrugs%2Bof%2B2%25E2%2580%25B2-C-Methylcytidine%2Bfor%2BTherapy%2Bof%2BHepatitis%2BC%2BVirus%2BInfection%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D17%26spage%3D5394%26epage%3D5407%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291308" title="Nucleic acids">Nucleic acids</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The application of a phosphoramidate prodrug approach to 2′-<i>C</i>-methylcytidine (NM107), the first nucleoside inhibitor of the hepatitis C virus (HCV) NS5B polymerase, is reported. 2′-<i>C</i>-Methylcytidine, as its valyl ester prodrug (NM283), was efficacious in reducing the viral load in patients infected with HCV. Several of the phosphoramidates prepared demonstrated a 10- to 200-fold superior potency with respect to the parent nucleoside in the cell-based replicon assay. This is due to higher levels of 2′-<i>C-</i>methylcytidine triphosphate in the cells. These prodrugs are efficiently activated and converted to the triphosphate in hepatocytes of several species. Our SAR studies ultimately led to compounds that gave high levels of NTP in hamster and rat liver after subcutaneous dosing and that were devoid of the toxic phenol moiety usually found in ProTides.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24333" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24333" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">An estimated 2% of the world’s population is infected with the hepatitis C virus.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Presently there is no vaccine to prevent the infection and the combination of weekly injections of pegylated interferon-α (PEG-IFN) with daily oral administration of ribavirin is the recommended therapy.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> This regimen gives a sustained viral response (SVR), which is defined as undetectable viral load 6 months after the end of treatment, in only 50% of the patients. The response rate is lower in patients infected with genotype 1 of the virus, where treatment can last up to 12 months, and considerably higher in infections associated with genotypes 2 and 3 where 6 months of treatment can be sufficient to achieve SVR. The current therapy is often associated with severe side effects such as depression, fatigue, flulike symptons, and hemolytic anemia that force many patients to discontinue treatment.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> On the basis of the successful paradigm established for HIV, the development of agents that target specific viral enzymes is an attractive way to arrive at new and better tolerated treatment regimens.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8 ref9 ref10">(5-10)</a></div><div class="NLM_p">The HCV<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a><div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: HCV, hepatitis C virus; SAR, structure−activity relationship; NTP, nucleoside triphosphate; DCM, dichloromethane; THF, tetrahydrofuran; <i>p</i>TsOH, <i>p</i>-toluenesulfonic acid; RP-HPLC, reverse phase high performance liquid chromatography; Py, pyridine; TFA, trifluoroacetic acid; EC<sub>50</sub>, compound concentration that returns 50% of inhibition; CC<sub>50</sub>, compound concentration that returns 50% of cytotoxicity; SI, selectivity index defined as CC<sub>50</sub>/EC<sub>50</sub>; AUC, area under the curve; PK, pharmacokinetic; BLQ, below the limit of quantification; RT, room temperature; DMSO, dimethyl sulfoxide; DMA, dimethylacetamide; ACN, acetonitrile; EDTA, ethylenediaminetetraacetic acid; EGTA, ethylenebis(oxyethylenenitrilo)tetraacetic acid; NADPH, reduced nicotinamide adenine dinucleotide phosphate.</p></div> nonstructural protein 5B (NS5B) is an RNA dependent RNA-polymerase (RdRp) which is at the core of the HCV replication complex. Inhibitors of the polymerase can be assigned to two broad categories based on their mechanism of action and their chemical structure: nucleoside analogues (NI) and allosteric non-nucleoside inhibitors (NNI). Nucleoside inhibitors are especially attractive and are expected to play a prominent role in future therapies. They target the active site of NS5B, which is highly conserved across the six major HCV genotypes, and are expected to be broadly effective against infections with HCV genotypes 1−6.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Another advantage of nucleoside inhibitors is that they show a higher barrier to the emergence of resistance with respect to allosteric polymerase inhibitors, whose binding sites display a considerable polymorphism.<a onclick="showRef(event, 'ref9 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref12">(9, 12)</a> This has been confirmed in studies using the standard subgenomic replicon system<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> and also on HCV isolates from patients, where resistance mutations to NNIs were observed at a low frequency within the clinical isolates’ viral quasispecies. This was not the case for the known mutations against nucleoside inhibitors.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p">Three nucleoside inhibitors, all of them cytidine analogues with a modified ribose unit, have shown anti-HCV activity as single agents in clinical trials (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Valopicitabine <b>1</b> (NM283) was the first polymerase inhibitor to achieve proof of concept for HCV NS5B inhibitors in the clinic. About 1.2 log<sub>10</sub> reduction of plasma HCV RNA was observed in 14 days upon an oral dose of 800 mg b.i.d. In similar settings <b>2</b> (R7128) achieved 2.7 log<sub>10</sub> (1500 mg, bid) and <b>3</b> (R1626) achieved 1.2 log<sub>10</sub> (1500 mg q.d.). Of these three nucleosides only <b>2</b> is still under development.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0017.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of <b>1</b> (NM283, valopicitabine), <b>2</b> (R7128), and <b>3</b> (R1626).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Nucleoside analogues need to be converted via cellular kinases to the active triphosphate (NTP), which in the cases of <b>1</b>−<b>3</b> act as a nonobligate chain-terminators, causing inhibition of viral replication.<a onclick="showRef(event, 'ref12 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref12 ref18 ref19">(12, 18, 19)</a></div><div class="NLM_p">The efficacy of the chain termination depends on the affinity of the modified NTP for the polymerase, the ratio of the NTP analogue to endogenous NTP’s, and the relative rate of incorporation of the polymerase for different nucleotides. Other factors that potentially limit the activity of the NIs are poor cell permeability, unwanted metabolic reactions, or poor conversion to the pharmacologically active triphosphate. In the latter case the first phosphorylation step that produces the 5′-monophosphate has often been found to be rate-limiting.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p">This might also be the case for 2′-<i>C</i>-methylcytidine. It was noted by us and others that the triphosphate of 2′-<i>C</i>-methylcytidine <b>4b</b> (2′-Me-C-TP, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) is highly active on the isolated NS5B enzyme (IC<sub>50</sub> = 0.025 μM), but the parent nucleoside <b>4a</b> (NM107) shows only modest potency in the cell-based assay (2−7 μM).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Recent results from the literature indicated that poor conversion of <b>4a</b> to its NTP is the reason. Among a variety of modified nucleosides investigated, <b>4a</b> was the poorest substrate for conversion to its monophosphate by human 2′-deoxycytidine kinase.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">To circumvent this problem, several monophosphate prodrug strategies can be applied, where the charged, non-cell-penetrable phosphate group is masked to give a more lipophilic membrane permeable compound.<a onclick="showRef(event, 'ref20 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref22">(20, 22)</a> Recent successful examples applied to HCV include liver-targeted prodrugs (HepDirect) of 2′-<i>C</i>-methyladenosine, where the nucleoside was protected from rapid metabolism to the inactive inosine derivative,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> or phosphoramidate (ProTide) prodrugs of 4′-azidouridine, which turned the inactive nucleoside, which was not monophosphorylated in cells, into a potent inhibitor of HCV in cell culture.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">The ProTide approach has also been successful with derivatives of ddA,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> d4T,<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> LCd4A,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and d4A.<a onclick="showRef(event, 'ref25 ref29'); return false;" href="javascript:void(0);" class="ref ref25 ref29">(25, 29)</a></div><div class="NLM_p">We started a program with the objective to discover a monophosphate prodrug of 2′-<i>C</i>-methylcytidine <b>4a</b>, hoping that by bypassing the initial kinase dependence of <b>4a</b>, we could generate high levels of NTP <b>4b</b> in the liver. If successful, this could lead to a potential new agent for the treatment of HCV infection or improve the therapeutic index of <b>4a</b>. As our starting point, we chose the ProTides <b>5</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0018.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of 2′-<i>C</i>-methylcytidine <b>4a</b> (NM107), the corresponding NTP <b>4b</b>, and the targeted aryl phosphoramidate prodrugs <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In the current study we also address issues such as the replacement of the potentially toxic aryl moiety present in <b>5</b>.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68082" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68082" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">The synthesis of aryl phosphoramidate prodrugs of 2′-<i>C</i>-methylcytidine was carried out as depicted in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The previously described chemistry for the synthesis of ProTide prodrugs, using 1-methylimidazole as the coupling agent, failed under various conditions. Uchiyama’s method was investigated next. The nucleoside <b>4a</b>, prepared as described in the literature,<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> was used as such or protected as its 2′,3′-isopropylidene ketal <b>9</b> to increase solubility and was then phosphorylated at the 5′ position with the appropriate aryloxyphosphorochloridate <b>8</b>,<a onclick="showRef(event, 'ref24 ref32'); return false;" href="javascript:void(0);" class="ref ref24 ref32">(24, 32)</a> using a strong organometallic base such as <i>tert</i>-butylmagnesium chloride to form the corresponding alkoxide.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Pathway for the Synthesis of 2′-<i>C</i>-Methylcytidine Aryloxy Phosphoramidates <b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Et<sub>3</sub>N, DCM; (b) <b>4a</b>, <i>t</i>-BuMgCl, dry THF; (c) acetone, <i>p</i>TsOH, 71−87% yield; (d) <b>8</b>, <i>t</i>-BuMgCl, dry THF; (e) HCOOH 80%, water. For details of the structures <b>5</b>, see Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>−<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</p></p></figure><div class="NLM_p">When the ketal <b>9</b> was used, the deprotection of <b>10</b> was performed with a solution of 80% formic acid in water for 4 h at room temperature. Because of the stereochemistry at the phosphorus center, the final compounds <b>5</b> were isolated as mixtures of two diastereoisomers that, whenever possible, were separated by reverse phase high performance liquid chromatography. The absolute stereochemistry of the diastereomers at phosphorus has not been elucidated, but HPLC retention times were used as parameters to discriminate between the two isomers.</div><div class="NLM_p">For the preparation of benzyloxy phosphoramidates <b>14a</b> and <b>14b</b> and the <i>des</i>-phenol derivative <b>16</b> a different chemical approach based on a final oxidative step (Atherton−Todd reaction)<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> was followed (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Diphenylphosphite was treated with fluorenylmethyl alcohol (FmOH) or benzyl alcohol to give the intermediates <b>12</b> which were then treated with the nucleoside <b>4a</b>, in pyridine at 0 °C. Pyridine was removed from the solution under reduced pressure, and the resulting bisphosphites <b>13</b> were subsequently reacted with alanine ethyl ester in the presence of CCl<sub>4</sub> and Et<sub>3</sub>N to give the desired products <b>14</b> and <b>15</b>. Because of solubility problems, this step had to be carried out in a mixture of isopropanol and <i>N</i>,<i>N</i>-dimethylacetamide in order to achieve good yields. The fluorenylmethyl derivative <b>15</b> was submitted to piperidine deprotection to give the phosphoramidate <b>16</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0012.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthetic Pathway for the Synthesis of 2′-<i>C</i>-Methylcytidine Aryloxy Phosphoramidates <b>14a</b>,<b> 14b</b>,<b> 15</b> and Monoester <b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BnOH or FmOH, Py, 0 °C; (b) <b>4a</b>, Py, 0−40 °C, 1 h; (c) <span class="smallcaps smallerCapital">l</span>-AlaCOOEt·HCl, Et<sub>3</sub>N, CCl<sub>4</sub>, <i>i</i>-PrOH, <i>N</i>,<i>N</i>-dimethylacetamide, 10 min, 0 °C; (d) piperidine, DCM.</p></p></figure><div class="NLM_p">Following a literature procedure,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> the alanyl phosphoramidate <b>18</b> was efficiently prepared by treating a 1:1 diastereomeric mixture <b>17</b> with Et<sub>3</sub>N in water (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Compound <b>18</b> is unstable at room temperature, but it could be stored at −80 °C for several weeks.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0013.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of the Metabolic Product <b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Et<sub>3</sub>N/water, yield 54%.</p></p></figure><div class="NLM_p">For the preparation of the phosphoramidate monoesters <b>50</b> and <b>51</b> we worked out conditions for a multigram scale synthesis that are reported in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. The protected nucleoside <b>9</b> was treated with biphenyl phosphite and then with benzyl alcohol to give compound <b>19</b>. The order of addition of the benzyl alcohol and the nucleoside is critical, since treating the phosphite first with benzyl alcohol leads mainly to addition of two molecules of BnOH to the phosphite and consequently low yields of <b>19</b>. Compound <b>19</b> was then coupled to esterified aminoacid <b>21-I</b> or aminoalcohol <b>21-II</b> under oxidative conditions, followed by deprotection of the acetonide and removal of the benzyl group. Hydrogenation in the presence of Pd/C 5% was the method of choice to avoid overreduction of the cytidine residue and to obtain the final compounds <b>50</b> and <b>51</b> in excellent purity.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0020.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Multigram Scale Synthesis of Compounds <b>50</b> and <b>51</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (PhO)<sub>2</sub>POH, Py, anhydrous conditions; (b) BnOH; (c) <b>21</b>-<b>I</b> or <b>21</b>-<b>II</b>, Et<sub>3</sub>N, CCl<sub>4</sub>, CH<sub>3</sub>CN, <i>i</i>-PrOH, THF, 50% yield over three steps; (d) TFA−H<sub>2</sub>O (8:2); (e) H<sub>2</sub>, Pd/C 5%, <i>i</i>-PrOH.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> SAR, Antiviral Activity, and in Vivo NTP Formation</h3><div class="NLM_p">On the basis of the extensive studies reported in the literature by McGuigan and co-workers,<a onclick="showRef(event, 'ref25 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref27">(25, 27)</a> we performed a comprehensive SAR study. The amino acid, its stereochemical variation, the ester functionality of the amino acid, and the aryloxy moiety were explored by preparing about 250 prodrugs. We were aware that a separate ProTide motif optimization process is needed for each nucleoside analogue versus a given target,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> since cell line dependent enzyme expression may determine different phosphoramidate SAR. The phosphoramidates were characterized as in vitro inhibitors of HCV replication in the subgenomic HCV replicon assay and compared to the parent nucleoside <b>4a</b> or its valyl ester <b>1</b>. Both reference compounds <b>1</b> and <b>4a</b> had an EC<sub>50</sub> of about 8 μM in our hands. In the first round of SAR we kept the <i>p</i>-chlorophenyl moiety constant and investigated the amino acid portion using the corresponding methyl or ethyl esters. Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> shows the most representative results. Compound <b>17</b>, as a 1:1 mixture of diastereoisomers, containing <span class="smallcaps smallerCapital">l</span>-alanine ethyl ester already showed a 4-fold improvement in potency with respect to <b>1</b> and no sign of cytotoxicity up to 20 μM.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Cell-Based Activity and Cytotoxicity of <b>1</b> and Prodrugs <b>17</b>, <b>17a</b>, <b>17b</b>, and <b>22</b>−<b>29</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0014.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">compd</th><th align="center">R</th><th align="center">R<sub>1</sub></th><th align="center">R<sub>2</sub></th><th align="center" char=".">EC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th align="center" char=".">CC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th align="center" char=".">SI CC<sub>50</sub>/EC<sub>50</sub></th></tr></thead><tbody><tr valign="top"><td align="left"><b>1</b> (NM283)</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="char" char=".">7.6</td><td align="char" char=".">>100</td><td align="char" char=".">>13</td></tr><tr valign="top"><td align="left"><b>17</b> (1:1)</td><td align="left">Me</td><td align="left">H</td><td align="left">Et</td><td align="char" char=".">1.8</td><td align="char" char=".">>20</td><td align="char" char=".">>11</td></tr><tr valign="top"><td align="left"><b>17a</b> (fe)</td><td align="left">Me</td><td align="left">H</td><td align="left">Et</td><td align="char" char=".">7.9</td><td align="char" char=".">>20</td><td align="char" char=".">>2.5</td></tr><tr valign="top"><td align="left"><b>17b</b> (se)</td><td align="left">Me</td><td align="left">H</td><td align="left">Et</td><td align="char" char=".">1.0</td><td align="char" char=".">>20</td><td align="char" char=".">>20</td></tr><tr valign="top"><td align="left"><b>22</b> (1:1)</td><td align="left">H</td><td align="left">H</td><td align="left">Me</td><td align="char" char=".">0.8</td><td align="char" char=".">>20</td><td align="char" char=".">>25</td></tr><tr valign="top"><td align="left"><b>23</b> (1:0.8)</td><td align="left"><i>n</i>-Bu</td><td align="left">H</td><td align="left">Et</td><td align="char" char=".">1.5</td><td align="char" char=".">>20</td><td align="char" char=".">>13</td></tr><tr valign="top"><td align="left"><b>24</b> (1.5:1)</td><td align="left">β-Ala</td><td align="left">β-Ala</td><td align="left">Me</td><td align="char" char=".">>20</td><td align="char" char=".">>20</td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>25</b> (2:1)</td><td align="left">H</td><td align="left">Me</td><td align="left">Me</td><td align="char" char=".">7.7</td><td align="char" char=".">>20</td><td align="char" char=".">>2.5</td></tr><tr valign="top"><td align="left"><b>26</b> (1:1.5)</td><td align="left">Bn</td><td align="left">H</td><td align="left">Me</td><td align="char" char=".">>20</td><td align="char" char=".">>20</td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>27</b> (1:1)</td><td align="left"><i>i</i>-Bu</td><td align="left">H</td><td align="left">Et</td><td align="char" char=".">7</td><td align="char" char=".">>50</td><td align="char" char=".">>7</td></tr><tr valign="top"><td align="left"><b>28</b> (1:0.8)</td><td align="left">Ph</td><td align="left">H</td><td align="left">Et</td><td align="char" char=".">7.4</td><td align="char" char=".">>20</td><td align="char" char=".">>2.5</td></tr><tr valign="top"><td align="left"><b>29</b> (1:0.9)</td><td align="left">3-indolyl-CH<sub>2</sub>-</td><td align="left">H</td><td align="left">Et</td><td align="char" char=".">17</td><td align="char" char=".">>50</td><td align="char" char=".">>3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values are quoted for <i>n</i> = 2−9 independent determinations.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Concentration of inhibitor reducing the cell viability by 50%.</p></div></div></div><div class="NLM_p">Other amino acids such as glycine methyl ester (<b>22</b>, EC<sub>50</sub> = 0.8 μM) or <span class="smallcaps smallerCapital">l</span>-norleucine (<b>23</b>, EC<sub>50</sub> = 1.5 μM) gave also efficient prodrugs. Compound <b>24</b>, containing β-alanine was inactive, while compounds with <span class="smallcaps smallerCapital">d</span>-alanine (<b>25</b>) or other amino acids (<b>26</b>−<b>29</b>) offered no advantage with respect to <b>1</b>. All the potent compounds (EC<sub>50</sub> ≤ 1 μM) showed CC<sub>50</sub> > 20 μM.</div><div class="NLM_p">Compound <b>17</b> was separated into its diastereoisomers using reversed phase HPLC, giving <b>17a</b>, the first eluting, and <b>17b</b>, the more lipophilic second eluting diastereomer. Interestingly, they showed an 8-fold difference in activity, the first eluting <b>17a</b> being the less active. This trend in activity was observed for all the pairs of diastereoisomers whenever we were able  to separate them. The higher activity of the second eluting, more lipophilic diastereoisomer is not unprecedented<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and could be due to a better diffusion through cell membranes or to a more efficient stereoselective metabolism of this diastereoisomer. Because of this trend in the activity, we report from now on only the activity of the second eluting diastereoisomer. A full set of replicon data for the first eluting diastereoisomers can be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Compound <b>17b</b> was used as a lead to develop further SAR on the phenol residue with particular focus on more hydrophobic moieties (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Cell-Based Activity of Prodrugs <b>30</b>−<b>42</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0015.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top"><td align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0016.gif" alt="" id="_i11" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">EC<sub>50</sub> values are quoted for <i>n</i> = 2−9 independent determinations.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Concentration of inhibitor reducing the cell viability by 50%.</p></div></div></div><div class="NLM_p">The SAR around the phenolic moiety showed that beyond 4-Cl, also 2-Cl and even 2-Me were very good substituents (compounds <b>32b</b> and <b>33b</b>). Substituents with higher electron withdrawing or electron donating effects gave compounds (<b>30</b>−<b>31</b>) less active than <b>17</b>. Very interesting results were obtained by replacing the phenyl ring with much more lipophilic groups such as naphthyls (compounds <b>34b</b>−<b>36</b>) or an extensively substituted phenyl ring (<b>37b</b>) leading to submicromolar inhibitors. Similar results were seen with potential anticancer phosphoramidates of BVdU.<a onclick="showRef(event, 'ref24 ref35'); return false;" href="javascript:void(0);" class="ref ref24 ref35">(24, 35)</a> In the case of compounds <b>34b</b> and <b>35b</b>, the contribution (2-fold) from a more lipophilic ester group, a butyl versus an ethyl, also needs to be appreciated. All these derivatives showed EC<sub>50</sub> below 0.2 μM, while salicylate derivative (<b>38</b>), nonaromatic (<b>39b</b>), or benzylic (<b>14b</b>) moieties offered no advantage. Efforts to release a natural amino acid such as tyrosine instead of phenol (<b>40b</b>) failed, probably due to poor processing by cellular esterases in the presence of a sterically more hindered substituent.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The release of an indole instead is possible as shown by the activity of prodrug <b>41b</b> that is equipotent to the unsubstituted phenol derivative <b>42b</b>, which is itself more active than <b>17b</b>. All the most active compounds (EC<sub>50</sub> ≤ 0.5 μM) demonstrated a selectivity index SI (CC<sub>50</sub>/EC<sub>50</sub>) of more than 40-fold. This suggests that inhibition of the replicon is due to conversion of the phosphoramidate prodrugs to the triphosphate species which acts as a nonobligate chain terminator of NS5B polymerase.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> To assess the selectivity toward other unrelated targets with different mechanism of action, the prodrug <b>42b</b> and the active species, the triphosphate <b>4b</b>, were also tested in the Pan Laboratories screening against 150 different enzymes, channels, and receptors; the two agents showed no significant activity up to 10 μM.</div><div class="NLM_p">On the basis of the encouraging results obtained in the cell based assay, we wanted to confirm that these prodrugs generate high levels of triphosphate in the replicon cells (HuH7/HB1 10a cells) and in hepatocytes. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, in the replicon HuH7/HB1 10a cells, NTP formation from prodrug <b>17b</b> was much higher than from the valyl ester <b>1</b> and the 10-fold more potent prodrug <b>35b</b> gave even higher NTP levels.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Time course of triphosphate formation in HBI10A cells. HBI10A cells were incubated with 100 μM compound <b>1</b> (empty square), compound <b>17b</b> (filled square), and compound <b>35b</b> (triangle). Intracellular NTP was quantified at the indicated time points, considering that 10<sup>6</sup> hepatoma cells is 2 μL in volume. Each point is the mean ± half-range of duplicate determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The same behavior was observed in human hepatocytes between prodrugs <b>17b</b> and <b>35b</b> and reference compound <b>1</b> (see Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). In human hepatocytes, the amount of NTP formed is dose dependent (see Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). When compound <b>17b</b> was incubated at 10 μM, the amount of NTP formed expressed as AUC<sub>0−4h</sub> was 62 μM·h, 10-fold lower than when the same compound was incubated at 100 μM, AUC<sub>0−4h</sub> = 698 μM·h. A good dose dependence was also observed with compound <b>35b</b>. With it AUC<sub>0−4h</sub> of 106, 343, and 553 μM·h were obtained at incubation concentrations of 10, 30, and 100 μM, respectively.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Kinetics of phosphorylation in primary human hepatocytes. Cryopreserved primary human hepatocytes were incubated with 10 μM compound <b>17b</b> (filled square), compound <b>35b</b> (triangle), and compound <b>1</b> (empty square). The intracellular concentration of NTP is estimated considering that 10<sup>6</sup> hepatocytes is 4 μL in volume. Results are the average ± half-range, <i>n</i> = 2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To validate these prodrugs in vivo, we screened them in rat hepatocytes, and also in this preclinical species, compound <b>17b</b> gave high NTP level (see Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Time course of triphosphate formation in rat hepatocytes. Rat hepatocytes were incubated with 10 μM compound <b>1</b> (empty symbol) and compound <b>17b</b> (filled symbol), and NTP levels were quantified at the indicated time points. Data are the average ± half-range from duplicate experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. NTP AUC of Compounds <b>1</b>, <b>17b</b>, and <b>35b</b> in HuH7 Cells and in Human and Rat Hepatocytes<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">compd [concn (μM)]</th><th align="center" char=".">HuH7/HB1 NTP AUC<sub>0−24h</sub> (μM·h)<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></th><th align="center" char=".">human hepatocytes NTP AUC<sub>0−4h</sub> (μM·h)<a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></th><th align="center" char=".">rat hepatocytes NTP AUC<sub>0−4h</sub> (μM·h)<a class="ref internalNav" href="#t3fn3" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top"><td align="char"><b>1</b> [10]</td><td align="char" char=".">70</td><td align="char" char=".">3</td><td align="char" char=".">7</td></tr><tr valign="top"><td align="char"><b>1</b> [100]</td><td align="char" char=".">830</td><td align="char" char="."> </td><td align="char" char="."> </td></tr><tr valign="top"><td align="char"><b>17b</b> [10]</td><td align="char" char="."> </td><td align="char" char=".">62</td><td align="char" char=".">517</td></tr><tr valign="top"><td align="char"><b>17b</b> [100]</td><td align="char" char=".">4265</td><td align="char" char=".">698</td><td align="char" char="."> </td></tr><tr valign="top"><td align="char"><b>35b</b> [10]</td><td align="char" char="."> </td><td align="char" char=".">106</td><td align="char" char="."> </td></tr><tr valign="top"><td align="char"><b>35b</b> [30]</td><td align="char" char="."> </td><td align="char" char=".">343</td><td align="char" char="."> </td></tr><tr valign="top"><td align="char"><b>35b</b> [100]</td><td align="char" char=".">12404</td><td align="char" char=".">553</td><td align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Summary of results reported in Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>−<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>.</p></div><div class="footnote" id="t3fn1"><sup>b</sup><p class="last">Intracellular 2′-<i>C</i>-methylcytidine triphosphate (NTP) after incubation in replicon HuH7/HB1 10a cells.</p></div><div class="footnote" id="t3fn2"><sup>c</sup><p class="last">Intracellular NTP after incubation with human hepatocytes.</p></div><div class="footnote" id="t3fn3"><sup>d</sup><p class="last">Intracellular NTP after incubation with rat hepatocytes.</p></div></div></div><div class="NLM_p">These results were very encouraging and consistent with the observations in the replicon assay, indicating that the prodrugs successfully deliver the monophosphate to the replicon cells and confirming that a kinase bypass approach can circumvent the poor conversion of <b>4a</b> to its NTP <b>4b</b>.</div><div class="NLM_p">The plasma stability of prodrug <b>17b</b> was tested in several species. No significant degradation occurred in human and dog plasma, while significant degradation was observed after 5 min of incubation time in rat and mouse plasma. To facilitate the identification of the degradation products of these pronucleotides, the hypothesized metabolite <b>18</b> was prepared,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and it proved to be the main hydrolysis product of compound <b>17b</b> in rat plasma (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Conversion of compound <b>17b</b> (square) to the metabolic product <b>18</b> (rhombus) in rat plasma.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Having shown that these prodrugs deliver NTP in human and rat hepatocytes, we turned our attention to the releasing moiety: 1 equiv of phenol is released by each molecule of pronucleotide administered. Since <i>p</i>-chlorophenol toxicity is less documented, the studies were focused on the unsubstituted phenol derivatives <b>42b</b>−<b>49b</b>, which are also more potent (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). An extensive SAR study was conducted, and a very wide range of esters were tested. From the results in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, it was clear that ester variation was widely tolerated: not only were the usually reported esters active (<b>42b</b>−<b>44b</b>) but also longer residues such as compounds <b>45b</b>−<b>49b</b>, with the 2-Pr-Pen derivative <b>49b</b> being one of the most potent phosphoramidates in the replicon assay with EC<sub>50</sub> = 0.037 μM. The reported compounds were all tested for their capacity to generate NTP in human hepatocytes (see Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). All the reported prodrugs were more active than the reference compound <b>1</b> in the replicon assay with EC<sub>50</sub> ≤ 1 μM, and these results were confirmed by the values of NTP measured after incubation of the prodrugs at 10 μM with cryopreserved human hepatocytes. In every case the NTP concentration was much higher than with compound <b>1</b>. The correlation between replicon activity and NTP concentration in human hepatocytes is good. Very potent compounds such as <b>46b</b>−<b>48b</b> with EC<sub>50</sub> < 250 nM generally form very high NTP concentrations in human hepatocytes with AUC<sub>0−2h</sub> above 450 μM·h.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Antiviral Activity and Conversion to NTP in Human Hepatocytes of Prodrugs <b>42b</b>−<b>49b</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0001.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">compd<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th align="center">R</th><th align="center" char=".">EC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fnb" aria-label="b">b</a></th><th align="center" char=".">CC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fnc" aria-label="c">c</a></th><th align="center" char=".">SI CC<sub>50</sub>/EC<sub>50</sub></th><th align="center" char=".">[NTP], AUC<sub>0−2h</sub> (μM·h)<a class="ref internalNav" href="#t4fn3" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>42b</b></td><td align="left">Et</td><td align="char" char=".">0.45</td><td align="char" char=".">>20</td><td align="char" char=".">>44</td><td align="char" char=".">65</td></tr><tr valign="top"><td align="left"><b>43b</b></td><td align="left"><i>n</i>Pr</td><td align="char" char=".">0.97</td><td align="char" char=".">>20</td><td align="char" char=".">>20</td><td align="char" char=".">57</td></tr><tr valign="top"><td align="left"><b>44b</b></td><td align="left"><i>i</i>-Pr</td><td align="char" char=".">0.21</td><td align="char" char=".">10</td><td align="char" char=".">47</td><td align="char" char=".">89</td></tr><tr valign="top"><td align="left"><b>45b</b></td><td align="left">MeO(CH<sub>2</sub>)<sub>3</sub></td><td align="char" char=".">1.9</td><td align="char" char=".">>20</td><td align="char" char=".">>10</td><td align="char" char=".">115</td></tr><tr valign="top"><td align="left"><b>46b</b></td><td align="left">2EtBu</td><td align="char" char=".">0.22</td><td align="char" char=".">7</td><td align="char" char=".">31</td><td align="char" char=".">460</td></tr><tr valign="top"><td align="left"><b>47b</b></td><td align="left">1-Hep</td><td align="char" char=".">0.10</td><td align="char" char=".">6</td><td align="char" char=".">60</td><td align="char" char=".">551</td></tr><tr valign="top"><td align="left"><b>48b</b></td><td align="left"><i>c</i>-Hep</td><td align="char" char=".">0.10</td><td align="char" char=".">9</td><td align="char" char=".">90</td><td align="char" char=".">638</td></tr><tr valign="top"><td align="left"><b>49b</b></td><td align="left">2-PrPen</td><td align="char" char=".">0.037</td><td align="char" char=".">2</td><td align="char" char=".">54</td><td align="char" char=".">107</td></tr><tr valign="top"><td align="left"><b>1</b> (NM283)</td><td align="left"> </td><td align="char" char=".">7.6</td><td align="char" char=".">>100</td><td align="char" char=".">13</td><td align="char" char=".">16</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Second eluting diastereoisomer.</p></div><div class="footnote" id="t4fnb"><sup>b</sup><p class="last">EC<sub>50</sub> values are quoted for <i>n</i> = 2−9 independent determinations.</p></div><div class="footnote" id="t4fnc"><sup>c</sup><p class="last">Concentration of inhibitor reducing the cell viability by 50%.</p></div><div class="footnote" id="t4fn3"><sup>d</sup><p class="last">Intracellular 2′-<i>C</i>-methylcytidine triphosphate (NTP) after incubation at 10 μM with cryopreserved human hepatocytes (10<sup>6</sup> cells/mL), <i>n</i> = 2−8.</p></div></div></div><div class="NLM_p">On the basis of the in vitro potency and of the data collected in the hepatocytes, compound <b>46b</b> was profiled further. The stability of prodrug <b>46b</b> was measured in plasma samples of several species. No significant degradation occurred in dog and human plasma, while a significant degradation occurred after 5 min of incubation in rat plasma samples. The poor stability in rat plasma of these prodrugs complicates their development. In the literature very interesting findings are reported to overcome these kinds of problems such as conducting the studies in commercially available carboxyesteresase deficient mice<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> or with the support of carboxyesterases inhibitors. However, the compound<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> was found to be moderately stable in hamster plasma (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0009.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Disappearance of compound <b>46b</b> in human (rhombus), rat (square), dog (triangle), and hamster (cross) plasma.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Because of its acceptable stability in hamster plasma, we could evaluate the pharmacokinetic profile of compound <b>46b</b> in this species. Compound <b>46b</b> was dosed orally, intramuscularly, and subcutaneously using compound <b>1</b> as a reference, and liver levels of NTP <b>4b</b> were determined at 3 and 6 h (time of maximum NTP concentration).<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Hamster Liver NTP Level (μM) of Compound <b>46b</b> and <b>1</b> after Different Administration Routes</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="" /></col><col align="char" char="." /></col><col align="char" char="" /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th align="center"> </th><th class="rowsep1" colspan="2" align="center" char=".">hamster liver NTP level (μM)<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th></tr><tr valign="top"><th align="center">compd</th><th align="center">administration route</th><th align="center" char="."><b>3h</b></th><th align="center"><b>6h</b></th></tr></thead><tbody><tr valign="top"><td align="left"><b>46b</b></td><td align="char">po<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td align="char" char="."> </td><td align="char">1.1</td></tr><tr valign="top"><td align="left"> </td><td align="char">im<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td align="char" char=".">3.6</td><td align="char">2.2</td></tr><tr valign="top"><td align="left"> </td><td align="char">sc<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td align="char" char=".">5.6</td><td align="char">10.1</td></tr><tr valign="top"><td align="left"><b>1</b></td><td align="char">po<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td align="char" char="."> </td><td align="char">0.48</td></tr><tr valign="top"><td align="left"> </td><td align="char">sc<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td><td align="char" char="."> </td><td align="char">BLQ<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">30.2 μmol/kg.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">1.5 μmol/kg.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last"><i>n</i> = 3.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">7.55 μmol/kg.</p></div><div class="footnote" id="t5fn5"><sup>e</sup><p class="last">Lower limit of quantification = 0.2 μM.</p></div></div></div><div class="NLM_p">As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, after oral administration of 30 μmol/kg compound <b>46b</b> to hamsters, the NTP concentration in the liver at 6 h was 1.1 μM. This low NTP concentration, albeit 2-fold higher than that obtained with <b>1</b>, is indicative of a very low bioavailability of this prodrug. The administration by intramuscular injection at 20-fold lower dose (1.5 μmol/kg) gave much higher liver NTP concentrations, 3.6 and 2.2 μM at 3 and 6 h, respectively. The administration by subcutaneous injection at the same dose gave even higher liver exposure with NTP concentrations of 5.6 and 10.1 μM at 3 and 6 h, respectively, while <b>1</b> gave NTP levels below the lower limit of quantification (0.2 μM). The stability of prodrug <b>46b</b> in simulated gastric fluid<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> was measured as well, and the compound was completely stable after 3 h; the reason for the low bioavailability might be poor intestinal absorption of the compound or metabolic degradation in the intestine.</div><div class="NLM_p">Subcutaneous administration gave a high level of NTP in the liver, and the remaining issue to be faced was the compatibility of this approach with the release of an equivalent amount of phenol. In the literature many of the effects of phenol toxicity are extensively documented;<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> therefore, the elimination of the phosphoramidate phenol moiety became the focus of our investigation.</div><div class="NLM_p">The lesson learned so far was that a more lipophilic residue is necessary to obtain higher NTP levels. With this in mind, supported by the work already present in the literature by Wagner and co-workers,<a onclick="showRef(event, 'ref42 ref43 ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44 ref45 ref46">(42-46)</a> two pairs of compounds with and without the phenol and based on a relevant difference in lipophilicity were prepared. The results are reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Antiviral Activity, Cytotoxicity, and Conversion to NTP in Human Hepatocytes of Prodrugs <b>42b</b>, <b>16</b>, <b>49b</b>, and <b>50</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0021.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center">compd</th><th align="center">R</th><th align="center">R<sub>1</sub></th><th align="center" char=".">EC<sub>50</sub> (μM)<a class="ref internalNav" href="#t6fna" aria-label="a">a</a></th><th align="center" char=".">CC<sub>50</sub> (μM)<a class="ref internalNav" href="#t6fnb" aria-label="b">b</a></th><th align="center" char=".">SI CC<sub>50</sub>/EC<sub>50</sub></th><th align="center" char=".">[NTP] AUC<sub>0−2 h</sub> (μM·h)<a class="ref internalNav" href="#t6fnc" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>42b</b></td><td align="left">Ph</td><td align="left">Et</td><td align="char" char=".">0.45</td><td align="char" char=".">>20</td><td align="char" char=".">>44</td><td align="char" char=".">65</td></tr><tr valign="top"><td align="left"><b>16</b></td><td align="left">H</td><td align="left">Et</td><td align="char" char=".">8.8</td><td align="char" char=".">>20</td><td align="char" char=".">>2</td><td align="char" char=".">10</td></tr><tr valign="top"><td align="left"><b>49b</b></td><td align="left">Ph</td><td align="left">2-PrPen</td><td align="char" char=".">0.037</td><td align="char" char=".">2</td><td align="char" char=".">54</td><td align="char" char=".">107</td></tr><tr valign="top"><td align="left"><b>50</b></td><td align="left">H</td><td align="left">2-PrPen</td><td align="char" char=".">8.2</td><td align="char" char=".">>100</td><td align="char" char=".">>12</td><td align="char" char=".">511</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fna"><div class="footnote" id="t6fna"><sup>a</sup><p class="last">EC<sub>50</sub> values are quoted for <i>n</i> = 2−9 independent determinations.</p></div><div class="footnote" id="t6fnb"><sup>b</sup><p class="last">Concentration of inhibitor reducing the cell viability by 50%.</p></div><div class="footnote" id="t6fnc"><sup>c</sup><p class="last">Intracellular NTP after incubation with human hepatocytes.</p></div></div></div><div class="NLM_p">In the case of the less polar pair of compounds <b>42b</b> and <b>16</b> bearing an alanine ethyl ester, the results were in favor of the phenol derivative <b>42b</b>, active in the replicon and more efficient in forming NTP in human hepatocytes. In the case of the more apolar pair of compounds <b>49b</b> and <b>50</b>, bearing the more lipophilic 2-propylpentyl ester, the behavior was inverted. We were very pleased to see that the monoester prodrug <b>50</b>, although not more active in the replicon assay than the parent compound <b>1</b>, generated very high NTP levels in human hepatocytes with AUC<sub>0−2h</sub> = 511 μM·h. The reason for the difference between the replicon cells and the hepatocyte data might be the completely different physicochemical properties of <b>50</b> with respect to the ProTide prodrugs. Possibly, nucleoside uptake mechanisms present in hepatocytes but not in the replicon cells could be involved, as well as differences in the expression of hydrolytic enzymes between the two types of cells.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div class="NLM_p">Compound <b>50</b> demonstrated a selectivity index SI (CC<sub>50</sub>/EC<sub>50</sub>) comparable to that of the parent compound. It was tested in the Pan Laboratories screening as well, and it showed no significant activity up to 10 μM.</div><div class="NLM_p">Prodrug <b>50</b> was stable in human, dog, rabbit, rhesus, and hamster plasma but turned over rapidly in rat plasma, as the corresponding phenol derivative <b>49b</b>. Compound <b>50</b> was dosed in hamster, rabbit, and rat subcutaneously at 1 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). Very efficient NTP formation was observed in the liver of all species. In hamster and rabbit, NTP levels were higher than in rat; at 24 h they were 6.0, 4.1, and 2.9 μM for hamsters, rabbit, and rat, respectively.</div><figure id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0010.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Profile of the liver concentration of NTP <b>4b</b> in hamster, rabbit, and rat after subcutaneous administration of <b>50</b> at 1 mg/kg.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>50</b> was also administered at higher doses, 5 and 10 mg/kg in hamster and rat, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>). After 1 and 5 mg/kg subcutaneous dosing, the AUC<sub>0−48h</sub> in hamster were near dose proportional, 700 and 4600 μM·h, respectively.</div><figure id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0019.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Profile of liver concentration of NTP <b>4b</b> and plasma concentration of nucleoside <b>4a</b> in hamster and rat after subcutaneous administration of <b>50</b> at 5 and 10 mg/kg, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Analysis of hamster and rat plasma showed the nucleoside <b>4a</b> as the major species, while only traces of <b>18</b>, prodrug <b>50</b>, and nucleoside monophosphate were detected (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>).</div><div class="NLM_p">The formation of NTP from compound <b>50</b> was studied in hepatocytes of several species and while lower levels of NTP were observed in dog and rabbit hepatocytes with AUC<sub>0−4h</sub> of 150 and 330 μM·h, respectively, a similar behavior was observed between human and hamster hepatocytes with AUC<sub>0−4h</sub> of 1720 and 2040 μM·h, respectively (see Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>, compound <b>50</b>).</div><div class="NLM_p">The metabolic stability of compound <b>50</b> was studied in rat and human liver S9 fractions in the presence of NADPH, and the prodrug showed a very high metabolic stability in human fractions (rat Cl<sub>int</sub> = 12 (μL/min)/mg; human Cl<sub>int</sub> < 1 (μL/min)/mg). On the basis of these data, the good levels of NTP found in human hepatocytes, the high stability in human plasma, and the good correlation between in vitro and in vivo data in preclinical species, we predict a favorable PK of this prodrug in humans.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Comparison of Triphosphate Levels (AUC) between Compounds <b>50</b> and <b>51</b> in Hepatocytes from Several Species</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="rowsep1"><th class="rowsep1" align="center"> </th><th class="rowsep1" colspan="2" align="center" char=".">NTP AUC<sub>0−4h</sub> (μM·h)</th></tr><tr valign="top" class="rowsep1"><th class="rowsep1" align="center">species</th><th class="rowsep1" align="center" char="."><b>50</b></th><th class="rowsep1" align="center" char="."><b>51</b></th></tr></thead><tbody><tr valign="top"><td align="left">dog</td><td align="char" char=".">150</td><td align="char" char=".">50</td></tr><tr valign="top"><td align="left">rabbit</td><td align="char" char=".">330</td><td align="char" char=".">70</td></tr><tr valign="top"><td align="left">rat</td><td align="char" char=".">860</td><td align="char" char=".">170</td></tr><tr valign="top"><td align="left">human</td><td align="char" char=".">1720</td><td align="char" char=".">190</td></tr><tr valign="top"><td align="left">rhesus</td><td align="char" char=".">2000<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td align="char" char=".">470<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td></tr><tr valign="top"><td class="rowsep0" align="left">hamster</td><td class="rowsep0" align="char" char=".">2040</td><td class="rowsep0" align="char" char=".">100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">AUC<sub>0−3h</sub>.</p></div></div></div><div class="NLM_p">Based on the work carried on in parallel in our laboratories,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> we wanted to investigate if the same approach could be used in the acyloxyethylaminophosphoramidate series, where the amino acid was replaced by an amino alcohol, and compound <b>51</b> was synthesized following the same synthetic route applied to obtain compound <b>50</b>. The potential for NTP formation was assessed in hepatocytes of several species, and although NTP levels were generally lower with respect to compound <b>50</b>, significant NTP concentrations were achieved in human and rat hepatocytes, with AUC<sub>0−4h</sub> of 190 and 170 μM·h, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>, compound <b>51</b>). Compound <b>51</b> showed a higher stability in rat plasma, and the compound was tested both in rat and in hamster for comparison (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>).</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Rat and Hamster Liver NTP Level (μM) of Compounds <b>50</b> and <b>51</b> after Different Administration Routes</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0002.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top"><td align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0003.gif" alt="" id="_i18" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Dose, 1.5 μmol/kg.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">Dose, 30.2 μmol/kg.</p></div></div></div><div class="NLM_p last">The values obtained both in human hepatocytes (NTP AUC<sub>0−2h</sub> = 70 μM·h) and after subcutaneous administration show that also this type of prodrug should be taken into consideration when a kinase bypass needs to be addressed. After subcutaneous administration at 1.5 μmol/kg, high liver exposure of <b>4b</b> was obtained in both rat and hamster (36 and 13 μM after 6 h). Compound <b>51</b> was also dosed orally in hamster at 30.2 μmol/kg, and at 6 h only 0.5 nmol/g 2′-Me-Cy-TP was observed in the liver, indicating a low oral bioavailability as for the phosphoramidate monoester.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30737" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30737" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A series of ProTide phosphoramidate prodrugs of 2′-Me-cytidine have been prepared and tested as HCV replication inhibitors. Not only were they tested in the replicon and cytotoxicity assays but their activation to nucleotide triphosphate was measured both in HuH7 cells and in hepatocytes of several species. The phenol release was an issue that was solved by the preparation of more lipophilic phosphoramidate monoesters. The most interesting compound in this series was compound <b>50</b>, which gave rise to high NTP concentrations in human hepatocytes. It demonstrated a selectivity index comparable to that of the parent drug. Together with its active anabolite <b>4b</b>, it was also tested in the Pan Laboratories screening where both species showed no significant activity up to 10 μM. This compound was also dosed subcutaneously in hamsters, reaching a high NTP exposure in liver, namely, an AUC<sub>0−48h</sub> of 4600 μM·h, after 5 mg/kg dosing.</div><div class="NLM_p last">This study demonstrates that it is possible to bypass the rate limiting first phosphorylation of 2′-<i>C</i>-methylcytidine by delivering directly into the cell the corresponding monophosphate that is then efficiently converted to the active triphosphate species <b>4b</b>, responsible for the antiviral activity.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16656" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16656" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Solvents and reagents were obtained from commercial suppliers and were used without further purification. Flash chromatography purifications were conducted using prepacked cartridges on a Biotage system, eluting with petroleum ether/ethyl acetate mixtures. Reactions were carried out under an atmosphere of nitrogen in oven-dried (110 °C) glassware. Organic extracts were dried over sodium sulfate (Na<sub>2</sub>SO<sub>4</sub>) and were concentrated (after filtration of the drying agent) on rotary evaporators operating under reduced pressure. <sup>1</sup>H and <sup>31</sup>P NMR spectra were recorded on Bruker AM series spectrometers operating at (reported) frequencies between 300 and 600 MHz. Chemical shifts (δ) for signals corresponding to nonexchangeable protons (and exchangeable protons where visible) are recorded in parts per million (ppm) relative to tetramethylsilane and are measured using the residual solvent peak as reference. As a criterion of purity, two different chromatographic systems with NMR and MS data were employed. Purity of final compounds was more than 95% by area. Preparative scale HPLC separations were carried out on a Waters 2525 pump equipped with a 2487 dual absorbance detector. Compounds were eluted with linear gradients of water and MeCN, with water containing 5 mM ammonium bicarbonate. As stationary phase, the following columns were used: Phenomenex Luna C<sub>18</sub> (2) 5 μm, 250 mm × 21.20 mm; Waters XBridge Pre C<sub>18</sub> OBD, 5 μm, 30 mm × 150 mm; Waters XTerra MS C<sub>18</sub> OBD, 5 μm, 19 mm × 150 mm, and 50 mm × 100 mm. Compound <b>50</b> was analyzed by HPLC on the column: Waters XTerra MS C<sub>18</sub>, 5 μm, 3 mm × 150 mm.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 2′-<i>C</i>-Methyl-2′,3′-<i>O</i>-(1-methylethylidene)cytidine (<b>9</b>)</h3><div class="NLM_p last">2′-<i>C</i>-Methylcytidine was diluted with acetone (0.04 M), and catalytic <i>p</i>-toluensulfonic acid and 2,2-dimethoxypropane were added. The resulting slurry was stirred for 24 h at RT. The solvent was removed under vacuo, the residue was dissolved in MeOH, and AmberliteA-26 (previously washed with 2 N NaOH and H<sub>2</sub>O) was added. The resulting mixture was stirred for 2 h. The Amberlite was filtered off, and the solution was evaporated. The crude product was purified by column chromatography, using as eluent DCM/MeOH (9/1), to obtain the pure product <b>9</b> as a white solid. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD, δ) 7.96 (d, <i>J</i> = 7.56 Hz, 1H), 6.18 (s, 1H), 5.90 (d, <i>J</i> = 7.56 Hz, 1H), 4.51−4.48 (m, 1H), 4.28−4.23 (m, 1H), 3.86 (dd, <i>J</i> = 3.04, 12.12 Hz, 1H), 3.78 (dd, <i>J</i> = 3.52, 12.12 Hz, 1H), 1.59 (s, 3H), 1.43 (s, 3H), 1.25 (s, 3H). MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 298 (M + H).<sup>+</sup></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure. Preparation of 2′-<i>C</i>-Methylcytidine Phosphoramidates (<b>17</b>, <b>22</b>−<b>49</b>)</h3><div class="NLM_p last">2′-<i>C</i>-Methylcytidine was diluted with dry THF (0.1 M). The resulting slurry was cooled to −78 °C, and then <i>tert</i>-butylmagnesium chloride (as 1.0 M solution in THF, 2.2 equiv) was added. The mixture was immediately warmed to 0 °C, stirred for 30 min, and again cooled to −78 °C. Then the appropriate aryloxyphosphorochloridate (as 1.0 M solution in THF, 2.2 equiv) was added dropwise. The mixture was allowed to reach room temperature overnight, and then the reaction was quenched by the addition of water. The aqueous phase was extracted three times with EtOAc, and the combined organic phases were washed with brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The crude was purified by column chromatography using as eluent DCM/MeOH (from 9/1 to 8/2), and the resulting off-white solid was dissolved in DMSO and purified by RP-HPLC. Fractions containing the pure diastereoisomers were combined and freeze-dried to afford the title compounds as a TFA salt.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 5′-<i>O</i>-[(4-Chlorophenoxy)[[(1<i>S</i>)-2-ethoxy-1-methyl-2-oxoethyl]mino]phosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">First eluting diastereoisomer (<b>17a</b>): <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, δ) 8.03 (d, <i>J</i> = 7.8 Hz, 1H), 7.41 (d, <i>J</i> = 8.9 Hz, 2H), 7.28 (d, <i>J</i> = 8.9 Hz, 2H), 6.09 (d, <i>J</i> = 7.8 Hz, 1H), 6.03 (s, 1H), 4.66−4.59 (m, 1H), 4.52−4.45 (m, 1H), 4.24−4.16 (m, 3H), 4.04−3.95 (m, 1H), 3.63 (d, <i>J</i> = 9.2 Hz, 1H), 1.39 (d, <i>J</i> = 7.1 Hz, 3H), 1.29 (t, <i>J</i> = 7.1 Hz, 3H), 1.21 (s, 3H). <sup>31</sup>P NMR (300 MHz, CD<sub>3</sub>OD, δ) 5.21. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 547 (M + H)<sup>+</sup>. Second eluting diastereoisomer (<b>17b</b>): <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD, δ) 8.01 (d, <i>J</i> = 7.74 Hz, 1H), 7.43 (d, <i>J</i> = 8.85 Hz, 2H), 7.31 (d, <i>J</i> = 8.85 Hz, 2H), 6.06 (d, <i>J</i> = 7.74 Hz, 1H), 6.02 (s, 1H), 4.58 (ddd, <i>J</i> = 1.82, 6.25, 11.89 Hz, 1H), 4.47−4.38 (m, 1H), 4.24−4.12 (m, 3H), 4.06−3.92 (m, 1H), 3.81 (d, <i>J</i> = 9.28 Hz, 1H), 1.41 (d, <i>J</i> = 6.85 Hz, 3H), 1.27 (t, <i>J</i> = 7.18 Hz, 3H), 1.21 (s, 3H). <sup>31</sup>P NMR (300 MHz, CD<sub>3</sub>OD, δ) 5.10. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 547 (M + H)<sup>+</sup>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 5′-<i>O</i>-[(4-Chlorophenoxy)[(2-methoxy-2-oxoethyl)amino]phosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Mixture 1.2:1 of diastereoisomers at phosphorus [(first eluting, ∗)/(second eluting)] (<b>22</b>): <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, δ) 8.09 (d, <i>J</i> = 7.9 Hz, 1H) and 8.04* (d, <i>J</i> = 7.9 Hz, 1H), 7.44−7.40 (m, 2H, both), 7.31−7.29 (m. 2H, both), 6.09* (d, <i>J</i> = 7.9 Hz, 1H) and 6.08 (d, <i>J</i> = 7.9 Hz, 1H), 6.03 (s, 1H, both), 4.67−4.60 (m, 1H, both), 4.52−4.45 (m, 1H, both), 4.20−4.18 (m, 2H, both), 3.87−3.79 (m, 3H, both), 3.76* (s, 3H) and 3.75 (s, 3H), 1.23 (s, 3H) and 1.21* (s, 3H). <sup>31</sup>P NMR (400 MHz, CD<sub>3</sub>OD, δ) 5.49 and 5.09*. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 541 (M + Na)<sup>+</sup>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 5′-<i>O</i>-[(4-Chlorophenoxy)[[(1<i>S</i>)-1-(ethoxycarbonyl)pentyl]amino]phosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Mixture 1:0.8* of diastereoisomers at phosphorus (<b>23</b>): <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, δ) 8.09−8.03 (m, 1H), 7.45−7.39 (m, 2H), 7.33−7.26 (m, 2H), 6.13 and 6.10* (d, <i>J</i> = 7.9 Hz, 1H), 6.02 and 6.01* (s, 1H), 4.65−4.55 (m, 1H), 4.52−4.39 (m, 1H), 4.24−4.11 (m, 3H), 3.91−3.80 (m, 2H), 1.83−1.71 (m, 1H), 1.71−1.57 (m, 1H), 1.40−1.19 (m, 10H), 0.95−0.85 (m, 3H). <sup>31</sup>P NMR (400 MHz, CD<sub>3</sub>OD, δ) 4.51, 4.24*. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 589 (M + H)<sup>+</sup>.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 5′-<i>O</i>-[(4-Chlorophenoxy)[(3-methoxy-3-oxopropyl)amino]phosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Mixture 1.5:1 of diastereoisomers at phosphorus (<b>24</b>): <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, δ) 8.05 (d, <i>J</i> = 7.9 Hz, 1H) and 8.01* (d, <i>J</i> = 7.9 Hz, 1H), 7.44−7.40 (m, 2H, both), 7.29−7.27 (m, 2H, both), 6.06 (d, <i>J</i> = 7.9 Hz, 1H) and 6.05* (d, <i>J</i> = 7.9 Hz, 1H), 6.01 (s, 1H, both), 4.59−4.53 (m, 1H, both), 4.43−4.38 (m, 1H, both), 4.21−4.18 (m, 1H, both), 3.84 (d, <i>J</i> = 9.2 Hz, 1H) and 3.82* (d, <i>J</i> = 9.2 Hz, 1H), 3.69* (s, 3H) and 3.68 (s, 3H), 3.33−3.28 (m, 2H, both), 2.57−2.54 (m, 2H, both), 1.22 (s, 3H) and 1.21* (s, 3H). <sup>31</sup>P NMR (400 MHz, CD<sub>3</sub>OD, δ) 5.77 and 5.55*. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 533 (M + H)<sup>+</sup>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 5′-<i>O</i>-[(4-Chlorophenoxy)[[(1<i>R</i>)-2-methoxy-1-methyl-2-oxoethyl]amino]phosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Mixture 1.9:1* of diastereoisomers at phosphorus (<b>25</b>). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, δ) 8.12 (d, <i>J</i> = 7.9 Hz, 1H) and 8.00* (d, <i>J</i> = 7.9 Hz, 1H), 7.45−7.41 (m, 2H, both), 7.32−7.27 (m, 2H, both), 6.11 (d, <i>J</i> = 7.9 Hz, 1H) and 6.10* (d, <i>J</i> = 7.9 Hz, 1H), 6.04 (s, 1H) and 6.01* (s, 1H), 4.63−4.56 (m, 1H, both), 4.49−4.37 (m, 1H, both), 4.21−4.16 (m, 1H, both), 4.06−3.98 (m, 1H, both), 3.86 (d, <i>J</i> = 9.2 Hz, 1H) and 3.77* (d, <i>J</i> = 9.2 Hz, 1H), 3.73 (s, 3H) and 3.72* (s, 3H), 1.41* (d, <i>J</i> = 7.2 Hz, 3H) and 1.37 (d, <i>J</i> = 7.2 Hz, 3H), 1.23 (s, 3H) and 1.21* (s, 3H). <sup>31</sup>P NMR (400 MHz, CD<sub>3</sub>OD, δ) 4.39 and 3.60*. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 533 (M + H)<sup>+</sup>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 5′-<i>O</i>-[(4-Chlorophenoxy)[[(1<i>S</i>)-2-methoxy-2-oxo-1-(phenylmethyl)ethyl]amino]phosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Mixture 1:1.5* of diastereoisomers at phosphorus (<b>26</b>). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD, 300 K) δ 7.99* and 7.96 (d, <i>J</i> = 7.9 Hz, 1H), 7.40−7.00 (m, 9H), 6.10* and 6.02 (d, <i>J</i> = 7.9 Hz, 1H), 6.01* and 5.97 (s, 1H), 4.38−4.02 (m, 4H), 3.81−3.74 (m, 1H), 3.73* and 3.66 (s, 3H), 3.21−3.10 (m, 1H), 2.97−2.83 (m, 1H), 1.20 (s, 3H). <sup>31</sup>P NMR (300 MHz, CD<sub>3</sub>OD, 300 K) δ 4.99, 4.79. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 609 (M + H)<sup>+</sup>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 5′-<i>O</i>-[(4-Chlorophenoxy)[[(1<i>S</i>)-1-(ethoxycarbonyl)-3-methylbutyl]amino]phosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Mixture 1:0.9* of diastereoisomers at phosphorus (<b>27</b>): <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, δ) 8.06 and 8.03* (d, <i>J</i> = 7.9 Hz, 1H), 7.45−7.39 (m, 2H), 7.33−7.26 (m, 2H), 6.13 and 6.08* (d, <i>J</i> = 7.9 Hz, 1H), 6.02 and 6.01* (s, 1H), 4.66−4.54 (m, 1H), 4.53−4.38 (m, 1H), 4.25−4.10 (m, 3H), 3.95−3.86 (m, 1H), 3.86−3.79 (m, 1H), 1.81−1.51 (m, 3H), 1.33−1.19 (m, 6H), 0.97−0.81 (m, 6H). <sup>31</sup>P NMR (400 MHz, CD<sub>3</sub>OD, δ) 4.45, 4.20*. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 589 (M + H)<sup>+</sup>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 5′-<i>O</i>-[(4-Chlorophenoxy)[[(1<i>S</i>)-2-ethoxy-2-oxo-1-phenylethyl]amino]phosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Mixture 1:0.8* of diastereoisomers at phosphorus (<b>28</b>): <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, δ) 7.90 and 7.82* (d, <i>J</i> = 7.9 Hz, 1H), 7.42−7.29 (m, 7H), 7.22 (d, <i>J</i> = 7.8 Hz, 1H), 7.15 (d, <i>J</i> = 7.8 Hz, 1H), 6.02* and 5.98 (s, 1H), 5.97 and 5.91* (d, <i>J</i> = 7.9 Hz, 1H), 5.20−4.96 (m, 1H), 4.58−4.30 (m, 2H), 4.22−4.10 (m, 3H), 3.78−3.69 (m, 1H), 1.21−1.18 (m, 3H), 1.16 (s, 3H). <sup>31</sup>P NMR (400 MHz, CD<sub>3</sub>OD, δ) 3.78, 3.71*. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 609 (M + H)<sup>+</sup>.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 5′-<i>O</i>-[(4-Chlorophenoxy)[[(1<i>S</i>)-2-ethoxy-1-(1<i>H</i>-indol-3-ylmethyl)-2-oxoethyl]amino]phosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Mixture 1:0.9* of diastereoisomers at phosphorus (<b>29</b>): <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, δ) 7.91 and 7.82* (d, <i>J</i> = 7.9 Hz, 1H), 7.55−7.49 (m, 1H), 7.42−7.29 (m, 2H), 7.26−7.19 (m, 1H), 7.18−7.06 (m, 3H), 7.05−6.96 (m, 2H), 6.01 and 5.87* (d, <i>J</i> = 7.9 Hz, 1H), 5.95 and 5.91* (s, 1H), 4.41−4.00 (m, 6H), 3.75−3.68 (m, 1H), 3.33−3.24 (m, 1H), 3.16−3.03 (m, 1H), 1.26−1.18 (m, 3H), 1.16 (s, 3H). <sup>31</sup>P NMR (400 MHz, CD<sub>3</sub>OD, δ) 3.75, 3.71*. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 663 (M + H)<sup>+</sup>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 5′-<i>O</i>-[[[(1<i>S</i>)-2-Methoxy-1-methyl-2-oxoethyl]amino][4-(trifluoromethyl)phenoxy]phosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Mixture 1:1 of diastereoisomers at phosphorus (<b>30</b>): <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD, δ) 8.05 (d, <i>J</i> = 7.7 Hz, 1H, both), 7.76−7.74 (m, 2H, both), 7.52−7.46 (m, 2H, both), 6.12−6.07 (m, 1H, both), 6.01 (s, 1H, both), 4.65−4.45 (m, 2H, both), 4.25−4.17 (m, 1H, both), 4.07−4.01 (m, 1H, both), 3.85−3.81 (m, 1H, both), 3.74 (s, 3H) and 3.70 (s, 3H), 1.40 (d, <i>J</i> = 6.9 Hz, 3H, both), 1.22 (s, 3H, both). <sup>31</sup>P NMR (300 MHz, CD<sub>3</sub>OD, δ) 4.85 and 4.78. <sup>19</sup>F NMR (300 MHz, CD<sub>3</sub>OD, δ) 65.9, 79.5. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 589 (M + Na)<sup>+</sup>.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 5′-<i>O</i>-[[[(1<i>S</i>)-2-Methoxy-1-methyl-2-oxoethyl]amino](4-methoxyphenoxy)phosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Mixture 1:1 of diastereoisomers at phosphorus (<b>31</b>): <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, δ) 8.08 (d, <i>J</i> = 7.9 Hz, 0.5H), 8.07 (d, <i>J</i> = 7.9 Hz, 0.5H), 7.25−7.17 (m, 2H), 6.98−6.91 (m, 2H), 6.1 (d, <i>J</i> = 7.9 Hz, 0.5H), 6.07 (d, <i>J</i> = 7.9 Hz, 0.5H), 6.02 (s, 0.5H), 6.01 (s, 0.5H), 4.65−4.53 (m, 1H), 4.50−4.36 (m, 1H), 4.23−4.15 (m, 1H), 4.05−3.95 (m, 1H), 3.87−3.80 (m, 1H), 3.82 (s, 1.5H), 3.81 (s, 1.5H), 3.75 (s, 1.5H), 3.72 (s, 1.5H), 1.42−1.33 (m, 3H), 1.22 (s, 1.5H), 1.21 (s, 1.5H). <sup>31</sup>P NMR (400 MHz, CD<sub>3</sub>OD, δ) 4.47, 4.29. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 530 (M + H)<sup>+</sup>.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 5′-<i>O</i>-[[[(1<i>S</i>)-2-Butoxy-1-methyl-2-oxoethyl]amino](2-chlorophenoxy)phosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Second eluting diastereoisomer (<b>32b</b>): <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD, δ) 8.0 (d, <i>J</i> = 7.9 Hz, 1H), 7.6−7.49 (m, 2H), 7.4−7.31 (m, 1H), 7.29−7.19 (m, 1H), 6.06 (d, <i>J</i> = 7.8 Hz, 1H), 6.01 (s, 1H), 4.67−4.55 (m, 1H), 4.53−4.42 (m, 1H), 4.23−3.98 (m, 4H), 3.82 (d, <i>J</i> = 9.2 Hz, 1H), 1.7−1.57 (m, 2H), 1.48−1.33 (m, 5H), 1.20 (s, 3H), 0.96 (t, <i>J</i> = 7.3 Hz, 3H). <sup>31</sup>P NMR (400 MHz, CD<sub>3</sub>OD, δ) 4.0. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 576−578 (M + H)<sup>+</sup>.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 5′-<i>O</i>-[[[(1<i>S</i>)-2-Ethoxy-1-methyl-2-oxoethyl]amino](2-methylphenoxy)phosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Second eluting diastereoisomer (<b>33b</b>): <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, δ) 7.96 (d, <i>J</i> = 7.6 Hz, 1H), 7.37−7.12 (m, 4H), 6.02−5.97 (m, 2H), 4.59−4.51 (m, 1H), 4.44−4.37 (m, 1H), 4.19−4.11 (m, 3H), 4.02−3.92 (m, 1H), 3.79 (d, <i>J</i> = 8.8 Hz, 1H), 2.35 (s, 3H), 1.39 (d, <i>J</i> = 6.8 Hz, 3H), 1.27−1.24 (m, 3H), 1.19 (s, 3H). <sup>31</sup>P NMR (400 MHz, CD<sub>3</sub>OD, δ) 3.97. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 528 (M + H)<sup>+</sup>.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 5′-<i>O</i>-[[[(1<i>S</i>)-2-Ethoxy-1-methyl-2-oxoethyl]amino](1-naphthalenyloxy)phosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Second eluting diastereoisomer (<b>34b</b>): <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, δ) 8.27−8.22 (m, 1H), 7.98−7.94 (m, 1H), 7.92 (d, <i>J</i> = 7.83 Hz, 1H), 7.79 (d, <i>J</i> = 7.83 Hz, 1H), 7.65−7.55 (m, 3H), 7.50 (t, <i>J</i> = 7.95 Hz, 1H), 6.01 (s, 1H), 5.85 (d, <i>J</i> = 7.83 Hz, 1H), 4.65 (ddd, <i>J</i> = 1.83, 6.12, 11.81 Hz, 1H), 4.49 (ddd, <i>J</i> = 11.87 Hz, <i>J</i> =5.81 Hz, <i>J</i> = 3.53 Hz, 1H), 4.23−4.17 (m, 1H), 4.11 (q, <i>J</i> = 7.07 Hz, 2H), 4.07−3.99 (m, 1H), 3.84 (d, <i>J</i> = 9.09 Hz, 1H), 1.36 (dd, <i>J</i> = 6.69 Hz, <i>J</i> = 0.37 Hz, 3H), 1.22 (t, <i>J</i> =7.07 Hz, 3H), 1.17 (s, 3H). <sup>31</sup>P NMR (400 MHz, CD<sub>3</sub>OD, δ) 4.35. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 563 (M + H)<sup>+</sup>.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 5′-<i>O</i>-[[[(1<i>S</i>)-2-Butoxy-1-methyl-2-oxoethyl]amino](1-naphthalenyloxy)phosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Second eluting diastereoisomer (<b>35b</b>): <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, δ) 8.28−8.22 (m, 1H), 7.99−7.92 (m, 2H), 7.79 (d, <i>J</i> = 8.1 Hz, 1H), 7.65−7.69 (m, 2H), 7.59−7.55 (m, 1H), 7.50 (t, <i>J</i> = 8.1 Hz, 1H), 6.00 (s, 1H), 5.86 (d, <i>J</i> = 7.83 Hz, 1H), 4.65 (ddd, <i>J</i> = 1.6, 6.3, 11.7 Hz, 1H), 4.53−4.46 (m, 1H), 4.24−4.17 (m, 1H), 4.10−4.00 (m, 3H), 3.83 (d, <i>J</i> = 9.3 Hz, 1H), 1.62−1.53 (m, 2H), 1.41−1.32 (m, 5H), 1.17 (s, 3H), 0.93 (t, <i>J</i> = 7.4 Hz, 3H). <sup>31</sup>P NMR: (300 MHz CD<sub>3</sub>OD, δ) 4.33. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 591 (M + H)<sup>+</sup>.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 5′-<i>O</i>-[[[(1<i>S</i>)-2-Butoxy-1-methyl-2-oxoethyl]amino][(4-chloro-1-naphthalenyl)oxy]phosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Mixture 1:2.5 of diastereoisomers at phosphorus (<b>36</b>): <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD, δ) 8.33−8.24 (m, 2H), 8.05−7.96 (m, 1H), 7.79−7.48 (m, 4H), 6.00−5.91 (m, 2H), 4.71−4.45 (m, 2H), 4.25−4.16 (m, 1H), 4.11−3.96 (m, 3H), 3.82 (d, <i>J</i> = 9.1 Hz, 1H), 1.62−1.46 (m, 2H), 1.44−1.26 (m, 5H), 1.18 (s, 3H), 0.97−0.85 (m, 3H). <sup>31</sup>P NMR (400 MHz, CD<sub>3</sub>OD, δ) 4.39, 4.26. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 626−628 (M + H)<sup>+</sup>.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 5′-<i>O</i>-[[4-Chloro-5-methyl-2-(1-methylethyl)phenoxy][[(1<i>S</i>)-2-ethoxy-1-methyl-2-oxoethyl]amino]phosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Second eluting diastereoisomer (<b>37b</b>): <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD, δ) 7.96 (d, <i>J</i> = 7.83 Hz, 1H), 7.37 (s, 1H), 7.33 (s, 1H), 6.02 (s, 1H), 6.00 (d, <i>J</i> = 7.83 Hz, 1H), 4.57 (ddd, <i>J</i> = 1.77, 6.45, 11.88 Hz, 1H), 4.41 (ddd, <i>J</i> = 4.04, 6.45, 11.81 Hz, 1H), 4.20−4.14 (m, 3H), 4.00 (dt, <i>J</i> = 7.33, 17.18 Hz, 1H), 3.80 (d, <i>J</i> = 9.34 Hz, 1H), 2.34 (s, 3H), 1.43 (d, <i>J</i> = 7.08 Hz, 3H), 1.29−1.25 (m, 9H), 1.20 (s, 3H), NH<sub>2</sub>, NH, 2 × OH not visible. <sup>31</sup>P NMR (300 MHz, CD<sub>3</sub>OD, δ) 5.03. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 625 and 627 (M + Na)<sup>+</sup>.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 5′-<i>O</i>-[[[(1<i>S</i>)-2-Ethoxy-1-methyl-2-oxoethyl]amino][2-(methoxycarbonyl)phenoxy]phosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Mixture 1:1 of diastereoisomers at phosphorus (<b>38</b>): <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD, δ) 8.17 (d, <i>J</i> = 7.9 Hz, 0.5H), 8.11 (d, <i>J</i> = 7.8 Hz, 0.5H), 7.99−7.89 (m, 1H), 7.69−7.3 (m, 3H), 6.16 (d, <i>J</i> = 7.8 Hz, 0.5H), 6.09 (d, <i>J</i> = 7.8 Hz, 0.5H), 6.03 (s, 0.5H), 6.01 (s, 0.5H), 4.73−4.44 (m, 2H), 4.27−3.84 (m, 5H), 3.94 (s, 3H), 1.35 (t, <i>J</i> = 7.3 Hz, 3H), 1.3−1.18 (m, 6H). <sup>31</sup>P NMR (300 MHz, CD<sub>3</sub>OD, δ) 4.78, 4.57. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 572 (M + H)<sup>+</sup>.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 5′-<i>O</i>-[[[(1<i>S</i>)-2-Ethoxy-1-methyl-2-oxoethyl]amino](2,2,2-trichloroethoxy)phosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Second eluting diastereoisomer (<b>39b</b>): <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, δ) 8.0 (d, <i>J</i> = 8.1 Hz, 1H), 6.15 (d, <i>J</i> = 7.8 Hz, 1H), 6.01 (s, 1H), 4.74−4.70 (m, 2H), 4.58−4.49 (m, 1H), 4.47−4.36 (m, 1H), 4.28−4.13 (m, 3H), 4.05−3.95 (m, 1H), 3.81 (d, <i>J</i> = 9.3 Hz, 1H), 1.47 (d, <i>J</i> = 6.8 Hz, 3H), 1.31 (t, <i>J</i> = 7.1 Hz, 3H), 1.21 (s, 3H). <sup>31</sup>P NMR (400 MHz, CD<sub>3</sub>OD, δ) 7.59. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 567 (M + H)<sup>+</sup>.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 5′-<i>O</i>-[[4-[(2<i>S</i>)-2-Amino-3-methoxy-3-oxopropyl]phenoxy][[(1<i>S</i>)-2-ethoxy-1-methyl-2-oxoethyl]amino]phosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Second eluting diastereoisomer (<b>40b</b>): <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD, δ) 8.0 (d, <i>J</i> = 7.8 Hz, 1H), 7.32 (m, 4H), 6.1 (d, <i>J</i> = 9.8 Hz, 1H), 6.02 (s, 1H), 4.59−4.31 (m, 3H), 4.25−4.13 (m, 3H), 4.06−3.94 (m, 1H), 3.85 (s, 3H), 3.81 (d, <i>J</i> = 9.4 Hz, 1H), 3.31−3.14 (m, 2H), 1.42 (d, <i>J</i> = 7.2 Hz, 3H), 1.31 (t, <i>J</i> = 7.2 Hz, 3H), 1.21 (s, 3H). <sup>31</sup>P NMR (300 MHz, CD<sub>3</sub>OD, δ) 5.23. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 615 (M + H)<sup>+</sup>.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 5′-<i>O</i>-[[[1-[(1,1-Dimethylethoxy)carbonyl]-1<i>H</i>-indol-5-yl]oxy][[(1<i>S</i>)-2-ethoxy-1-methyl-2-oxoethyl]amino]phosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Second eluting diastereoisomer (<b>41b</b>): <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 8.02 (d, <i>J</i> = 8.91 Hz, 1H), 7.72 (d, <i>J</i> = 3.63 Hz, 1H), 7.57 (d, <i>J</i> = 7.54 Hz, 1H), 7.49 (s, 1H), 7.20 (d, <i>J</i> = 7.60 Hz, 1H), 7.18 (br s, 1H), 7.10 (br s, 1H), 6.71 (d, <i>J</i> = 3.63 Hz, 1H), 6.00 (dd, <i>J</i> = 10.42, 12.34 Hz, 1H), 5.94 (s, 1H), 5.70 (d, <i>J</i> = 7.44 Hz, 1H), 5.23 (d, <i>J</i> = 7.05 Hz, 1H), 5.09 (s, 1H), 4.43−4.32 (m, 1H), 4.30−4.18 (m, 1H), 4.13−3.93 (m, 3H), 3.92−3.80 (m, 1H), 3.62 (t, <i>J</i> = 7.02 Hz, 1H), 1.65 (s, 9H), 1.25 (d, <i>J</i> = 7.02 Hz, 3H), 1.13 (t, <i>J</i> = 7.11 Hz, 3H), 0.96 (s, 3H). <sup>31</sup>P NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 4.16. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 653 (M + H)<sup>+</sup>.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 5′-<i>O</i>-[[[(1<i>S</i>)-2-Ethoxy-1-methyl-2-oxoethyl]amino]phenoxyphosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Second eluting diastereoisomer (<b>42b</b>): <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, δ) 8.05 (d, <i>J</i> = 7.9 Hz, 1H), 7.43 (t, <i>J</i> = 7.6 Hz, 2H), 7.32 (d, <i>J</i> = 7.6 Hz, 2H), 7.26 (t, <i>J</i> = 7.6 Hz, 1H), 6.05 (d, <i>J</i> = 7.9 Hz, 1H), 6.01 (s, 1H), 4.62−4.54 (m, 1H), 4.46−4.39 (m, 1H), 4.22−4.13 (m, 3H), 4.04−3.94 (m, 1H), 3.83 (d, <i>J</i> = 9.2 Hz, 1H), 1.40 (d, <i>J</i> = 7.1 Hz, 3H), 1.27 (t, <i>J</i> = 7.2 Hz, 3H), 1.21 (s, 3H). <sup>31</sup>P NMR (400 MHz, CD<sub>3</sub>OD, δ) 3.85. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 513 (M + H)<sup>+</sup>.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 5′-<i>O</i>-[[[(1<i>S</i>)-1-Methyl-2-oxo-2-propoxyethyl]amino]phenoxyphosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Second eluting diastereoisomer (<b>43b</b>): <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, δ) 8.01 (d, <i>J</i> = 7.8 Hz, 1H), 7.45−7.41 (m, 2H), 7.32−7.24 (m, 3H), 6.04−6.02 (m, 2H), 4.60−4.55 (ddd, <i>J</i> = 1.8, 5.9, 11.9 Hz, 1H), 4.45−4.39 (ddd, <i>J</i> = 3.4, 5.9, 11.9 Hz, 1H), 4.19−4.17 (m, 1H), 4.10−4.06 (m, 2H), 4.03−3.98 (m, 1H), 3.83−3.81 (d, <i>J</i> = 9.2 Hz, 1H), 1.72−1.63 (m, 2H), 1.40 (d, <i>J</i> = 7.1 Hz, 3H), 1.21 (s, 3H), 0.97 (t, <i>J</i> = 7.4 Hz, 3H). <sup>31</sup>P NMR (400 MHz, CD<sub>3</sub>OD, δ) 3.84. (ES<sup>+</sup>) <i>m</i>/<i>z</i> 527 (M + H)<sup>+</sup>.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 5′-<i>O</i>-[[[(1<i>S</i>)-1-Methyl-2-(1-methylethoxy)-2-oxoethyl]amino]phenoxyphosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Second eluting diastereoisomer (<b>44b</b>): <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD, δ) 8.06 (d, <i>J</i> = 7.8 Hz, 1H), 7.5−7.19 (m, 5H), 6.06 (d, <i>J</i> = 7.8 Hz, 1H), 6.01 (s, 1H), 5.08−4.93 (m, 1H), 4.64−4.37 (m, 2H), 4.23−4.14 (m, 1H), 4.02−3.88 (m, 1H), 3.83 (d, <i>J</i> = 9.2 Hz, 1H), 1.39 (d, <i>J</i> = 7.0 Hz, 3H), 1.26 (d, <i>J</i> = 6.2 Hz, 6H), 1.22 (s, 3H). <sup>31</sup>P NMR (300 MHz, CD<sub>3</sub>OD, δ) 5.01. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 528 (M + H)<sup>+</sup>.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 5′-<i>O</i>-[[[(1<i>S</i>)-2-(3-Methoxypropoxy)-1-methyl-2-oxoethyl]amino]phenoxyphosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Second eluting diastereoisomer (<b>45b</b>): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 7.53 (d, <i>J</i> = 7.2 Hz, 1H), 7.46−7.33 (m, 2H), 7.31−7.14 (m, 4H), 7.09 (br s, 1H), 6.05 (t, <i>J</i> = 11.4 Hz, 1H), 5.94 (br s, 1H), 5.68 (d, <i>J</i> = 7.2 Hz, 1H), 5.23 (d, <i>J</i> = 6.6 Hz, 1H), 5.09 (s, 1H), 4.43−4.30 (m, 1H), 4.29−4.16 (m, 1H), 4.16−3.78 (m, 4H), 3.69−3.52 (m, 1H), 3.43−3.36 (m, 2H), 3.22 (s, 3H), 1.84−1.73 (m, 2H), 1.26 (d, <i>J</i> = 6.5 Hz, 3H), 0.96 (s, 3H). <sup>31</sup>P NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 3.75. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 557 (M + H)<sup>+</sup>.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 5′-<i>O</i>-[[[(1<i>S</i>)-2-(2-Ethylbutoxy)-1-methyl-2-oxoethyl]amino]phenoxyphosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Second eluting diastereoisomer (<b>46b</b>): <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, δ) 7.70 (d, <i>J</i> = 7.5 Hz, 1H), 7.41−7.37 (m, 2H), 7.30−7.28 (m, 2H), 7.22 (t, <i>J</i> = 7.3 Hz, 1H), 6.06 (s, 1H), 5.85 (d, <i>J</i> = 7.5 Hz, 1H), 4.52 (dd, <i>J</i> = 5.7, 10.3 Hz, 1H), 4.39 (dd, <i>J</i> = 5.3, 9.5 Hz, 1H), 4.12−3.95 (m, 4H), 3.74 (d, <i>J</i> = 9.2 Hz, 1H), 1.54−1.48 (m, 1H), 1.39−1.33 (m, 7H), 1.12 (s, 3H), 0.90 (t, <i>J</i> = 7.5 Hz, 6H). <sup>31</sup>P NMR (400 MHz, CD<sub>3</sub>OD, δ) 3.79. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 569 (M + H)<sup>+</sup>.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 5′-<i>O</i>-[[[(1<i>S</i>)-2-(Heptyloxy)-1-methyl-2-oxoethyl]amino]phenoxyphosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Second eluting diastereoisomer (<b>47b</b>): <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD, δ) 7.72 (d, <i>J</i> = 7.7 Hz, 1H), 7.44−7.39 (m, 2H), 7.32−7.22 (m, 3H), 6.08 (s, 1H), 5.86 (d, <i>J</i> = 7.7 Hz, 1H), 4.58−4.52 (m, 1H), 4.42−4.39 (m, 1H), 4.15−4.07 (m, 3H), 4.03−3.98 (m, 1H), 3.76 (d, <i>J</i> = 9.1 Hz, 1H), 1.67−1.62 (m, 1H), 1.41−1.34 (m, 13H), 1.14 (s, 3H), 0.96−0.91 (m, 3H). <sup>31</sup>P NMR (300 MHz, CD<sub>3</sub>OD, δ) 3.67. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 583 (M + H)<sup>+</sup>.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 5′-<i>O</i>-[[[(1<i>S</i>)-2-(Cycloheptyloxy)-1-methyl-2-oxoethyl]amino]phenoxyphosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Second eluting diastereoisomer (<b>48b</b>): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 7.52 (d, <i>J</i> = 7.4 Hz, 1H), 7.39 (t, <i>J</i> = 7.7 Hz, 2H), 7.30−7.14 (m, 4H), 7.09 (br s, 1H), 6.08−5.96 (m, 1H), 5.94 (s, 1H), 5.69 (d, <i>J</i> = 7.4 Hz, 1H), 5.23 (d, <i>J</i> = 6.9 Hz, 1H), 5.09 (s, 1H), 4.87−4.74 (m, 1H), 4.43−4.29 (m, 1H), 4.29−4.14 (m, 1H), 4.03−3.91 (m, 1H), 3.90−3.71 (m, 1H), 3.66−3.52 (m, 1H), 1.88−1.71 (m, 2H), 1.67−1.44 (m, 8H), 1.44−1.32 (m, 2H), 1.24 (d, <i>J</i> = 7.0 Hz, 3H), 0.95 (s, 3H). <sup>31</sup>P NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 3.73. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 581 (M + H)<sup>+</sup>.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 5′-<i>O</i>-[[[(1<i>S</i>)-1-Methyl-2-oxo-2-[(2-propylpentyl)oxy]ethyl]amino]phenoxyphosphinyl]-2′-<i>C</i>-methylcytidine</h3><div class="NLM_p last">Second eluting diastereoisomer (<b>49b</b>): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 7.50 (d, <i>J</i> = 7.4 Hz, 1H), 7.40−7.34 (m, 2H), 7.24−7.15 (m, 4H), 7.11−7.03 (bs, 1H), 6.08−5.99 (m, 1H), 5.94−5.88 (bs, 1H), 5.66 (d, <i>J</i> = 7.4 Hz, 1H), 5.20 (d, <i>J</i> = 7.1 Hz, 1H), 5.10−5.06 (bs, 1H), 4.37−4.29 (m, 1H), 4.23−4.16 (m, 1H), 4.00−3.90 (m, 2H), 3.90−3.81 (m, 2H), 3.60−3.52 (m, 1H), 1.64−1.55 (m, 1H), 1.31−1.15 (m, 11H), 0.93 (s, 3H), 0.87−0.79 (m, 6H). <sup>31</sup>P NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 3.90. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 597 (M + H)<sup>+</sup>.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 5′-<i>O</i>-[[[(1<i>S</i>)-2-Ethoxy-1-methyl-2-oxoethyl]amino](9 <i>H</i>-fluoren-9-ylmethoxy)phosphinyl]-2′-<i>C</i>-methylcytidine (<b>15</b>)</h3><div class="NLM_p last">Bisphenyl phosphite was dissolved in pyridine (0.3 M), and a solution of fluorenylmethyl alcohol in pyridine (0.3 M) was added. The mixture was stirred at 0 °C for 20 min. Then a solution of 2′-<i>C</i>-methylcytidine in pyridine (0.3 M) was added at 0 °C. The resulting solution was warmed to 40 °C and stirred for 1 h at this temperature. The solvent was evaporated, and the crude <b>13-II</b> was dissolved in DMA (0.19 M). The resulting solution was added to a solution of <span class="smallcaps smallerCapital">l</span>-alanine ethyl ester hydrochloride (1.2 equiv) and Et<sub>3</sub>N (2.0 equiv) in <i>i</i>-PrOH/CCl<sub>4</sub> (0.24 M, 10/1). The mixture was stirred for 10 min at 0 °C, and then the solvent was evaporated. The residue was dissolved in EtOAc and water. The aqueous phase was extracted three times with EtOAc, and the combined organic phases were washed with brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The crude product was purified by RP-HPLC. Fractions containing the pure compound were freeze-dried to afford the title compound <b>15</b> as white powder and as a 1:1 mixture of diastereoisomers. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, δ) 8.1 (d, <i>J</i> = 7.9 Hz, 0.5H), 7.95 (d, <i>J</i> = 7.9 Hz, 0.5H), 7.85−7.81 (m, 2H), 7.74−7.64 (m, 2H), 7.45−7.38 (m, 2H), 7.36−7.29 (m, 2H), 6.02 (d, <i>J</i> = 7.8 Hz, 1H), 5.97 (d, <i>J</i> = 9.1 Hz, 1H), 4.56−4.2 (m, 4H), 4.2−4.04 (m, 3H), 3.89−3.73 (m, 2H), 1.37 (d, <i>J</i> = 7.2 Hz, 1.5H), 1.34 (d, <i>J</i> = 7.2 Hz, 1.5H), 1.25 (t, <i>J</i> = 7.2 Hz, 3H), 1.19 (s, 1.5H), 1.19 (s, 1.5H). <sup>31</sup>P NMR (400 MHz, CD<sub>3</sub>OD, δ) 8.46, 8.14. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 615 (M + H)<sup>+</sup>.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 5′-<i>O</i>-[[[(1<i>S</i>)-2-Ethoxy-1-methyl-2-oxoethyl]amino]hydroxyphosphinyl]-2′-<i>C</i>-methylcytidine (<b>16</b>)</h3><div class="NLM_p last">Compound <b>15</b> was dissolved in DCM (0.012 M), and piperidine (56 equiv) was added. The resulting solution was evaporated and the residue washed with water. The precipitate was discarded, and the solution was concentrated to give a residue that was purified by RP-HPLC. Fractions containing the pure compound were freeze-dried to afford the title compound <b>16</b> as a white powder as an NH<sub>4</sub> salt. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, δ) 8.23 (d, <i>J</i> = 7.6 Hz, 1H), 6.08−6.06 (m, 2H), 4.25−4.15 (m, 3H), 4.10−4.02 (m, 2H), 3.95−3.87 (m, 2H), 1.36 (d, <i>J</i> = 7.1 Hz, 3H), 1.28 (t, <i>J</i> = 7.1 Hz, 3H), 1.15 (s, 3H). <sup>31</sup>P NMR (400 MHz, CD<sub>3</sub>OD, δ) 6.87. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 436 (M + H)<sup>+</sup>.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 5′-<i>O</i>-[[[(1<i>S</i>)-1-Methyl-2-oxo-2-[propylpentyl)oxy]ethyl]amino]phenylmethoxy)phosphinyl]-2′-<i>C</i>-methyl-2′,3′-<i>O</i>-(1-methylethylidene)cytidine (<b>20-I</b>)</h3><div class="NLM_p last">Compound <b>9</b> was diluted with pyridine (0.67 M) in the presence of molecular sieves. The resulting solution was cooled to 0 °C, diphenylphosphite (80%, 1.3 equiv) was added, and the mixture was stirred for 1 h at 0 °C. To this solution benzyl alcohol (2.0 equiv) was added, and the mixture was stirred at RT for 1 h. The solvent was evaporated, and the residue <b>19</b> was dissolved in THF/CCl<sub>4</sub> (0.08 M, 12/1). The resulting solution was cooled to 0 °C, and Et<sub>3</sub>N (7.0 equiv) and a solution of <span class="smallcaps smallerCapital">l</span>-alanine, 2-propylpentyl ester hydrochloride <b>21-I</b> (1.3 equiv) in <i>i</i>-PrOH were added. The mixture was stirred for 30 min at 0 °C and then was quenched by the addition of water. The aqueous phase was extracted three times with EtOAc, and the combined organic phases were washed with brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The crude product was purified by column chromatography using as eluent DCM/MeOH (95/5) to give <b>20-I</b> as a white solid as a 1:1 mixture of diastereoisomers. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD, δ) 7.76 (d, <i>J</i> = 7.6 Hz, 0.5H), 7.75 (d, <i>J</i> = 7.6 Hz, 0.5H), 7.46−7.33 (m, 5H), 6.15 (s, 0.5H), 6.13 (s, 0.5H), 5.88−5.82 (m, 1H), 5.11 (d, <i>J</i> = 7.6 Hz, 1H), 5.09−5.05 (m, 1H), 4.54−4.43 (m, 1H), 4.41−4.35 (m, 1H), 4.33−4.21 (m, 2H), 4.14−3.88 (m, 3H), 1.75−1.65 (m, 1H), 1.58 (s, 3H), 1.44−1.27 (m, 8H), 1.41 (s, 6H), 1.20 (d, <i>J</i> = 7.3 Hz, 3H), 0.92 (t, <i>J</i> = 5.9 Hz, 6H). <sup>31</sup>P NMR (400 MHz, CD<sub>3</sub>OD, δ) 8.68, 8.48. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 652 (M + H)<sup>+</sup>.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 5′-<i>O</i>-[Hydroxy[[(1<i>S</i>)-1-methyl-2-oxo-2-[(2-propylpentyl)oxy]ethyl]amino]phosphinyl]-2′-<i>C</i>-methylcytidine (<b>50</b>)</h3><div class="NLM_p last">Compound <b>20-I</b> was dissolved in a solution of TFA/H<sub>2</sub>O (0.1 M, 8/2). The resulting solution was warmed to 30 °C and stirred for 20 min. The solvent was evaporated and the residue dissolved in water and EtOAc. The aqueous phase was extracted three times with EtOAc, and the combined organic phases were washed with brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The crude product was purified by column chromatography using as eluent DCM/MeOH (95/5) to give a white solid as mixture of diastereoisomers. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 611 (M + H)<sup>+</sup>. This mixture was dissolved in isopropanol (0.08 M), and Pd/C (5%) (20% w/w) was added. The resulting suspension was stirred under H<sub>2</sub> atmosphere for 2 h at RT. The mixture was filtered, and the solvent was evaporated. The residue was dissolved in acetonitrile and purified by RP-HPLC. Fractions containing the pure compound were freeze-dried to afford the title compound <b>50</b> as a white powder. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD, δ) 8.26 (d, <i>J</i> = 7.65 Hz, 1H), 6.11 (d, <i>J</i> = 7.47 Hz, 1H), 6.05 (s, 1H), 4.27−4.2 (m, 1H), 4.18−3.90 (m, 6H), 1.75−1.6 (m, 1H), 1.4−1.35 (m, 11H), 1.16 (s, 3H), 0.95−0.9 (m, 6H). <sup>13</sup>C NMR (100 MHz, MeOD, δ) 176.99, 165.61, 155.97, 144.15, 96.19, 93.47, 82.73, 82.64, 80.20, 73.09, 69.95, 68.66, 63.07, 51.71, 38.21, 34.74, 34.67, 21.91, 20.93, 20.87, 20.18, 14.71. <sup>31</sup>P NMR (300 MHz, CD<sub>3</sub>OD, δ) 5.22. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 521 (M + H)<sup>+</sup>.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 5′-<i>O</i>-[[[2-[(1-Oxo-2-propylpentyl)oxy]ethyl]amino]phenylmethoxy)phosphinyl]-2′-<i>C</i>-methy-2′,3′-<i>O</i>-(1-methylethylidene)cytidine (<b>20-II</b>)</h3><div class="NLM_p last">Following the same procedure used to obtain compound <b>20-I</b> but using a solution of 2-aminoethyl 2-propylpentanoate hydrochloride <b>21-II</b>, the desired compound (1.3 equiv) in <i>i</i>-PrOH/THF was added. The mixture was stirred for 30 min at 0 °C, and then the salts were filtrated. The resulting solution was evaporated and then diluted with EtOAc and water. The aqueous phase was separated and extracted three times with EtOAc, and the combined organic phases were washed with brine and dried (Na<sub>2</sub>SO<sub>4</sub>). The crude product was purified by column chromatography using as eluent DCM/MeOH (95/5) to give <b>20-II</b>, a white solid as 1:1 mixture of diastereoisomers. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 8.78 (bs, 1H), 8.01 (bs, 1H), 7.95−7.85 (m, 1H), 7.42−7.30 (m, 5H), 6.02 (s, 1H), 5.93 (d, <i>J</i> = 7.26 Hz, 1H), 5.46−5.38 (m, 1H), 5.0 (d, <i>J</i> = 7.44 Hz, 2H), 4.51 (s, 1H), 4.38 (s, 1H), 4.22−4.19 (m, 2H), 4.06−4.01 (m, 2H), 3.09−3.03 (m, 2H), 2.37−2.30 (m, 1H), 1.53 (s, 3H), 1.58−1.21 (m, 8H), 1.39 (s, 3H), 1.21 (s, 3H), 0.86 (t, <i>J</i> = 7.26 Hz, 6H). <sup>31</sup>P NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 10.2, 10.4. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 637 (M + H)<sup>+</sup>.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 5′-<i>O</i>-[Hydroxy[[2-[(1-oxo-2-propylpentyl)oxy]ethyl]amino]phosphinyl]-2′-<i>C</i>-methylcytidine (<b>51</b>)</h3><div class="NLM_p last">Compound <b>20-II</b> was dissolved in a solution of TFA/H<sub>2</sub>O (0.1 M, 8/2). The resulting solution was warmed to 30 °C and stirred for 20 min. The solvent was evaporated and the residue dissolved in water and EtOAc. The aqueous phase was extracted three times with EtOAc, and the combined organic phases were washed with brine and dried (Na<sub>2</sub>SO<sub>4</sub>). The crude product was purified by column chromatography using as eluent DCM/MeOH (95/5) to give a white solid as mixture of diastereoisomers. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 597 (M + H)<sup>+</sup>. This mixture was dissolved in methanol (0.08 M), and Pd/C (10%) (20% w/w) was added. The resulting suspension was stirred under H<sub>2</sub> atmosphere for 18 h at RT. The mixture was filtered, and the solvent was evaporated. The residue was dissolved in acetonitrile and purified by RP-HPLC. Fractions containing the pure compound were freeze-dried to afford the title compound <b>51</b> as white powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 8.76 (s, 1H), 8.08 (d, <i>J</i> = 7.8 Hz, 1H), 6.05 (d, <i>J</i> = 5.88 Hz, 1H), 5.79 (s, 1H), 4.21−4.13 (m, 1H), 4.02−3.95 (m, 4H), 3.6 (d, <i>J</i> = 9.1 Hz, 1H), 2.96−2.9 (m, 2H), 2.35−2.27 (m, 1H), 1.51−1.3 (m, 4H), 1.25−1.16 (m, 4H), 1.03 (s, 3H), 0.82 (t, <i>J</i> = 6.3 Hz, 6H). <sup>31</sup>P NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>, δ) 7.87. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 507 (M + H)<sup>+</sup>.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Diammonium 5′-<i>O</i>-({[(1<i>S</i>)-1-Carboxylatoethyl]amino}phosphinato)-2′-<i>C</i>-methylcytidine (<b>18</b>)</h3><div class="NLM_p last">Compound <b>17</b> (39 mg, 0.072 mmol; as a 1:1 mixture of isomers <b>17a</b> and <b>17b</b>) was dissolved in water (3 mL) and triethylamine (3 mL) and stirred at RT for 15 h. All volatiles were removed in vacuo, and the resulting crude was redissolved in ACN (0.5 mL) and water (1 mL) and purified by RP-HPLC (eluent, H<sub>2</sub>O (containing 5 mM ammonium bicarbonate)/MeCN). The fractions containing the pure compound were combined and freeze-dried to constant weight to afford the title compound <b>18</b> as a bis-ammonium salt (17.2 mg, 54%) as a white powder. <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O, δ) 8.05 (d, <i>J</i> = 7.7 Hz, 1H), 6.13 (d, <i>J</i> = 7.6 Hz, 1H), 5.95 (s, 1H), 4.13 (m, 1H), 4.04 (m, 1H), 3.95−3.87 (m, 2H), 3.55 (app t, <i>J</i> = 7.2 Hz, 1H), 1.22 (d, <i>J</i> = 6.7 Hz, 3H), 1.08 (s, 3H). <sup>31</sup>P NMR (300 MHz, D<sub>2</sub>O, δ) 6.79. MS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 409 (M + H)<sup>+</sup>.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Prodrug Conversion to NTP in Hepatic Cells</h3><div class="NLM_p last">HBI10A cells and primary hepatocytes were used for nucleoside triphosphate quantification. Briefly, HBI10A cells were plated at 800 000 cells/well in six-well tissue culture plates and, 24 h after plating, incubated with compounds at 37 °C in 5% CO<sub>2</sub>. Primary hepatocytes (10<sup>6</sup> cells/mL) were incubated with compounds in 96-well plates in a shaking water bath at 37 °C, under an atmosphere of 95% O<sub>2</sub>/5% CO<sub>2</sub>. At different times, cells were then extracted in 70% methanol, 20 mM EDTA, and 20 mM EGTA and centrifuged. Samples were dried, reconstituted, and purified by solid-phase extraction, and triphosphate levels were quantified by LC−MS/MS.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i61"><a href="/doi/suppl/10.1021/jm900447q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78172" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78172" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Analytical data for target compounds and biological data for the first eluting diastereoisomers. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm900447q/suppl_file/jm900447q_si_001.pdf">jm900447q_si_001.pdf (63.95 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm900447q" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47874" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47874" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristina Gardelli</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology, Istituto di Ricerche di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9dfeeff4eee9f4f3fcc2fafceff9f8f1f1f4ddf0f8effef6b3fef2f0"><span class="__cf_email__" data-cfemail="2c4f5e455f5845424d734b4d5e48494040456c41495e4f47024f4341">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara Attenni</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology, Istituto di Ricerche di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Monica Donghi</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology, Istituto di Ricerche di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Malte Meppen</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology, Istituto di Ricerche di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara Pacini</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology, Istituto di Ricerche di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Harper</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology, Istituto di Ricerche di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Annalise Di Marco</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology, Istituto di Ricerche di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabrizio Fiore</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology, Istituto di Ricerche di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudio Giuliano</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology, Istituto di Ricerche di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincenzo Pucci</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology, Istituto di Ricerche di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ralph Laufer</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology, Istituto di Ricerche di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nadia Gennari</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology, Istituto di Ricerche di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isabella Marcucci</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology, Istituto di Ricerche di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph F. Leone</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Merck Research Laboratories, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David B. Olsen</span> - <span class="hlFld-Affiliation affiliation">Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania 19486</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Malcolm MacCoss</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Merck Research Laboratories, Rahway, New Jersey 07065</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Rowley</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology, Istituto di Ricerche di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank Narjes</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry and Pharmacology, Istituto di Ricerche di Biologia Molecolare, P. Angeletti S.p.A. (IRBM-MRL Rome), Via Pontina Km 30,600, 00040 Pomezia, Italy</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88001" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88001" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Fabio Bonelli and Renzo Bazzo for purity checks on compounds <b>50</b> and <b>51</b>, Simona Cianetti for stability and solubility testing on compound <b>50</b>, and Antonella Cellucci for technical support for nucleoside phosphorylation studies in cells.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08673" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08673" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 48 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Shepard, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alter, M. J.</span><span> </span><span class="NLM_article-title">Global epidemiology of hepatitis C virus infection</span> <span class="citation_source-journal">Lancet Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">558</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1016%2FS1473-3099%2805%2970216-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=16122679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A280%3ADC%252BD2Mvls1Wlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=558-567&author=C.+W.+Shepardauthor=L.+Finelliauthor=M.+J.+Alter&title=Global+epidemiology+of+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Global epidemiology of hepatitis C virus infection</span></div><div class="casAuthors">Shepard Colin W; Finelli Lyn; Alter Miriam J</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Infectious diseases</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">558-67</span>
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    </div><div class="casAbstract">Hepatitis C virus (HCV) is a major cause of liver disease worldwide and a potential cause of substantial morbidity and mortality in the future.  The complexity and uncertainty related to the geographic distribution of HCV infection and chronic hepatitis C, determination of its associated risk factors, and evaluation of cofactors that accelerate its progression, underscore the difficulties in global prevention and control of HCV.  Because there is no vaccine and no post-exposure prophylaxis for HCV, the focus of primary prevention efforts should be safer blood supply in the developing world, safe injection practices in health care and other settings, and decreasing the number of people who initiate injection drug use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQyQ65qEM2alVm8bhe6roZYfW6udTcc2eY4Ny9Gn0q-4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mvls1Wlsg%253D%253D&md5=4d5f81fa0c2191b8c32b328e39933fad</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2805%2970216-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252805%252970216-4%26sid%3Dliteratum%253Aachs%26aulast%3DShepard%26aufirst%3DC.%2BW.%26aulast%3DFinelli%26aufirst%3DL.%26aulast%3DAlter%26aufirst%3DM.%2BJ.%26atitle%3DGlobal%2520epidemiology%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2005%26volume%3D5%26spage%3D558%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Hayashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takehara, T.</span><span> </span><span class="NLM_article-title">Antiviral therapy for chronic hepatitis C infection: past, present and future</span> <span class="citation_source-journal">J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1007%2Fs00535-005-1740-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=16501853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A280%3ADC%252BD287hsVaruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=17-27&author=N.+Hayashiauthor=T.+Takehara&title=Antiviral+therapy+for+chronic+hepatitis+C+infection%3A+past%2C+present+and+future"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Antiviral therapy for chronic hepatitis C: past, present, and future</span></div><div class="casAuthors">Hayashi Norio; Takehara Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of gastroenterology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-27</span>
        ISSN:<span class="NLM_cas:issn">0944-1174</span>.
    </div><div class="casAbstract">Antiviral therapy for chronic hepatitis C has dramatically advanced since the discovery of the hepatitis C virus (HCV) in 1989 and the introduction of interferon (IFN) monotherapy in the early 1990s.  The current standard therapy uses a combination of pegylated IFN and ribavirin.  The duration of therapy and response to therapy are HCV genotype-specific.  Genotype 1 patients require 48 weeks of the combination therapy for 50% successful viral elimination, while genotype 2 patients require 24 weeks of therapy for 80% or 90% viral elimination.  Early viral kinetics after the initiation of therapy is a useful predictor of the sustained virologic response (SVR), which is formally determined at 24 weeks after completion of the treatment.  For example, an early virologic response, which is determined by a 2-log reduction of HCV RNA or viral elimination at 12 weeks after the initiation of therapy, is a strong negative predictor of SVR in genotype 1 patients.  In contrast, a rapid virologic response of HCV RNA-negative at 4 weeks after the initiation of therapy identifies genotype 2 "super-responders," who may require a shorter period of therapy.  Adherence to therapy is one of the most important factors for successful viral clearance.  Hematopoietic growth factors such as epoetin and granulocyte-colony stimulating factor help reduce therapy-mediated cytopenia and improve patient compliance, thereby leading to better viral clearance.  New types of anti-HCV agents such as HCV protease and polymerase inhibitors are needed for those patients that do not respond to combination therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYcPayZzNeEc-crCu0nI_sfW6udTcc2eY4Ny9Gn0q-4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD287hsVaruw%253D%253D&md5=d19727776dc8acdeadc3955d8f6261a1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs00535-005-1740-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00535-005-1740-7%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DN.%26aulast%3DTakehara%26aufirst%3DT.%26atitle%3DAntiviral%2520therapy%2520for%2520chronic%2520hepatitis%2520C%2520infection%253A%2520past%252C%2520present%2520and%2520future%26jtitle%3DJ.%2520Gastroenterol.%26date%3D2006%26volume%3D41%26spage%3D17%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Pawlotski, J. M.</span><span> </span><span class="NLM_article-title">Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2003&pages=1-11&author=J.+M.+Pawlotski&title=Mechanisms+of+antiviral+treatment+efficacy+and+failure+in+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPawlotski%26aufirst%3DJ.%2BM.%26atitle%3DMechanisms%2520of%2520antiviral%2520treatment%2520efficacy%2520and%2520failure%2520in%2520chronic%2520hepatitis%2520C%26jtitle%3DAntiviral%2520Res.%26date%3D2003%26volume%3D59%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Thompson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tillman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHutchison, J. G.</span><span> </span><span class="NLM_article-title">Directly acting antivirals for the treatment of patients with hepatitis C infection: a clinical development update addressing key future challenges</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1016%2Fj.jhep.2008.10.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=19022518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCkt77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=184-194&author=A.+Thompsonauthor=K.+Patelauthor=H.+Tillmanauthor=J.+G.+McHutchison&title=Directly+acting+antivirals+for+the+treatment+of+patients+with+hepatitis+C+infection%3A+a+clinical+development+update+addressing+key+future+challenges"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Directly acting antivirals for the treatment of patients with hepatitis C infection: A clinical development update addressing key future challenges</span></div><div class="casAuthors">Thompson, Alex; Patel, Keyur; Tillman, Hans; McHutchison, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">184-194</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Current therapy for chronic hepatitis C virus (HCV) infection is effective in less than 50% of genotype 1-infected patients.  Antiviral agents specifically targeting either the HCV protease or polymerase, or other targets, are now in clin. development.  In general, direct antivirals are potent inhibitors of HCV replication and can result in rapid declines in serum HCV RNA levels.  Yet these agents drive selection pressure for mutant viruses that can reduce susceptibility to any given drug.  Using pegylated interferon (PEG-IFN) and ribavirin (RBV) in combination with direct antivirals can suppress viral breakthrough and increase the likelihood of sustained virol. response.  Direct antivirals also result in adverse events in a proportion of patients, adding to concerns of tolerability that exist with PEG-IFN and RBV.  Direct antivirals are very likely to become an integral part of treatment within the next decade, and already their use in clin. trials has raised important issues related to duration of treatment, early stopping rules, retreatment of previously treated patients, and how or when direct antivirals should be combined.  Here, we provide current information regarding the effectiveness of direct antivirals in treating chronic HCV infection and discuss the key questions and challenges now facing the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXk6iZ2bv6trVg90H21EOLACvtfcHk0libQdkYPwSn5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCkt77F&md5=4a7040ab882f0dfbc7b441610a4852f6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2008.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2008.10.011%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DTillman%26aufirst%3DH.%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26atitle%3DDirectly%2520acting%2520antivirals%2520for%2520the%2520treatment%2520of%2520patients%2520with%2520hepatitis%2520C%2520infection%253A%2520a%2520clinical%2520development%2520update%2520addressing%2520key%2520future%2520challenges%26jtitle%3DJ.%2520Hepatol.%26date%3D2009%26volume%3D50%26spage%3D184%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Finger loop inhibitors of the HCV NS5B polymerase: discovery and prospects for new HCV Therapy</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">626</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=618-626&author=P.+L.+Beaulieu&title=Finger+loop+inhibitors+of+the+HCV+NS5B+polymerase%3A+discovery+and+prospects+for+new+HCV+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DFinger%2520loop%2520inhibitors%2520of%2520the%2520HCV%2520NS5B%2520polymerase%253A%2520discovery%2520and%2520prospects%2520for%2520new%2520HCV%2520Therapy%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D9%26spage%3D618%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, G.</span><span> </span><span class="NLM_article-title">Challenges and successes in developing new therapies for hepatitis C</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=953-960&author=R.+De+Francescoauthor=G.+Migliaccio&title=Challenges+and+successes+in+developing+new+therapies+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DMigliaccio%26aufirst%3DG.%26atitle%3DChallenges%2520and%2520successes%2520in%2520developing%2520new%2520therapies%2520for%2520hepatitis%2520C%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D953%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carfì, A.</span><span> </span><span class="NLM_article-title">Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1242</span><span class="NLM_x">–</span> <span class="NLM_lpage">1262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2007&pages=1242-1262&author=R.+De+Francescoauthor=A.+Carf%C3%AC&title=Advances+in+the+development+of+new+therapeutic+agents+targeting+the+NS3-4A+serine+protease+or+the+NS5B+RNA-dependent+RNA+polymerase+of+the+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DCarf%25C3%25AC%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520the%2520development%2520of%2520new%2520therapeutic%2520agents%2520targeting%2520the%2520NS3-4A%2520serine%2520protease%2520or%2520the%2520NS5B%2520RNA-dependent%2520RNA%2520polymerase%2520of%2520the%2520hepatitis%2520C%2520virus%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2007%26volume%3D59%26spage%3D1242%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span> </span><span class="NLM_article-title">The therapeutic potential of NS3 protease inhibitors in HCV infection</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1129</span><span class="NLM_x">–</span> <span class="NLM_lpage">1144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1517%2F13543784.14.9.1129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=16144497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsleju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=1129-1144&author=N.+Goudreauauthor=M.+Llinas-Brunet&title=The+therapeutic+potential+of+NS3+protease+inhibitors+in+HCV+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic potential of NS3 protease inhibitors in HCV infection</span></div><div class="casAuthors">Goudreau, Nathalie; Llinas-Brunet, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1129-1144</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Hepatitis C virus (HCV) infection is a serious cause of chronic liver disease worldwide and afflicts > 170 million people.  The HCV-encoded NS3 protease is essential for viral replication and has long been recognized as a prime target for antiviral drugs.  However, the peculiar active site structure of this enzyme, a shallow dent on the surface of the protein, has rendered the development of small-mol. inhibitors a highly challenging task.  Nevertheless, perseverance and creativity has led to significant progress in this field over the last few years resulting in three compds. that are reported to enter the clinic.  The impressive redn. of HCV RNA plasma levels obsd. with two of these inhibitors (ciluprevir and VX-950) in clin. trials has undoubtedly illustrated the potential of this viral enzyme-targeted drug discovery approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroso_d0nbjPrVg90H21EOLACvtfcHk0lhZpWAGmGaR9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsleju74%253D&md5=4c719c15a74d6011761e96ea9e0de437</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1517%2F13543784.14.9.1129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.14.9.1129%26sid%3Dliteratum%253Aachs%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26atitle%3DThe%2520therapeutic%2520potential%2520of%2520NS3%2520protease%2520inhibitors%2520in%2520HCV%2520infection%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2005%26volume%3D14%26spage%3D1129%26epage%3D1144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Recent progress in the development of inhibitors of the hepatitis C virus RNA-dependent RNA polymerase</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1302</span><span class="NLM_x">–</span> <span class="NLM_lpage">1329</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.2174%2F156802607781212211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=17627559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1302-1329&author=U.+Kochauthor=F.+Narjes&title=Recent+progress+in+the+development+of+inhibitors+of+the+hepatitis+C+virus+RNA-dependent+RNA+polymerase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of inhibitors of the hepatitis C virus RNA-dependent RNA polymerase</span></div><div class="casAuthors">Koch, Uwe; Narjes, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1302-1329</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The global prevalence of hepatitis C virus (HCV) infection and the serious consequences assocd. with the chronic state of the disease have become a worldwide health problem.  A combination therapy comprising Interferon-alpha and Ribavirin represents the current std. treatment for chronic HCV infection, although it has demonstrated limited success and causes serious side effects.  Promising alternative approaches toward the control of HCV infection include the development of small mol. inhibitors of viral enzymes interfering with the essential steps in the life cycle of the virus.  In this review we will focus on inhibitors of the HCV-encoded NS5B RNA-dependent RNA polymerase (NS5B RdRp) which is essential for viral replication and has been recognized as a prime target for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiFy9xnAKP5rVg90H21EOLACvtfcHk0lhZpWAGmGaR9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvI&md5=02ed6506840e322371e043ce557a31d4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F156802607781212211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607781212211%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DRecent%2520progress%2520in%2520the%2520development%2520of%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520RNA-dependent%2520RNA%2520polymerase%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1302%26epage%3D1329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Pawlotski, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gish, R. G.</span><span> </span><span class="NLM_article-title">Future therapies for hepatitis C</span> <span class="citation_source-journal">Antiviral Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=397-408&author=J.+M.+Pawlotskiauthor=R.+G.+Gish&title=Future+therapies+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPawlotski%26aufirst%3DJ.%2BM.%26aulast%3DGish%26aufirst%3DR.%2BG.%26atitle%3DFuture%2520therapies%2520for%2520hepatitis%2520C%26jtitle%3DAntiviral%2520Ther.%26date%3D2006%26volume%3D11%26spage%3D397%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Gane, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHutchison, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shulman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symonds, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albanis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrey, M. M.</span><span> </span><span class="NLM_article-title">Antiviral activity of the HCV nucleoside polymerase inhibitor R7128 in HCV genotype 2 and 3 prior non-responders: interim results of R7128 1500 mg bid with Peg-IFN and ribavirin for 28 days</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1024A</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=1024A&author=E.+J.+Ganeauthor=M.+Rodriguez-Torresauthor=D.+R.+Nelsonauthor=I.+M.+Jacobsonauthor=J.+G.+McHutchisonauthor=L.+Jeffersauthor=A.+Beardauthor=S.+Walkerauthor=N.+Shulmanauthor=W.+Symondsauthor=E.+Albanisauthor=M.+M.+Berrey&title=Antiviral+activity+of+the+HCV+nucleoside+polymerase+inhibitor+R7128+in+HCV+genotype+2+and+3+prior+non-responders%3A+interim+results+of+R7128+1500+mg+bid+with+Peg-IFN+and+ribavirin+for+28+days"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGane%26aufirst%3DE.%2BJ.%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26aulast%3DNelson%26aufirst%3DD.%2BR.%26aulast%3DJacobson%26aufirst%3DI.%2BM.%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26aulast%3DJeffers%26aufirst%3DL.%26aulast%3DBeard%26aufirst%3DA.%26aulast%3DWalker%26aufirst%3DS.%26aulast%3DShulman%26aufirst%3DN.%26aulast%3DSymonds%26aufirst%3DW.%26aulast%3DAlbanis%26aufirst%3DE.%26aulast%3DBerrey%26aufirst%3DM.%2BM.%26atitle%3DAntiviral%2520activity%2520of%2520the%2520HCV%2520nucleoside%2520polymerase%2520inhibitor%2520R7128%2520in%2520HCV%2520genotype%25202%2520and%25203%2520prior%2520non-responders%253A%2520interim%2520results%2520of%2520R7128%25201500%2520mg%2520bid%2520with%2520Peg-IFN%2520and%2520ribavirin%2520for%252028%2520days%26jtitle%3DHepatology%26date%3D2008%26volume%3D48%26spage%3D1024A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span> </span><span class="NLM_article-title">Nucleoside analog inhibitors of hepatitis C virus replication</span> <span class="citation_source-journal">Infect. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.2174%2F187152606776056698" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=16787301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt1Ggu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=17-29&author=S.+S.+Carrollauthor=D.+B.+Olsen&title=Nucleoside+analog+inhibitors+of+hepatitis+C+virus+replication"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleoside analog inhibitors of hepatitis C virus replication</span></div><div class="casAuthors">Carroll, S. S.; Olsen, D. B.</div><div class="citationInfo"><span class="NLM_cas:title">Infectious Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-29</span>CODEN:
                <span class="NLM_cas:coden">IDDTAD</span>;
        ISSN:<span class="NLM_cas:issn">1871-5265</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Of the 30 compds. currently marketed in the United States for treatment of viral infections, 15 are nucleoside analogs, demonstrating the utility of this class of compd. as a source of antiviral drugs.  The success of nucleoside analogs in treating other viral infections provides a compelling rationale for the significant effort that is currently being devoted to the discovery and development of nucleoside analogs to treat infection by hepatitis C virus (HCV) that may lead to improvements in response rates compared to currently available therapies.  Several different approaches were adopted to identify promising analogs, including the use of surrogate viruses in cell culture assays, screening in the cell-based bicistronic HCV replicon assay, and screening nucleoside triphosphates for the ability to inhibit the activity of the HCV RNA-dependent RNA polymerase in vitro.  Several classes of ribonucleoside analogs with modifications of the ribose inhibit HCV replication.  Nucleoside analogs incorporating a 2'-C-Me modification are potent inhibitors in the replicon assay in the absence of cytotoxicity, and appear to exert their inhibition by acting as functional chain terminators of RNA synthesis.  NM283, a prodrug of 2'-C-methylcytidine, has entered clin. trials and demonstrated viral load redns. in subjects infected with genotype 1 HCV, a genotype known to be difficult to treat effectively with currently approved therapies.  Overall, results to date offer encouragement that improved therapies to treat HCV infection including newly developed nucleoside analogs may become available within the next few years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVhFYWU3S1hbVg90H21EOLACvtfcHk0lgUxI8lYy65uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt1Ggu7Y%253D&md5=27a3f74bc6da7bfd4ce02a1266511f5c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F187152606776056698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152606776056698%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26atitle%3DNucleoside%2520analog%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520replication%26jtitle%3DInfect.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2006%26volume%3D6%26spage%3D17%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Ali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philipp, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inocencio, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W. R.</span><span> </span><span class="NLM_article-title">Selected replicon variants with low-level in vitro resistance to the hepatitis C virus NS5B polymerase inhibitor PSI-6130 lack cross-resistance with R1479</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4356</span><span class="NLM_x">–</span> <span class="NLM_lpage">4369</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=4356-4369&author=S.+Aliauthor=V.+Levequeauthor=S.+Le+Pogamauthor=H.+Maauthor=F.+Philippauthor=N.+Inocencioauthor=M.+Smithauthor=A.+Alkerauthor=H.+Kangauthor=I.+Najeraauthor=K.+Klumppauthor=J.+Symonsauthor=N.+Cammackauthor=W.+R.+Jiang&title=Selected+replicon+variants+with+low-level+in+vitro+resistance+to+the+hepatitis+C+virus+NS5B+polymerase+inhibitor+PSI-6130+lack+cross-resistance+with+R1479"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DS.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DPhilipp%26aufirst%3DF.%26aulast%3DInocencio%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DAlker%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DNajera%26aufirst%3DI.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSymons%26aufirst%3DJ.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DW.%2BR.%26atitle%3DSelected%2520replicon%2520variants%2520with%2520low-level%2520in%2520vitro%2520resistance%2520to%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%2520inhibitor%2520PSI-6130%2520lack%2520cross-resistance%2520with%2520R1479%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D4356%26epage%3D4369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boots, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simcoe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markel, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobler, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafemina, R. L.</span><span> </span><span class="NLM_article-title">Replication fitness and NS5B drug sensitivity of diverse hepatitis C virus isolates characterized by using a transient replication assay</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2059</span><span class="NLM_x">–</span> <span class="NLM_lpage">2069</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=2059-2069&author=S.+W.+Ludmererauthor=D.+J.+Grahamauthor=E.+Bootsauthor=E.+M.+Murrayauthor=A.+Simcoeauthor=E.+J.+Markelauthor=J.+A.+Groblerauthor=O.+A.+Floresauthor=D.+B.+Olsenauthor=D.+J.+Hazudaauthor=R.+L.+Lafemina&title=Replication+fitness+and+NS5B+drug+sensitivity+of+diverse+hepatitis+C+virus+isolates+characterized+by+using+a+transient+replication+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DBoots%26aufirst%3DE.%26aulast%3DMurray%26aufirst%3DE.%2BM.%26aulast%3DSimcoe%26aufirst%3DA.%26aulast%3DMarkel%26aufirst%3DE.%2BJ.%26aulast%3DGrobler%26aufirst%3DJ.%2BA.%26aulast%3DFlores%26aufirst%3DO.%2BA.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DLafemina%26aufirst%3DR.%2BL.%26atitle%3DReplication%2520fitness%2520and%2520NS5B%2520drug%2520sensitivity%2520of%2520diverse%2520hepatitis%2520C%2520virus%2520isolates%2520characterized%2520by%2520using%2520a%2520transient%2520replication%2520assay%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26volume%3D49%26spage%3D2059%26epage%3D2069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">McCown, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyaguru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span> </span><span class="NLM_article-title">The hepatitis C virus replicon presents a higher barrier to resistance to nucleoside analogs than to non nucleoside polymerase or protease inhibitors</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1604</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=1604-1612&author=M.+F.+McCownauthor=S.+Rajyaguruauthor=S.+Le+Pogamauthor=S.+Aliauthor=W.+R.+Jiangauthor=H.+Kangauthor=J.+Symonsauthor=N.+Cammackauthor=I.+Najera&title=The+hepatitis+C+virus+replicon+presents+a+higher+barrier+to+resistance+to+nucleoside+analogs+than+to+non+nucleoside+polymerase+or+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCown%26aufirst%3DM.%2BF.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DAli%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DW.%2BR.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DSymons%26aufirst%3DJ.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DNajera%26aufirst%3DI.%26atitle%3DThe%2520hepatitis%2520C%2520virus%2520replicon%2520presents%2520a%2520higher%2520barrier%2520to%2520resistance%2520to%2520nucleoside%2520analogs%2520than%2520to%2520non%2520nucleoside%2520polymerase%2520or%2520protease%2520inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D1604%26epage%3D1612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seshaadri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyaguru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span> </span><span class="NLM_article-title">Existence of hepatitis C virus NS5B variants naturally resistant to non-nucleoside, but not to nucleoside, polymerase inhibitors among untreated patients</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1205</span><span class="NLM_x">–</span> <span class="NLM_lpage">1216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1093%2Fjac%2Fdkn085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=18343801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVajtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2008&pages=1205-1216&author=S.+Le+Pogamauthor=A.+Seshaadriauthor=A.+Kosakaauthor=S.+Chiuauthor=H.+Kangauthor=S.+Huauthor=S.+Rajyaguruauthor=J.+Symonsauthor=N.+Cammackauthor=I.+Najera&title=Existence+of+hepatitis+C+virus+NS5B+variants+naturally+resistant+to+non-nucleoside%2C+but+not+to+nucleoside%2C+polymerase+inhibitors+among+untreated+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Existence of hepatitis C virus NS5B variants naturally resistant to non-nucleoside, but not to nucleoside, polymerase inhibitors among untreated patients</span></div><div class="casAuthors">Le Pogam, Sophie; Seshaadri, Amritha; Kosaka, Alan; Chiu, Sophie; Kang, Hyunsoon; Hu, Steven; Rajyaguru, Sonal; Symons, Julian; Cammack, Nick; Najera, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1205-1216</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">To characterize the effect of hepatitis C virus (HCV) polymerase intrinsic genetic heterogeneity on the inhibitory activity of nucleoside and nonnucleoside HCV polymerase inhibitors.  The sensitivity of genotype (GT) 1 HCV NS5B clin. isolates from treatment-naive patients to nucleoside and nonnucleoside polymerase inhibitors was assessed.  The genetic diversity at the population level, as well as that of their quasispecies, was correlated with the obsd. reduced sensitivity to inhibitors.  R1479 and NM107 (nucleoside analogs that have entered Phase 2 clin. trials as prodrugs R1626 and NM283, resp.) were similarly active across the tested clin. isolates.  Resistance mutations to nucleoside analogs were not obsd. in any of the isolates.  However, the activity of the nonnucleoside thumb II inhibitor NNI-1, palm I inhibitors NNI-2 and NNI-3, and palm II inhibitor HCV-796 was reduced across different isolates.  This redn. in inhibitory activity for nonnucleoside inhibitors (NNIs) was, in most cases, correlated with the existence of known NNI resistance mutations in the NS5B polymerase population of the clin. isolates, as detected by population sequencing.  Resistance mutations to NNIs were also obsd. at a low frequency within the clin. isolates' viral quasispecies that allowed for their rapid selection upon drug selective pressure.  The higher frequency of known NNI resistance mutations or polymorphisms known to affect their antiviral potency when compared with the lack of detection of resistance mutations to the nucleoside analogs suggests a potential for primary reduced responsiveness as well as faster development of clin. significant resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTFPmws2lf_bVg90H21EOLACvtfcHk0lgUxI8lYy65uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVajtb4%253D&md5=9ab251b640d8e1c5d0d4b334dc6fe053</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkn085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkn085%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DSeshaadri%26aufirst%3DA.%26aulast%3DKosaka%26aufirst%3DA.%26aulast%3DChiu%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DSymons%26aufirst%3DJ.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DNajera%26aufirst%3DI.%26atitle%3DExistence%2520of%2520hepatitis%2520C%2520virus%2520NS5B%2520variants%2520naturally%2520resistant%2520to%2520non-nucleoside%252C%2520but%2520not%2520to%2520nucleoside%252C%2520polymerase%2520inhibitors%2520among%2520untreated%2520patients%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2008%26volume%3D61%26spage%3D1205%26epage%3D1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNair, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, S.</span><span> </span><span class="NLM_article-title">Recent progress in the development of selected hepatitis C virus NS3-4A protease and NS5B polymerase inhibitors</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1016%2Fj.coph.2008.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=18835365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlaqsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=522-531&author=A.+D.+Kwongauthor=L.+McNairauthor=I.+Jacobsonauthor=S.+George&title=Recent+progress+in+the+development+of+selected+hepatitis+C+virus+NS3-4A+protease+and+NS5B+polymerase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of selected hepatitis C virus NS3·4A protease and NS5B polymerase inhibitors</span></div><div class="casAuthors">Kwong, Ann D.; McNair, Lindsay; Jacobson, Ira; George, Shelley</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">522-531</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Chronic hepatitis C virus (HCV) infection is a pressing medical problem worldwide.  Current therapy with pegylated interferon plus ribavirin (Peg-IFN/RBV) is assocd. with a poor risk benefit profile, a long treatment duration (48 wk) and inadequate success rate (∼40-50%) of SVR (sustained viral response) in patients infected with genotype 1 HCV.  This review is focused on recent clin. trial results with specifically targeted antiviral therapy for HCV (STAT-C) protease and polymerase inhibitors.  In the past decade, anti-HCV drug discovery has focused first on targeting host factors required for viral replication and second on multiple HCV antiviral agents.  Owing to the large no. of HCV inhibitors currently in pre-clin. and clin. development today, we have focused on the most advanced compds. in the HCV polymerase and HCV protease inhibitor classes.  Within each class, compds. will be used to illustrate some of the properties assocd. with inhibitors that bind to the active site of HCV polymerase, the active site of HCV protease (macrocyclic and linear ketoamide inhibitors) and allosteric polymerase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb0B_J-gyRGLVg90H21EOLACvtfcHk0lh10fEPM5JLVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlaqsLrE&md5=0787600cc6e2a2c28c1240470bf6bf22</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2008.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2008.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DMcNair%26aufirst%3DL.%26aulast%3DJacobson%26aufirst%3DI.%26aulast%3DGeorge%26aufirst%3DS.%26atitle%3DRecent%2520progress%2520in%2520the%2520development%2520of%2520selected%2520hepatitis%2520C%2520virus%2520NS3-4A%2520protease%2520and%2520NS5B%2520polymerase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D522%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granycome, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laxton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hang, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heindl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrett, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span> </span><span class="NLM_article-title">The novel nucleoside analog R1479 (4′-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">3793</span><span class="NLM_x">–</span> <span class="NLM_lpage">3799</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=3793-3799&author=K.+Klumppauthor=V.+Levequeauthor=S.+Le+Pogamauthor=H.+Maauthor=W.+R.+Jiangauthor=H.+Kangauthor=C.+Granycomeauthor=M.+Singerauthor=C.+Laxtonauthor=J.+Q.+Hangauthor=K.+Sarmaauthor=D.+B.+Smithauthor=D.+Heindlauthor=C.+J.+Hobbsauthor=J.+H.+Merrettauthor=J.+Symonsauthor=N.+Cammackauthor=J.+A.+Martinauthor=R.+Devosauthor=I.+Najera&title=The+novel+nucleoside+analog+R1479+%284%E2%80%B2-azidocytidine%29+is+a+potent+inhibitor+of+NS5B-dependent+RNA+synthesis+and+hepatitis+C+virus+replication+in+cell+culture"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DW.%2BR.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DGranycome%26aufirst%3DC.%26aulast%3DSinger%26aufirst%3DM.%26aulast%3DLaxton%26aufirst%3DC.%26aulast%3DHang%26aufirst%3DJ.%2BQ.%26aulast%3DSarma%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DHeindl%26aufirst%3DD.%26aulast%3DHobbs%26aufirst%3DC.%2BJ.%26aulast%3DMerrett%26aufirst%3DJ.%2BH.%26aulast%3DSymons%26aufirst%3DJ.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DDevos%26aufirst%3DR.%26aulast%3DNajera%26aufirst%3DI.%26atitle%3DThe%2520novel%2520nucleoside%2520analog%2520R1479%2520%25284%25E2%2580%25B2-azidocytidine%2529%2520is%2520a%2520potent%2520inhibitor%2520of%2520NS5B-dependent%2520RNA%2520synthesis%2520and%2520hepatitis%2520C%2520virus%2520replication%2520in%2520cell%2520culture%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D3793%26epage%3D3799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Murakami, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramesh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBrayer, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitaker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micolochik Steyer, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinanzi, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuyver, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obikhod, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span> </span><span class="NLM_article-title">Mechanism of activation of β-2′-deoxy-2′-fluoro-2′-<i>C</i>-methylcytidine and inhibition of hepatitis C virus NS5B RNA polymerase</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=503&author=E.+Murakamiauthor=H.+Baoauthor=M.+Rameshauthor=T.+R.+McBrayerauthor=T.+Whitakerauthor=H.+M.+Micolochik+Steyerauthor=R.+F.+Schinanziauthor=L.+J.+Stuyverauthor=A.+Obikhodauthor=M.+J.+Ottoauthor=P.+A.+Furman&title=Mechanism+of+activation+of+%CE%B2-2%E2%80%B2-deoxy-2%E2%80%B2-fluoro-2%E2%80%B2-C-methylcytidine+and+inhibition+of+hepatitis+C+virus+NS5B+RNA+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DE.%26aulast%3DBao%26aufirst%3DH.%26aulast%3DRamesh%26aufirst%3DM.%26aulast%3DMcBrayer%26aufirst%3DT.%2BR.%26aulast%3DWhitaker%26aufirst%3DT.%26aulast%3DMicolochik%2BSteyer%26aufirst%3DH.%2BM.%26aulast%3DSchinanzi%26aufirst%3DR.%2BF.%26aulast%3DStuyver%26aufirst%3DL.%2BJ.%26aulast%3DObikhod%26aufirst%3DA.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DMechanism%2520of%2520activation%2520of%2520%25CE%25B2-2%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-fluoro-2%25E2%2580%25B2-C-methylcytidine%2520and%2520inhibition%2520of%2520hepatitis%2520C%2520virus%2520NS5B%2520RNA%2520polymerase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2007%26volume%3D51%26spage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Hecker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erion, M. D.</span><span> </span><span class="NLM_article-title">Prodrugs of phosphates and phosphonates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2328</span><span class="NLM_x">–</span> <span class="NLM_lpage">2345</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701260b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2328-2345&author=S.+J.+Heckerauthor=M.+D.+Erion&title=Prodrugs+of+phosphates+and+phosphonates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrugs of Phosphates and Phosphonates</span></div><div class="casAuthors">Hecker, Scott J.; Erion, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2328-2345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The field of prodrugs for phosph(on)ates has evolved considerably in the past decade.  There are now several approaches available to the researcher who finds that a phosphonate moiety achieves the right balance of properties in the lead series, yet needs a prodrug for oral delivery.  The overall best choice in this situation, taking into account stability, byproduct toxicity, avoidance of stereoisomers, and validation in humans, appears to be the diamide class.  Given its relatively recent appearance, there are few examples to date, but it is expected that phosphonic diamides will play an increasingly important role as phosphonate prodrugs going forward.  For drugs given at low to moderate doses, where risks assocd. with the byproduct formaldehyde are low, acyloxyalkyl prodrugs will continue to find application.  If selective targeting to the liver is desired, HepDirect prodrugs are the clear choice, whereas aryl amidates (and possibly diamides) offer the potential for targeting to lymphatic tissue.  The increasing availability of prodrug options should encourage the practicing medicinal chemist to explore phosphonic acids in the course of lead development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrooUagDflp3rVg90H21EOLACvtfcHk0lh10fEPM5JLVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWisbo%253D&md5=62699075f111d09d2ba3f19f089cb7c2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm701260b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701260b%26sid%3Dliteratum%253Aachs%26aulast%3DHecker%26aufirst%3DS.%2BJ.%26aulast%3DErion%26aufirst%3DM.%2BD.%26atitle%3DProdrugs%2520of%2520phosphates%2520and%2520phosphonates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2328%26epage%3D2345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Pierra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amador, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzaria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cretton-Scott, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D'Amours, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moussa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standring, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommadossi, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosselin, G.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacokinetic of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 2′-<i>C</i>-methylcytidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6614</span><span class="NLM_x">–</span> <span class="NLM_lpage">6620</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6614-6620&author=C.+Pierraauthor=A.+Amadorauthor=S.+Benzariaauthor=E.+Cretton-Scottauthor=M.+D%27Amoursauthor=J.+Maoauthor=S.+Mathieuauthor=A.+Moussaauthor=E.+G.+Bridgesauthor=D.+N.+Standringauthor=J.-P.+Sommadossiauthor=R.+Storerauthor=G.+Gosselin&title=Synthesis+and+pharmacokinetic+of+valopicitabine+%28NM283%29%2C+an+efficient+prodrug+of+the+potent+anti-HCV+agent+2%E2%80%B2-C-methylcytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm0603623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603623%26sid%3Dliteratum%253Aachs%26aulast%3DPierra%26aufirst%3DC.%26aulast%3DAmador%26aufirst%3DA.%26aulast%3DBenzaria%26aufirst%3DS.%26aulast%3DCretton-Scott%26aufirst%3DE.%26aulast%3DD%2527Amours%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DMoussa%26aufirst%3DA.%26aulast%3DBridges%26aufirst%3DE.%2BG.%26aulast%3DStandring%26aufirst%3DD.%2BN.%26aulast%3DSommadossi%26aufirst%3DJ.-P.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DGosselin%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520pharmacokinetic%2520of%2520valopicitabine%2520%2528NM283%2529%252C%2520an%2520efficient%2520prodrug%2520of%2520the%2520potent%2520anti-HCV%2520agent%25202%25E2%2580%25B2-C-methylcytidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6614%26epage%3D6620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Cahard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span> </span><span class="NLM_article-title">Aryloxy phosphoramidate triesters as ProTides</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=371-381&author=D.+Cahardauthor=C.+McGuiganauthor=J.+Balzarini&title=Aryloxy+phosphoramidate+triesters+as+ProTides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCahard%26aufirst%3DD.%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DBalzarini%26aufirst%3DJ.%26atitle%3DAryloxy%2520phosphoramidate%2520triesters%2520as%2520ProTides%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D371%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Hecker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Poelje, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varkhedkar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujitaki, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linemeyer, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erion, M. D.</span><span> </span><span class="NLM_article-title">Liver-targeted prodrugs of 2′-<i>C</i>-methyladenosine for therapy of hepatitis C virus infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3891</span><span class="NLM_x">–</span> <span class="NLM_lpage">3896</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0701021" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3891-3896&author=S.+J.+Heckerauthor=K.+R.+Reddyauthor=P.+D.+Van+Poeljeauthor=Z.+Sunauthor=W.+Huangauthor=V.+Varkhedkarauthor=M.+V.+Reddyauthor=J.+M.+Fujitakiauthor=D.+B.+Olsenauthor=K.+A.+Koeplingerauthor=S.+H.+Boyerauthor=D.+L.+Linemeyerauthor=M.+MacCossauthor=M.+D.+Erion&title=Liver-targeted+prodrugs+of+2%E2%80%B2-C-methyladenosine+for+therapy+of+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm0701021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0701021%26sid%3Dliteratum%253Aachs%26aulast%3DHecker%26aufirst%3DS.%2BJ.%26aulast%3DReddy%26aufirst%3DK.%2BR.%26aulast%3DVan%2BPoelje%26aufirst%3DP.%2BD.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DVarkhedkar%26aufirst%3DV.%26aulast%3DReddy%26aufirst%3DM.%2BV.%26aulast%3DFujitaki%26aufirst%3DJ.%2BM.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DBoyer%26aufirst%3DS.%2BH.%26aulast%3DLinemeyer%26aufirst%3DD.%2BL.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DErion%26aufirst%3DM.%2BD.%26atitle%3DLiver-targeted%2520prodrugs%2520of%25202%25E2%2580%25B2-C-methyladenosine%2520for%2520therapy%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3891%26epage%3D3896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Perrone, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luoni, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelleher, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daverio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulready, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congiatu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyaguru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuigan, C.</span><span> </span><span class="NLM_article-title">Application of the phosphoramidate ProTide approach to 4′-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1840</span><span class="NLM_x">–</span> <span class="NLM_lpage">1849</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0613370" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1840-1849&author=P.+Perroneauthor=G.+M.+Luoniauthor=M.+R.+Kelleherauthor=F.+Daverioauthor=A.+Angellauthor=S.+Mulreadyauthor=C.+Congiatuauthor=S.+Rajyaguruauthor=J.+A.+Martinauthor=V.+Levequeauthor=S.+Le+Pogamauthor=I.+Najeraauthor=K.+Klumppauthor=D.+B.+Smithauthor=C.+McGuigan&title=Application+of+the+phosphoramidate+ProTide+approach+to+4%E2%80%B2-azidouridine+confers+sub-micromolar+potency+versus+hepatitis+C+virus+on+an+inactive+nucleoside"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm0613370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0613370%26sid%3Dliteratum%253Aachs%26aulast%3DPerrone%26aufirst%3DP.%26aulast%3DLuoni%26aufirst%3DG.%2BM.%26aulast%3DKelleher%26aufirst%3DM.%2BR.%26aulast%3DDaverio%26aufirst%3DF.%26aulast%3DAngell%26aufirst%3DA.%26aulast%3DMulready%26aufirst%3DS.%26aulast%3DCongiatu%26aufirst%3DC.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DNajera%26aufirst%3DI.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DMcGuigan%26aufirst%3DC.%26atitle%3DApplication%2520of%2520the%2520phosphoramidate%2520ProTide%2520approach%2520to%25204%25E2%2580%25B2-azidouridine%2520confers%2520sub-micromolar%2520potency%2520versus%2520hepatitis%2520C%2520virus%2520on%2520an%2520inactive%2520nucleoside%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1840%26epage%3D1849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Balzarini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruining, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedgwoog, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannecouque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aquaro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perno, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witvrouw, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heijtink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clerq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuigan, C.</span><span> </span><span class="NLM_article-title">Conversion of 2′,3′-dideoxyadenosine (ddA) and 2′,3′-didehydro-2′,3′-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">410</span><span class="NLM_x">, </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=1997&pages=324-328&author=J.+Balzariniauthor=J.+Kruiningauthor=O.+Wedgwoogauthor=C.+Pannecouqueauthor=S.+Aquaroauthor=C.+F.+Pernoauthor=L.+Naesensauthor=M.+Witvrouwauthor=R.+Heijtinkauthor=E.+De+Clerqauthor=C.+McGuigan&title=Conversion+of+2%E2%80%B2%2C3%E2%80%B2-dideoxyadenosine+%28ddA%29+and+2%E2%80%B2%2C3%E2%80%B2-didehydro-2%E2%80%B2%2C3%E2%80%B2-dideoxyadenosine+%28d4A%29+to+their+corresponding+aryloxyphosphoramidate+derivatives+markedly+potentiates+their+activity+against+human+immunodeficiency+virus+and+hepatitis+B+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DKruining%26aufirst%3DJ.%26aulast%3DWedgwoog%26aufirst%3DO.%26aulast%3DPannecouque%26aufirst%3DC.%26aulast%3DAquaro%26aufirst%3DS.%26aulast%3DPerno%26aufirst%3DC.%2BF.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DWitvrouw%26aufirst%3DM.%26aulast%3DHeijtink%26aufirst%3DR.%26aulast%3DDe%2BClerq%26aufirst%3DE.%26aulast%3DMcGuigan%26aufirst%3DC.%26atitle%3DConversion%2520of%25202%25E2%2580%25B2%252C3%25E2%2580%25B2-dideoxyadenosine%2520%2528ddA%2529%2520and%25202%25E2%2580%25B2%252C3%25E2%2580%25B2-didehydro-2%25E2%2580%25B2%252C3%25E2%2580%25B2-dideoxyadenosine%2520%2528d4A%2529%2520to%2520their%2520corresponding%2520aryloxyphosphoramidate%2520derivatives%2520markedly%2520potentiates%2520their%2520activity%2520against%2520human%2520immunodeficiency%2520virus%2520and%2520hepatitis%2520B%2520virus%26jtitle%3DFEBS%2520Lett.%26date%3D1997%26volume%3D410%26spage%3D324%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheeka, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahmood, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, A.</span><span> </span><span class="NLM_article-title">Phosphate derivatives of d4T as inhibitors of HIV</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1203</span><span class="NLM_x">–</span> <span class="NLM_lpage">1206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1993&pages=1203-1206&author=C.+McGuiganauthor=H.+M.+Sheekaauthor=N.+Mahmoodauthor=A.+Hay&title=Phosphate+derivatives+of+d4T+as+inhibitors+of+HIV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DSheeka%26aufirst%3DH.%2BM.%26aulast%3DMahmood%26aufirst%3DN.%26aulast%3DHay%26aufirst%3DA.%26atitle%3DPhosphate%2520derivatives%2520of%2520d4T%2520as%2520inhibitors%2520of%2520HIV%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1993%26volume%3D3%26spage%3D1203%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheeka, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clerq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span> </span><span class="NLM_article-title">Arylphosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1748</span><span class="NLM_x">–</span> <span class="NLM_lpage">1753</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950605j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1748-1753&author=C.+McGuiganauthor=D.+Cahardauthor=H.+M.+Sheekaauthor=E.+De+Clerqauthor=J.+Balzarini&title=Arylphosphoramidate+derivatives+of+d4T+have+improved+anti-HIV+efficacy+in+tissue+culture+and+may+act+by+the+generation+of+a+novel+intracellular+metabolite"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm950605j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950605j%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DCahard%26aufirst%3DD.%26aulast%3DSheeka%26aufirst%3DH.%2BM.%26aulast%3DDe%2BClerq%26aufirst%3DE.%26aulast%3DBalzarini%26aufirst%3DJ.%26atitle%3DArylphosphoramidate%2520derivatives%2520of%2520d4T%2520have%2520improved%2520anti-HIV%2520efficacy%2520in%2520tissue%2520culture%2520and%2520may%2520act%2520by%2520the%2520generation%2520of%2520a%2520novel%2520intracellular%2520metabolite%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1748%26epage%3D1753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassan-Abdallah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daluge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peckham, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnette, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condreay, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span> </span><span class="NLM_article-title">Application of phosphoramidate protide technology significantly improves antiviral potency of carbocyclic adenosine derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7215</span><span class="NLM_x">–</span> <span class="NLM_lpage">7226</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060776w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOmtLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7215-7226&author=C.+McGuiganauthor=A.+Hassan-Abdallahauthor=S.+Srinivasanauthor=Y.+Wangauthor=A.+Siddiquiauthor=S.+M.+Dalugeauthor=K.+S.+Gudmundssonauthor=H.+Zhouauthor=E.+W.+McLeanauthor=J.+P.+Peckhamauthor=T.+C.+Burnetteauthor=H.+Marrauthor=R.+Hazenauthor=L.+D.+Condreayauthor=L.+Johnsonauthor=J.+Balzarini&title=Application+of+phosphoramidate+protide+technology+significantly+improves+antiviral+potency+of+carbocyclic+adenosine+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Application of phosphoramidate ProTide technology significantly improves antiviral potency of carbocyclic adenosine derivatives</span></div><div class="casAuthors">McGuigan, Christopher; Hassan-Abdallah, Alshaimaa; Srinivasan, Sheila; Wang, Yikang; Siddiqui, Adam; Daluge, Susan M.; Gudmundsson, Kristjan S.; Zhou, Huiqiang; McLean, Ed W.; Peckham, Jennifer P.; Burnette, Thimysta C.; Marr, Harry; Hazen, Richard; Condreay, Lynn D.; Johnson, Lance; Balzarini, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7215-7226</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the application of phosphoramidate pronucleotide (ProTide) technol. to the antiviral agent carbocyclic L-d4A (L-Cd4A).  The Ph Me alaninyl parent ProTide of L-Cd4A was prepd. by Grignard-mediated phosphorochloridate reaction and resulted in a compd. with significantly improved anti-HIV (2600-fold) and HBV activity.  We describe modifications of the aryl, ester, and amino acid regions of the ProTide and how these changes affect antiviral activity and metabolic stability.  Sep. and distinct SARs were noted for HIV and HBV.  Addnl., ProTides were prepd. from the D-nucleoside D-Cd4A and the dideoxy analogs L-CddA and D-CddA.  These compds. showed more modest potency improvements over the parent drug.  In conclusion, the ProTide approach is highly successful when applied to L-Cd4A with potency improvements in vitro as high as 9000-fold against HIV.  With a view to preclin. candidate selection we carried out metabolic stability studies using cynomolgus monkey liver and intestinal S9 fractions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnYwJaILYt0rVg90H21EOLACvtfcHk0lhk5MYFVpjYCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOmtLfN&md5=dc7f7592f250c3fb2f63817ecabc89dc</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm060776w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060776w%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DHassan-Abdallah%26aufirst%3DA.%26aulast%3DSrinivasan%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSiddiqui%26aufirst%3DA.%26aulast%3DDaluge%26aufirst%3DS.%2BM.%26aulast%3DGudmundsson%26aufirst%3DK.%2BS.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DMcLean%26aufirst%3DE.%2BW.%26aulast%3DPeckham%26aufirst%3DJ.%2BP.%26aulast%3DBurnette%26aufirst%3DT.%2BC.%26aulast%3DMarr%26aufirst%3DH.%26aulast%3DHazen%26aufirst%3DR.%26aulast%3DCondreay%26aufirst%3DL.%2BD.%26aulast%3DJohnson%26aufirst%3DL.%26aulast%3DBalzarini%26aufirst%3DJ.%26atitle%3DApplication%2520of%2520phosphoramidate%2520protide%2520technology%2520significantly%2520improves%2520antiviral%2520potency%2520of%2520carbocyclic%2520adenosine%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7215%26epage%3D7226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedgwood, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clerq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span> </span><span class="NLM_article-title">Phosphoramidate derivatives of 2′,3′-didehydro-2′,3′-dideoxyadenosine (d4A) have markedly improved anti-HIV potency and selectivity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2359</span><span class="NLM_x">–</span> <span class="NLM_lpage">2362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=2359-2362&author=C.+McGuiganauthor=O.+M.+Wedgwoodauthor=E.+De+Clerqauthor=J.+Balzarini&title=Phosphoramidate+derivatives+of+2%E2%80%B2%2C3%E2%80%B2-didehydro-2%E2%80%B2%2C3%E2%80%B2-dideoxyadenosine+%28d4A%29+have+markedly+improved+anti-HIV+potency+and+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DWedgwood%26aufirst%3DO.%2BM.%26aulast%3DDe%2BClerq%26aufirst%3DE.%26aulast%3DBalzarini%26aufirst%3DJ.%26atitle%3DPhosphoramidate%2520derivatives%2520of%25202%25E2%2580%25B2%252C3%25E2%2580%25B2-didehydro-2%25E2%2580%25B2%252C3%25E2%2580%25B2-dideoxyadenosine%2520%2528d4A%2529%2520have%2520markedly%2520improved%2520anti-HIV%2520potency%2520and%2520selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1996%26volume%3D6%26spage%3D2359%26epage%3D2362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Pierra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzaria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amador, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moussa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosselin, G.</span><span> </span><span class="NLM_article-title">NM283, an efficient prodrug of the potent anti-HCV agent 2′-methylcytidine</span> <span class="citation_source-journal">Nucleosides, Nucleotides Nucleic Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">767</span><span class="NLM_x">–</span> <span class="NLM_lpage">770</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1081%2FNCN-200060112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=16248033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFGisbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=767-770&author=C.+Pierraauthor=S.+Benzariaauthor=A.+Amadorauthor=A.+Moussaauthor=S.+Mathieuauthor=R.+Storerauthor=G.+Gosselin&title=NM283%2C+an+efficient+prodrug+of+the+potent+anti-HCV+agent+2%E2%80%B2-methylcytidine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">NM 283, an efficient prodrug of the potent anti-HCV agent 2'-C-methylcytidine</span></div><div class="casAuthors">Pierra, C.; Benzaria, S.; Amador, A.; Moussa, A.; Mathieu, S.; Storer, R.; Gosselin, G.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5-7</span>),
    <span class="NLM_cas:pages">767-770</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">In order to improve the oral bioavailability of 2'-C-methylcytidine, a potent anti-HCV agent, the corresponding 3'-O-L-valinyl ester deriv. (NM 283) has been synthesized.  Based on its ease of synthesis and its physicochem. properties, NM 283 has emerged as a promising antiviral drug for treatment of chronic HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoafc6FbtvUsrVg90H21EOLACvtfcHk0lhk5MYFVpjYCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFGisbbF&md5=50888c7dd06c8d49f1f56204c43f69a0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1081%2FNCN-200060112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FNCN-200060112%26sid%3Dliteratum%253Aachs%26aulast%3DPierra%26aufirst%3DC.%26aulast%3DBenzaria%26aufirst%3DS.%26aulast%3DAmador%26aufirst%3DA.%26aulast%3DMoussa%26aufirst%3DA.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DGosselin%26aufirst%3DG.%26atitle%3DNM283%252C%2520an%2520efficient%2520prodrug%2520of%2520the%2520potent%2520anti-HCV%2520agent%25202%25E2%2580%25B2-methylcytidine%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2005%26volume%3D24%26spage%3D767%26epage%3D770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Tang, X.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccirilli, J. A.</span><span> </span><span class="NLM_article-title">2′-C-Branched ribonucleosides: synthesis of the phosphoramidite derivatives of 2′-<i>C</i>-β-methylcytidine and their incorporation into oligonucleotides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo981329u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1999&pages=747-754&author=X.-Q.+Tangauthor=X.+Liaoauthor=J.+A.+Piccirilli&title=2%E2%80%B2-C-Branched+ribonucleosides%3A+synthesis+of+the+phosphoramidite+derivatives+of+2%E2%80%B2-C-%CE%B2-methylcytidine+and+their+incorporation+into+oligonucleotides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo981329u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo981329u%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DX.-Q.%26aulast%3DLiao%26aufirst%3DX.%26aulast%3DPiccirilli%26aufirst%3DJ.%2BA.%26atitle%3D2%25E2%2580%25B2-C-Branched%2520ribonucleosides%253A%2520synthesis%2520of%2520the%2520phosphoramidite%2520derivatives%2520of%25202%25E2%2580%25B2-C-%25CE%25B2-methylcytidine%2520and%2520their%2520incorporation%2520into%2520oligonucleotides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1999%26volume%3D64%26spage%3D747%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Uchiyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aso, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noyori, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, Y.</span><span> </span><span class="NLM_article-title">O-Selective phosphorylation of nucleosides without N-protection</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00054a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1993&pages=373-379&author=M.+Uchiyamaauthor=Y.+Asoauthor=R.+Noyoriauthor=Y.+Hayakawa&title=O-Selective+phosphorylation+of+nucleosides+without+N-protection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjo00054a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00054a020%26sid%3Dliteratum%253Aachs%26aulast%3DUchiyama%26aufirst%3DM.%26aulast%3DAso%26aufirst%3DY.%26aulast%3DNoyori%26aufirst%3DR.%26aulast%3DHayakawa%26aufirst%3DY.%26atitle%3DO-Selective%2520phosphorylation%2520of%2520nucleosides%2520without%2520N-protection%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1993%26volume%3D58%26spage%3D373%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuyang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yufen, Z.</span><span> </span><span class="NLM_article-title">Convenient and regioselective synthesis of nucleoside phosphoramidate monoesters</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1927</span><span class="NLM_x">–</span> <span class="NLM_lpage">1929</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=1927-1929&author=J.+Zhuauthor=H.+Fuauthor=J.+Yuyangauthor=Z.+Yufen&title=Convenient+and+regioselective+synthesis+of+nucleoside+phosphoramidate+monoesters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DYuyang%26aufirst%3DJ.%26aulast%3DYufen%26aufirst%3DZ.%26atitle%3DConvenient%2520and%2520regioselective%2520synthesis%2520of%2520nucleoside%2520phosphoramidate%2520monoesters%26jtitle%3DSynlett%26date%3D2005%26volume%3D12%26spage%3D1927%26epage%3D1929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daluge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnette, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condreay, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clerq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span> </span><span class="NLM_article-title">Application of phosphoramidate pronucleotide technology to abacavir leads to a significant enhancement of antiviral potency</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3504</span><span class="NLM_x">–</span> <span class="NLM_lpage">3515</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0491400" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjt1Okuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3504-3515&author=C.+McGuiganauthor=S.+A.+Harrisauthor=S.+M.+Dalugeauthor=K.+S.+Gudmundssonauthor=E.+W.+McLeanauthor=T.+C.+Burnetteauthor=H.+Marrauthor=R.+Hazenauthor=L.+D.+Condreayauthor=L.+Johnsonauthor=E.+De+Clerqauthor=J.+Balzarini&title=Application+of+phosphoramidate+pronucleotide+technology+to+abacavir+leads+to+a+significant+enhancement+of+antiviral+potency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Phosphoramidate Pronucleotide Technology to Abacavir Leads to a Significant Enhancement of Antiviral Potency</span></div><div class="casAuthors">McGuigan, Christopher; Harris, Sarah A.; Daluge, Susan M.; Gudmundsson, Kristjan S.; McLean, Ed W.; Burnette, Thimysta C.; Marr, Harry; Hazen, Richard; Condreay, Lynn D.; Johnson, Lance; De Clercq, Erik; Balzarini, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3504-3515</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the first application of pronucleotide (ProTide) technol. to the antiviral agent abacavir (Ziagen), used for the treatment of HIV infection.  The phenylmethoxyalaninyl phosphoramidate of abacavir was prepd. in good yield in one step.  Also prepd. was the corresponding phosphoramidate of the guanine nucleoside analog "carbovir".  The antiviral profile of each of the parent nucleosides was compared to that of the phosphoramidate ProTides.  A significant (28- to 60-fold) increase in anti-HIV potency was noted for the ProTide of abacavir but not for that of carbovir.  These findings were in agreement with the markedly higher (ca. 37-fold) levels of carbovir triphosphate that are formed in CEM cells upon response to the abacavir ProTide compared with the parent abacavir compd.  In contrast the anti-HBV potency of both abacavir and carbovir were improved (10- and 20-fold, resp.) by ProTide formation.  As in CEM cells, the abacavir ProTide provided significantly enhanced carbovir triphosphate levels in HepG2 2.2.15 cells over that of the parent nucleoside.  On the basis of these data, a series of phosphoramidate analogs with structural variation in the ester and amino acid regions were prepd. and their antiviral profiles described.  In addn., the pharmacokinetic disposition of the abacavir phenylethoxyalaninyl phosphoramidate was evaluated in Cynomolgus monkeys.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3b0LhbMvaULVg90H21EOLACvtfcHk0lg7uEIQeM74oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjt1Okuro%253D&md5=32ba0bb2d6648f0602f9bad08dd5e482</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm0491400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0491400%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DS.%2BA.%26aulast%3DDaluge%26aufirst%3DS.%2BM.%26aulast%3DGudmundsson%26aufirst%3DK.%2BS.%26aulast%3DMcLean%26aufirst%3DE.%2BW.%26aulast%3DBurnette%26aufirst%3DT.%2BC.%26aulast%3DMarr%26aufirst%3DH.%26aulast%3DHazen%26aufirst%3DR.%26aulast%3DCondreay%26aufirst%3DL.%2BD.%26aulast%3DJohnson%26aufirst%3DL.%26aulast%3DDe%2BClerq%26aufirst%3DE.%26aulast%3DBalzarini%26aufirst%3DJ.%26atitle%3DApplication%2520of%2520phosphoramidate%2520pronucleotide%2520technology%2520to%2520abacavir%2520leads%2520to%2520a%2520significant%2520enhancement%2520of%2520antiviral%2520potency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3504%26epage%3D3515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Congiatu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuigan, C.</span><span> </span><span class="NLM_article-title">Novel potential anticancer naphthyl phosphoramidates of BVdU: separation of diastereoisomers and assignment of the absolute configuration of the phosphorus center</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">452</span><span class="NLM_x">–</span> <span class="NLM_lpage">455</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0509896" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=452-455&author=C.+Congiatuauthor=A.+Brancaleauthor=M.+D.+Masonauthor=W.+G.+Jiangauthor=C.+McGuigan&title=Novel+potential+anticancer+naphthyl+phosphoramidates+of+BVdU%3A+separation+of+diastereoisomers+and+assignment+of+the+absolute+configuration+of+the+phosphorus+center"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm0509896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0509896%26sid%3Dliteratum%253Aachs%26aulast%3DCongiatu%26aufirst%3DC.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DMason%26aufirst%3DM.%2BD.%26aulast%3DJiang%26aufirst%3DW.%2BG.%26aulast%3DMcGuigan%26aufirst%3DC.%26atitle%3DNovel%2520potential%2520anticancer%2520naphthyl%2520phosphoramidates%2520of%2520BVdU%253A%2520separation%2520of%2520diastereoisomers%2520and%2520assignment%2520of%2520the%2520absolute%2520configuration%2520of%2520the%2520phosphorus%2520center%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D452%26epage%3D455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Siddiqui, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span> </span><span class="NLM_article-title">Enhancing the aqueous solubility of d4T-based phosphoramidate prodrugs</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=381-384&author=A.+Siddiquiauthor=C.+McGuiganauthor=C.+Ballatoreauthor=S.+Srinivasanauthor=E.+De+Clercqauthor=J.+Balzarini&title=Enhancing+the+aqueous+solubility+of+d4T-based+phosphoramidate+prodrugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqui%26aufirst%3DA.%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DSrinivasan%26aufirst%3DS.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DBalzarini%26aufirst%3DJ.%26atitle%3DEnhancing%2520the%2520aqueous%2520solubility%2520of%2520d4T-based%2520phosphoramidate%2520prodrugs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D381%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Morton, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iacono, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyatt, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheshire, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danks, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, P. M.</span><span> </span><span class="NLM_article-title">Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">629</span><span class="NLM_x">–</span> <span class="NLM_lpage">636</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1007%2Fs00280-005-1027-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=15918039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKqu7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2005&pages=629-636&author=C.+L.+Mortonauthor=L.+Iaconoauthor=J.+L.+Hyattauthor=K.+R.+Taylorauthor=P.+J.+Cheshireauthor=P.+J.+Houghtonauthor=M.+K.+Danksauthor=C.+F.+Stewartauthor=P.+M.+Potter&title=Activation+and+antitumor+activity+of+CPT-11+in+plasma+esterase-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice</span></div><div class="casAuthors">Morton, Christopher L.; Iacono, Lisa; Hyatt, Janice L.; Taylor, Kody R.; Cheshire, Pamela J.; Houghton, Peter J.; Danks, Mary K.; Stewart, Clinton F.; Potter, Philip M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">629-636</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: To examine the antitumor activity and the pharmacokinetics of CPT-11 (irinotecan, 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) in a plasma esterase-deficient scid mouse model, bearing human tumor xenografts.  Exptl. design: Plasma carboxylesterase (CE)-deficient mice were bred with scid animals to develop a strain that would allow growth of human tumor xenografts.  Following xenotransplantation, the effect of the plasma esterase on antitumor activity following CPT-11 administration was assessed.  In addn., detailed pharmacokinetic studies examg. plasma and biliary disposition of CPT-11 and its metabolites were performed.  Results: In mice lacking plasma carboxylesterase, the mean SN-38 systemic exposures were approx. fourfold less than that obsd. in control animals.  Consistent with the pharmacokinetic data, four to fivefold more CPT-11 was required to induce regressions in human Rh30 xenografts grown in esterase-deficient scid mice, as opposed to those grown in scid animals.  Addnl., the route of elimination of CPT-11, SN-38, and SN-38 glucuronide (SN-38G) was principally in the bile.  Conclusions: The pharmacokinetic profile for CPT-11 and its metabolites in the esterase-deficient mice more closely reflects that seen in humans.  Hence, these mice may represent a more accurate model for antitumor studies with this drug and other agents metabolized by CEs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosjcaJcbFkKrVg90H21EOLACvtfcHk0lg7uEIQeM74oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKqu7nF&md5=1144eab9d1cb06d91c75d3e1302c610b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs00280-005-1027-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-005-1027-y%26sid%3Dliteratum%253Aachs%26aulast%3DMorton%26aufirst%3DC.%2BL.%26aulast%3DIacono%26aufirst%3DL.%26aulast%3DHyatt%26aufirst%3DJ.%2BL.%26aulast%3DTaylor%26aufirst%3DK.%2BR.%26aulast%3DCheshire%26aufirst%3DP.%2BJ.%26aulast%3DHoughton%26aufirst%3DP.%2BJ.%26aulast%3DDanks%26aufirst%3DM.%2BK.%26aulast%3DStewart%26aufirst%3DC.%2BF.%26aulast%3DPotter%26aufirst%3DP.%2BM.%26atitle%3DActivation%2520and%2520antitumor%2520activity%2520of%2520CPT-11%2520in%2520plasma%2520esterase-deficient%2520mice%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2005%26volume%3D56%26spage%3D629%26epage%3D636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="note"><p class="first last">The initial concentration of compound <b>46b</b> was 1 μM. The degradation of the substrate was monitored by LC−MS/MS within a 2 h experiment incubating at 37 °C. The monitoring was carried out at the following time points: 0, 5, 10, 30, 60, and 120 min.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Pucci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonelli, F.</span><span> </span><span class="NLM_article-title">HILIC LC−MS for the determination of 2′-<i>C</i>-methyl-cytidine-triphosphate in rat liver</span> <span class="citation_source-journal">J. Sep. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1275</span><span class="NLM_x">–</span> <span class="NLM_lpage">1283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1002%2Fjssc.200800722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=19347863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1Kjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2009&pages=1275-1283&author=V.+Pucciauthor=C.+Giulianoauthor=R.+Zhangauthor=K.+A.+Koeplingerauthor=J.+F.+Leoneauthor=E.+Monteagudoauthor=F.+Bonelli&title=HILIC+LC%E2%88%92MS+for+the+determination+of+2%E2%80%B2-C-methyl-cytidine-triphosphate+in+rat+liver"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">HILIC LC-MS for the determination of 2'-C-methylcytidine-triphosphate in rat liver</span></div><div class="casAuthors">Pucci, Vincenzo; Giuliano, Claudio; Zhang, Rena; Koeplinger, Kenneth Alan; Leone, Joseph F.; Monteagudo, Edith; Bonelli, Fabio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Separation Science</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1275-1283</span>CODEN:
                <span class="NLM_cas:coden">JSSCCJ</span>;
        ISSN:<span class="NLM_cas:issn">1615-9306</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A very accurate and selective LC-MS/MS method was developed and validated for the quantification of 2'-C-modified nucleoside triphosphate in liver tissue samples.  An efficient pretreatment procedure of liver tissue samples was developed, using a fully automated SPE procedure with 96-well SPE plate (weak anion exchange sorbent, 30 mg).  Nucleotide hydrophilic interaction chromatog. has been performed on an aminopropyl column (100 mm × 2.0 mm, 3 μm) using a gradient mixt. of ACN and ACN/water (5:95 vol./vol.) with 20 mM ammonium acetate at pH 9.45 as mobile phase at 300 μL/min flow rate.  The 2'-C-modified nucleoside triphosphate was detected in the neg. ESI mode in multiple reaction monitoring (MRM) mode.  Calibration curve was linear over the 0.05-50 μM concn. range.  Satisfying results, confirming the high reliability of the established LC-MS/MS method, were obtained for intraday precision (CV = 2.5-9.1%) and accuracy (92.6-94.8%) and interday precision (CV = 9.6-11.5%) and accuracy (94.4-102.4%) as well as for recovery (82.0-112.6%) and selectivity.  The method has been successfully applied for pharmacokinetic studies of 2'-C-methyl-cytidine-triphosphate in liver tissue samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomFTcxsRh_vLVg90H21EOLACvtfcHk0lhUxRHoLvwWRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1Kjsrc%253D&md5=290a9d8a04b8dd890efc16499e6d79ac</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fjssc.200800722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjssc.200800722%26sid%3Dliteratum%253Aachs%26aulast%3DPucci%26aufirst%3DV.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DLeone%26aufirst%3DJ.%2BF.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DBonelli%26aufirst%3DF.%26atitle%3DHILIC%2520LC%25E2%2588%2592MS%2520for%2520the%2520determination%2520of%25202%25E2%2580%25B2-C-methyl-cytidine-triphosphate%2520in%2520rat%2520liver%26jtitle%3DJ.%2520Sep.%2520Sci.%26date%3D2009%26volume%3D32%26spage%3D1275%26epage%3D1283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span>Composition for 1 L in water: NaCl (2.0 g), pepsin (3.2 g), HCl (7 mL). Final pH of 1.2.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Composition+for+1+L+in+water%3A+NaCl+%282.0+g%29%2C+pepsin+%283.2+g%29%2C+HCl+%287+mL%29.+Final+pH+of+1.2."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span>Toxicological Profile for Phenol; 1-205; Agency for Toxic Substances and Disease Registry, U.S. Department of Health and Human Services: Atlanta, GA,<span class="NLM_x"> </span><span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Toxicological+Profile+for+Phenol%3B+1-205%3B+Agency+for+Toxic+Substances+and+Disease+Registry%2C+U.S.+Department+of+Health+and+Human+Services%3A+Atlanta%2C+GA%2C+1998."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Abraham, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntee, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidhya, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinazi, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, C. R.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity and decomposition studies of amino acid phosphomonoester amidates of Aciclovir</span> <span class="citation_source-journal">Nucleosides, Nucleotides Nucleic Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2079</span><span class="NLM_x">–</span> <span class="NLM_lpage">2092</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1080%2F07328319708002557" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADyaK2sXotVCqtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=2079-2092&author=T.+W.+Abrahamauthor=E.+J.+McInteeauthor=V.+I.+Vidhyaauthor=R.+F.+Schinaziauthor=C.+R.+Wagner&title=Synthesis+and+biological+activity+and+decomposition+studies+of+amino+acid+phosphomonoester+amidates+of+Aciclovir"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, biological activity and decomposition studies of amino acid phosphomonoester amidates of acyclovir</span></div><div class="casAuthors">Abraham, Timothy W.; Mcintee, Edward J.; Iyer, Vidhya V.; Schinazi, Raymond F.; Wagner, Carston R.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides & Nucleotides</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10 & 11</span>),
    <span class="NLM_cas:pages">2079-2092</span>CODEN:
                <span class="NLM_cas:coden">NUNUD5</span>;
        ISSN:<span class="NLM_cas:issn">0732-8311</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">Highly stable and water sol. amino acid phosphomonoester amidates of acyclovir (ACV) were synthesized and shown to function predominantly as prodrugs of ACV and not acyclovir monophosphate (ACV-MP) with activities within two fold of the amino acid prodrug of ACV, valaciclovir (VACV).  Metab. studies revealed that incubation of cell-free exts. of Vero cells with the L-leucine phosphomonoester amidate of ACV (3c), resulted in a burst of ACV-MP prodn. followed by the rapid generation of ACV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUk5K6LuI0ArVg90H21EOLACvtfcHk0lhUxRHoLvwWRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXotVCqtr8%253D&md5=61e0af839cfd823edc2ed8b3454c7f20</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1080%2F07328319708002557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07328319708002557%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DT.%2BW.%26aulast%3DMcIntee%26aufirst%3DE.%2BJ.%26aulast%3DVidhya%26aufirst%3DV.%2BI.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26aulast%3DWagner%26aufirst%3DC.%2BR.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520and%2520decomposition%2520studies%2520of%2520amino%2520acid%2520phosphomonoester%2520amidates%2520of%2520Aciclovir%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D1997%26volume%3D16%26spage%3D2079%26epage%3D2092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Chang, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griesgraber, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southern, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, C. R.</span><span> </span><span class="NLM_article-title">Amino acid phosphoramidate monoesters of 3′-azido-3′-deoxy-thymidine: relationship between antiviral potency and intracellular metabolism</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000260r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=223-231&author=S.+L.+Changauthor=G.+W.+Griesgraberauthor=P.+J.+Southernauthor=C.+R.+Wagner&title=Amino+acid+phosphoramidate+monoesters+of+3%E2%80%B2-azido-3%E2%80%B2-deoxy-thymidine%3A+relationship+between+antiviral+potency+and+intracellular+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm000260r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000260r%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DS.%2BL.%26aulast%3DGriesgraber%26aufirst%3DG.%2BW.%26aulast%3DSouthern%26aufirst%3DP.%2BJ.%26aulast%3DWagner%26aufirst%3DC.%2BR.%26atitle%3DAmino%2520acid%2520phosphoramidate%2520monoesters%2520of%25203%25E2%2580%25B2-azido-3%25E2%2580%25B2-deoxy-thymidine%253A%2520relationship%2520between%2520antiviral%2520potency%2520and%2520intracellular%2520metabolism%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D223%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Chang, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griesgraber, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, C. R.</span><span> </span><span class="NLM_article-title">Comparison of the antiviral activity of hydrophobic amino acid phosphoramidate monoesters of 2′,3′-dideoxyadenosine (DDA) and 3′-azido-3′-deoxythymidine (AZT)</span> <span class="citation_source-journal">Nucleosides, Nucleotides Nucleic Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1571</span><span class="NLM_x">–</span> <span class="NLM_lpage">1582</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1081%2FNCN-100105248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=11554546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFOht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=1571-1582&author=S.+L.+Changauthor=G.+W.+Griesgraberauthor=C.+R.+Wagner&title=Comparison+of+the+antiviral+activity+of+hydrophobic+amino+acid+phosphoramidate+monoesters+of+2%E2%80%B2%2C3%E2%80%B2-dideoxyadenosine+%28DDA%29+and+3%E2%80%B2-azido-3%E2%80%B2-deoxythymidine+%28AZT%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the antiviral activity of hydrophobic amino acid phosphoramidate monoesters of 2',3'-dideoxyadenosine (DDA) and 3'-azido-3'-deoxythymidine (AZT)</span></div><div class="casAuthors">Chang, Shu-Ling; Griesgraber, George; Wagner, Carston R.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1571-1582</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A series of hydrophobic, water sol. and non-toxic amino acid phosphoramidate monoesters of dideoxyadenosine (ddA) and 3'-azido-3'-deoxythymidine were shown to inhibit the replication of HIV-1 in human peripheral blood mononuclear cells (PBMC) from two donors.  The tryptophan Me ester phosphoramidates of AZT and ddA were equally potent (EC50S = 0.3-0.4 μM), while the Ph Me ester of ddA was 40- and 100- fold more potent than the AZT derivs.  The alaninyl Me ester of AZT was found to be 70- fold more potent than the ddA deriv.  The Me amide derivs. were found to be 5-20 fold less active than the Me esters for the ddA series, while for AZT the derivs. were found to be of similar potency or 60- to 166-fold more potent than the Me esters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjOMTnDH_qMbVg90H21EOLACvtfcHk0lhUxRHoLvwWRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFOht7k%253D&md5=81b5a13436fa2e24160eb320fe31f152</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1081%2FNCN-100105248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FNCN-100105248%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DS.%2BL.%26aulast%3DGriesgraber%26aufirst%3DG.%2BW.%26aulast%3DWagner%26aufirst%3DC.%2BR.%26atitle%3DComparison%2520of%2520the%2520antiviral%2520activity%2520of%2520hydrophobic%2520amino%2520acid%2520phosphoramidate%2520monoesters%2520of%25202%25E2%2580%25B2%252C3%25E2%2580%25B2-dideoxyadenosine%2520%2528DDA%2529%2520and%25203%25E2%2580%25B2-azido-3%25E2%2580%25B2-deoxythymidine%2520%2528AZT%2529%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2001%26volume%3D20%26spage%3D1571%26epage%3D1582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">McIntee, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remmel, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinazi, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, C. R.</span><span> </span><span class="NLM_article-title">Probing the mechanism of action and decomposition of amino acid phosphomonoester amidates of antiviral nucleoside prodrugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">3323</span><span class="NLM_x">–</span> <span class="NLM_lpage">3331</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm960694f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=3323-3331&author=E.+J.+McInteeauthor=R.+P.+Remmelauthor=R.+F.+Schinaziauthor=T.+W.+Abrahamauthor=C.+R.+Wagner&title=Probing+the+mechanism+of+action+and+decomposition+of+amino+acid+phosphomonoester+amidates+of+antiviral+nucleoside+prodrugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm960694f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960694f%26sid%3Dliteratum%253Aachs%26aulast%3DMcIntee%26aufirst%3DE.%2BJ.%26aulast%3DRemmel%26aufirst%3DR.%2BP.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26aulast%3DAbraham%26aufirst%3DT.%2BW.%26aulast%3DWagner%26aufirst%3DC.%2BR.%26atitle%3DProbing%2520the%2520mechanism%2520of%2520action%2520and%2520decomposition%2520of%2520amino%2520acid%2520phosphomonoester%2520amidates%2520of%2520antiviral%2520nucleoside%2520prodrugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D3323%26epage%3D3331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Wagner, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntee, E. J.</span><span> </span><span class="NLM_article-title">Pronucleotides: toward the in vivo delivery of antiviral and anticancer nucleotides</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1002%2F1098-1128%28200011%2920%3A6%3C417%3A%3AAID-MED1%3E3.0.CO%3B2-Z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=11058891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotVOiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=417-451&author=C.+R.+Wagnerauthor=V.+V.+Iyerauthor=E.+J.+McIntee&title=Pronucleotides%3A+toward+the+in+vivo+delivery+of+antiviral+and+anticancer+nucleotides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Pronucleotides: Toward the in vivo delivery of antiviral and anticancer nucleotides</span></div><div class="casAuthors">Wagner, Carston R.; Iyer, Vidhya V.; McIntee, Edward J.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">417-451</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review with 168 refs.  To overcome the many hurdles preventing the use of antiviral and anticancer nucleosides as therapeutics, the development of a prodrug methodol. (i.e., pronucleotide) for the in vivo delivery of nucleotides has been proposed as a soln.  The ideal pronucleotide should be non-toxic, stable in plasma and blood, capable of being i.v. and/or orally dosed, and intracellularly convertible to the corresponding nucleotide.  Although this goal has yet to be achieved, many clever and imaginative pronucleotide approaches have been developed, which are likely to be important pharmacol. tools.  This review will discuss the major advances and future directions of the emerging field of antiviral and anticancer pronucleotide design and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSvddFrhBi07Vg90H21EOLACvtfcHk0lgDwpLUkfGCyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotVOiurc%253D&md5=02a724f8be792902e021385c76371e63</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2F1098-1128%28200011%2920%3A6%3C417%3A%3AAID-MED1%3E3.0.CO%3B2-Z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1098-1128%2528200011%252920%253A6%253C417%253A%253AAID-MED1%253E3.0.CO%253B2-Z%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DC.%2BR.%26aulast%3DIyer%26aufirst%3DV.%2BV.%26aulast%3DMcIntee%26aufirst%3DE.%2BJ.%26atitle%3DPronucleotides%253A%2520toward%2520the%2520in%2520vivo%2520delivery%2520of%2520antiviral%2520and%2520anticancer%2520nucleotides%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2000%26volume%3D20%26spage%3D417%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Meppen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazzo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Paz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span> </span><span class="NLM_article-title">Cyclic phosphoramidates as prodrugs of 2′-<i>C</i>-methylcytidine</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3765</span><span class="NLM_x">–</span> <span class="NLM_lpage">3770</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=3765-3770&author=M.+Meppenauthor=B.+Paciniauthor=R.+Bazzoauthor=U.+Kochauthor=J.+F.+Leoneauthor=K.+A.+Koeplingerauthor=M.+Rowleyauthor=S.+Altamuraauthor=A.+Di+Marcoauthor=F.+Fioreauthor=C.+Giulianoauthor=O.+Gonzalez-Pazauthor=R.+Lauferauthor=V.+Pucciauthor=F.+Narjesauthor=C.+Gardelli&title=Cyclic+phosphoramidates+as+prodrugs+of+2%E2%80%B2-C-methylcytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeppen%26aufirst%3DM.%26aulast%3DPacini%26aufirst%3DB.%26aulast%3DBazzo%26aufirst%3DR.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DLeone%26aufirst%3DJ.%2BF.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DDi%2BMarco%26aufirst%3DA.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DGonzalez-Paz%26aufirst%3DO.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DPucci%26aufirst%3DV.%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DGardelli%26aufirst%3DC.%26atitle%3DCyclic%2520phosphoramidates%2520as%2520prodrugs%2520of%25202%25E2%2580%25B2-C-methylcytidine%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D3765%26epage%3D3770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Donghi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attenni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of novel phosphoramidate prodrugs of 2′-methyl cytidine as inhibitors of hepatitis C virus NS5B polymerase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1392</span><span class="NLM_x">–</span> <span class="NLM_lpage">1395</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1392-1395&author=M.+Donghiauthor=B.+Attenniauthor=C.+Gardelliauthor=A.+Di+Marcoauthor=F.+Fioreauthor=C.+Giulianoauthor=R.+Lauferauthor=J.+F.+Leoneauthor=V.+Pucciauthor=M.+Rowleyauthor=F.+Narjes&title=Synthesis+and+evaluation+of+novel+phosphoramidate+prodrugs+of+2%E2%80%B2-methyl+cytidine+as+inhibitors+of+hepatitis+C+virus+NS5B+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDonghi%26aufirst%3DM.%26aulast%3DAttenni%26aufirst%3DB.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DDi%2BMarco%26aufirst%3DA.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DLeone%26aufirst%3DJ.%2BF.%26aulast%3DPucci%26aufirst%3DV.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%2520phosphoramidate%2520prodrugs%2520of%25202%25E2%2580%25B2-methyl%2520cytidine%2520as%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1392%26epage%3D1395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':[],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 40 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Nicholas
A. Lentini, Chia-Hung Christine Hsiao, George B. Crull, Andrew J. Wiemer, <span class="NLM_string-name hlFld-ContribAuthor">David F. Wiemer</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Bioactivity of the Alanyl Phosphonamidate Stereoisomers Derived from a Butyrophilin Ligand. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (9)
                                     , 1284-1289. <a href="https://doi.org/10.1021/acsmedchemlett.9b00153" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00153%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BBioactivity%252Bof%252Bthe%252BAlanyl%252BPhosphonamidate%252BStereoisomers%252BDerived%252Bfrom%252Ba%252BButyrophilin%252BLigand%26aulast%3DLentini%26aufirst%3DNicholas%2BA.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D03042019%26date%3D06082019%26date%3D13082019%26date%3D06082019%26volume%3D10%26issue%3D9%26spage%3D1284%26epage%3D1289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aniekan  Okon</span>, <span class="hlFld-ContribAuthor ">Marcos Romário  Matos de Souza</span>, <span class="hlFld-ContribAuthor ">Rachit  Shah</span>, <span class="hlFld-ContribAuthor ">Raquel  Amorim</span>, <span class="hlFld-ContribAuthor ">Luciana Jesus  da Costa</span>, and <span class="hlFld-ContribAuthor ">Carston R.  Wagner</span>  . </span><span class="cited-content_cbyCitation_article-title">Anchimerically Activatable Antiviral ProTides. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (9)
                                     , 958-962. <a href="https://doi.org/10.1021/acsmedchemlett.7b00277" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00277</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00277%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAnchimerically%252BActivatable%252BAntiviral%252BProTides%26aulast%3DOkon%26aufirst%3DAniekan%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D08072017%26date%3D14082017%26date%3D24082017%26date%3D14092017%26date%3D14082017%26volume%3D8%26issue%3D9%26spage%3D958%26epage%3D962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Le  Zhen</span>, <span class="hlFld-ContribAuthor ">Liang  Dai</span>, <span class="hlFld-ContribAuthor ">Xiaoan  Wen</span>, <span class="hlFld-ContribAuthor ">Lan  Yao</span>, <span class="hlFld-ContribAuthor ">Xiaoliang  Jin</span>, <span class="hlFld-ContribAuthor ">Xiao-Wen  Yang</span>, <span class="hlFld-ContribAuthor ">Wenfeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Sheng-Qi  Yu</span>, <span class="hlFld-ContribAuthor ">Haoliang  Yuan</span>, <span class="hlFld-ContribAuthor ">Guangji  Wang</span>, and <span class="hlFld-ContribAuthor ">Hongbin  Sun</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Nucleotide Prodrugs with Improved Potency Against HCV Variants Carrying NS5B S282T Mutation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (14)
                                     , 6077-6088. <a href="https://doi.org/10.1021/acs.jmedchem.7b00262" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00262</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00262%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BNucleotide%252BProdrugs%252Bwith%252BImproved%252BPotency%252BAgainst%252BHCV%252BVariants%252BCarrying%252BNS5B%252BS282T%252BMutation%26aulast%3DZhen%26aufirst%3DLe%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D22022017%26date%3D10072017%26date%3D27072017%26date%3D26062017%26volume%3D60%26issue%3D14%26spage%3D6077%26epage%3D6088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ugo  Pradere</span>, <span class="hlFld-ContribAuthor ">Ethel C.  Garnier-Amblard</span>, <span class="hlFld-ContribAuthor ">Steven J.  Coats</span>, <span class="hlFld-ContribAuthor ">Franck  Amblard</span>, and <span class="hlFld-ContribAuthor ">Raymond F.  Schinazi</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2014,</strong> <em>114 </em>
                                    (18)
                                     , 9154-9218. <a href="https://doi.org/10.1021/cr5002035" title="DOI URL">https://doi.org/10.1021/cr5002035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr5002035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr5002035%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DSynthesis%252Bof%252BNucleoside%252BPhosphate%252Band%252BPhosphonate%252BProdrugs%26aulast%3DPradere%26aufirst%3DUgo%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D11042014%26date%3D21082014%26date%3D24092014%26volume%3D114%26issue%3D18%26spage%3D9154%26epage%3D9218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin A.  Mayes</span>, <span class="hlFld-ContribAuthor ">Jeevanandam  Arumugasamy</span>, <span class="hlFld-ContribAuthor ">Erkan  Baloglu</span>, <span class="hlFld-ContribAuthor ">David  Bauer</span>, <span class="hlFld-ContribAuthor ">Alan  Becker</span>, <span class="hlFld-ContribAuthor ">Narayan  Chaudhuri</span>, <span class="hlFld-ContribAuthor ">G. Mark  Latham</span>, <span class="hlFld-ContribAuthor ">Jie  Li</span>, <span class="hlFld-ContribAuthor ">Steve  Mathieu</span>, <span class="hlFld-ContribAuthor ">F. Patrick  McGarry</span>, <span class="hlFld-ContribAuthor ">Elodie  Rosinovsky</span>, <span class="hlFld-ContribAuthor ">Alistair  Stewart</span>, <span class="hlFld-ContribAuthor ">Christophe  Trochet</span>, <span class="hlFld-ContribAuthor ">Jingyang  Wang</span>, and <span class="hlFld-ContribAuthor ">Adel  Moussa</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of a Nucleoside Phosphoramidate Prodrug Inhibitor of HCV NS5B Polymerase: Phenylboronate as a Transient Protecting Group. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2014,</strong> <em>18 </em>
                                    (6)
                                     , 717-724. <a href="https://doi.org/10.1021/op500042u" title="DOI URL">https://doi.org/10.1021/op500042u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op500042u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop500042u%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DSynthesis%252Bof%252Ba%252BNucleoside%252BPhosphoramidate%252BProdrug%252BInhibitor%252Bof%252BHCV%252BNS5B%252BPolymerase%25253A%252BPhenylboronate%252Bas%252Ba%252BTransient%252BProtecting%252BGroup%26aulast%3DMayes%26aufirst%3DBenjamin%2BA.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D05022014%26date%3D21052014%26date%3D20062014%26volume%3D18%26issue%3D6%26spage%3D717%26epage%3D724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aesop  Cho</span>, <span class="hlFld-ContribAuthor ">Lijun  Zhang</span>, <span class="hlFld-ContribAuthor ">Jie  Xu</span>, <span class="hlFld-ContribAuthor ">Rick  Lee</span>, <span class="hlFld-ContribAuthor ">Thomas  Butler</span>, <span class="hlFld-ContribAuthor ">Sammy  Metobo</span>, <span class="hlFld-ContribAuthor ">Vangelis  Aktoudianakis</span>, <span class="hlFld-ContribAuthor ">Willard  Lew</span>, <span class="hlFld-ContribAuthor ">Hong  Ye</span>, <span class="hlFld-ContribAuthor ">Michael  Clarke</span>, <span class="hlFld-ContribAuthor ">Edward  Doerffler</span>, <span class="hlFld-ContribAuthor ">Daniel  Byun</span>, <span class="hlFld-ContribAuthor ">Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Darius  Babusis</span>, <span class="hlFld-ContribAuthor ">Anne C.  Carey</span>, <span class="hlFld-ContribAuthor ">Polina  German</span>, <span class="hlFld-ContribAuthor ">Dorothea  Sauer</span>, <span class="hlFld-ContribAuthor ">Weidong  Zhong</span>, <span class="hlFld-ContribAuthor ">Stephen  Rossi</span>, <span class="hlFld-ContribAuthor ">Martijn  Fenaux</span>, <span class="hlFld-ContribAuthor ">John G.  McHutchison</span>, <span class="hlFld-ContribAuthor ">Jason  Perry</span>, <span class="hlFld-ContribAuthor ">Joy  Feng</span>, <span class="hlFld-ContribAuthor ">Adrian S.  Ray</span>, and <span class="hlFld-ContribAuthor ">Choung U.  Kim</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of the First C-Nucleoside HCV Polymerase Inhibitor (GS-6620) with Demonstrated Antiviral Response in HCV Infected Patients. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 1812-1825. <a href="https://doi.org/10.1021/jm400201a" title="DOI URL">https://doi.org/10.1021/jm400201a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400201a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400201a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bthe%252BFirst%252BC-Nucleoside%252BHCV%252BPolymerase%252BInhibitor%252B%252528GS-6620%252529%252Bwith%252BDemonstrated%252BAntiviral%252BResponse%252Bin%252BHCV%252BInfected%252BPatients%26aulast%3DCho%26aufirst%3DAesop%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D07022013%26date%3D01052013%26date%3D13032014%26date%3D02042013%26volume%3D57%26issue%3D5%26spage%3D1812%26epage%3D1825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jong Hyun  Cho</span>, <span class="hlFld-ContribAuthor ">Steven J.  Coats</span>, and <span class="hlFld-ContribAuthor ">Raymond F.  Schinazi</span>  . </span><span class="cited-content_cbyCitation_article-title">Efficient Synthesis of Exo-N-carbamoyl Nucleosides: Application to the Synthesis of Phosphoramidate Prodrugs. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2012,</strong> <em>14 </em>
                                    (10)
                                     , 2488-2491. <a href="https://doi.org/10.1021/ol300777p" title="DOI URL">https://doi.org/10.1021/ol300777p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol300777p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol300777p%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DEfficient%252BSynthesis%252Bof%252BExo-N-carbamoyl%252BNucleosides%25253A%252BApplication%252Bto%252Bthe%252BSynthesis%252Bof%252BPhosphoramidate%252BProdrugs%26aulast%3DCho%26aufirst%3DJong%2BHyun%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D26032012%26date%3D03052012%26date%3D18052012%26volume%3D14%26issue%3D10%26spage%3D2488%26epage%3D2491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael J.  Sofia</span>, <span class="hlFld-ContribAuthor ">Wonsuk  Chang</span>, <span class="hlFld-ContribAuthor ">Phillip A.  Furman</span>, <span class="hlFld-ContribAuthor ">Ralph T.  Mosley</span>, and <span class="hlFld-ContribAuthor ">Bruce S.  Ross</span>  . </span><span class="cited-content_cbyCitation_article-title">Nucleoside, Nucleotide, and Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B RNA-Dependent RNA-Polymerase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (6)
                                     , 2481-2531. <a href="https://doi.org/10.1021/jm201384j" title="DOI URL">https://doi.org/10.1021/jm201384j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201384j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201384j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNucleoside%25252C%252BNucleotide%25252C%252Band%252BNon-Nucleoside%252BInhibitors%252Bof%252BHepatitis%252BC%252BVirus%252BNS5B%252BRNA-Dependent%252BRNA-Polymerase%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D13102011%26date%3D23012012%26date%3D22032012%26date%3D16122011%26volume%3D55%26issue%3D6%26spage%3D2481%26epage%3D2531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruce S.  Ross</span>, <span class="hlFld-ContribAuthor ">P.  Ganapati Reddy</span>, <span class="hlFld-ContribAuthor ">Hai-Ren  Zhang</span>, <span class="hlFld-ContribAuthor ">Suguna  Rachakonda</span>, and <span class="hlFld-ContribAuthor ">Michael J.  Sofia</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of Diastereomerically Pure Nucleotide Phosphoramidates. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2011,</strong> <em>76 </em>
                                    (20)
                                     , 8311-8319. <a href="https://doi.org/10.1021/jo201492m" title="DOI URL">https://doi.org/10.1021/jo201492m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo201492m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo201492m%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BDiastereomerically%252BPure%252BNucleotide%252BPhosphoramidates%26aulast%3DRoss%26aufirst%3DBruce%2BS.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D18072011%26date%3D26092011%26date%3D21102011%26date%3D14092011%26volume%3D76%26issue%3D20%26spage%3D8311%26epage%3D8319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina Arbelo  Roman</span>, <span class="hlFld-ContribAuthor ">Jan  Balzarini</span>, and <span class="hlFld-ContribAuthor ">Chris  Meier</span>  . </span><span class="cited-content_cbyCitation_article-title">Diastereoselective Synthesis of Aryloxy Phosphoramidate Prodrugs of 3′-Deoxy-2′,3′-didehydrothymidine Monophosphate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (21)
                                     , 7675-7681. <a href="https://doi.org/10.1021/jm100817f" title="DOI URL">https://doi.org/10.1021/jm100817f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100817f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100817f%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiastereoselective%252BSynthesis%252Bof%252BAryloxy%252BPhosphoramidate%252BProdrugs%252Bof%252B3%2525E2%252580%2525B2-Deoxy-2%2525E2%252580%2525B2%25252C3%2525E2%252580%2525B2-didehydrothymidine%252BMonophosphate%26aulast%3DRoman%26aufirst%3DCristina%2BArbelo%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D02072010%26date%3D14102010%26date%3D11112010%26volume%3D53%26issue%3D21%26spage%3D7675%26epage%3D7681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael J.  Sofia</span>, <span class="hlFld-ContribAuthor ">Donghui  Bao</span>, <span class="hlFld-ContribAuthor ">Wonsuk  Chang</span>, <span class="hlFld-ContribAuthor ">Jinfa  Du</span>, <span class="hlFld-ContribAuthor ">Dhanapalan  Nagarathnam</span>, <span class="hlFld-ContribAuthor ">Suguna  Rachakonda</span>, <span class="hlFld-ContribAuthor ">P. Ganapati  Reddy</span>, <span class="hlFld-ContribAuthor ">Bruce S.  Ross</span>, <span class="hlFld-ContribAuthor ">Peiyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Hai-Ren  Zhang</span>, <span class="hlFld-ContribAuthor ">Shalini  Bansal</span>, <span class="hlFld-ContribAuthor ">Christine  Espiritu</span>, <span class="hlFld-ContribAuthor ">Meg  Keilman</span>, <span class="hlFld-ContribAuthor ">Angela M.  Lam</span>, <span class="hlFld-ContribAuthor ">Holly M. Micolochick  Steuer</span>, <span class="hlFld-ContribAuthor ">Congrong  Niu</span>, <span class="hlFld-ContribAuthor ">Michael J.  Otto</span>, and <span class="hlFld-ContribAuthor ">Phillip A.  Furman</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a β-d-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (19)
                                     , 7202-7218. <a href="https://doi.org/10.1021/jm100863x" title="DOI URL">https://doi.org/10.1021/jm100863x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100863x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100863x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252B%2525CE%2525B2-d-2%2525E2%252580%2525B2-Deoxy-2%2525E2%252580%2525B2-%2525CE%2525B1-fluoro-2%2525E2%252580%2525B2-%2525CE%2525B2-C-methyluridine%252BNucleotide%252BProdrug%252B%252528PSI-7977%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D10072010%26date%3D16092010%26date%3D14102010%26volume%3D53%26issue%3D19%26spage%3D7202%26epage%3D7218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nanci  Santos-Ferreira</span>, <span class="hlFld-ContribAuthor ">Jana  Van Dycke</span>, <span class="hlFld-ContribAuthor ">Johan  Neyts</span>, <span class="hlFld-ContribAuthor ">Joana  Rocha-Pereira</span>. </span><span class="cited-content_cbyCitation_article-title">Current and Future Antiviral Strategies to Tackle Gastrointestinal Viral Infections. </span><span class="cited-content_cbyCitation_journal-name">Microorganisms</span><span> <strong>2021,</strong> <em>9 </em>
                                    (8)
                                     , 1599. <a href="https://doi.org/10.3390/microorganisms9081599" title="DOI URL">https://doi.org/10.3390/microorganisms9081599</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/microorganisms9081599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmicroorganisms9081599%26sid%3Dliteratum%253Aachs%26jtitle%3DMicroorganisms%26atitle%3DCurrent%252Band%252BFuture%252BAntiviral%252BStrategies%252Bto%252BTackle%252BGastrointestinal%252BViral%252BInfections%26aulast%3DSantos-Ferreira%26aufirst%3DNanci%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D8%26spage%3D1599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sonam  Bhatia</span>, <span class="hlFld-ContribAuthor ">Naveen  Narayanan</span>, <span class="hlFld-ContribAuthor ">Shilpi  Nagpal</span>, <span class="hlFld-ContribAuthor ">Deepak T.  Nair</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral therapeutics directed against RNA dependent RNA polymerases from positive-sense viruses. </span><span class="cited-content_cbyCitation_journal-name">Molecular Aspects of Medicine</span><span> <strong>2021,</strong> <em>8 </em>, 101005. <a href="https://doi.org/10.1016/j.mam.2021.101005" title="DOI URL">https://doi.org/10.1016/j.mam.2021.101005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mam.2021.101005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mam.2021.101005%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Aspects%2520of%2520Medicine%26atitle%3DAntiviral%252Btherapeutics%252Bdirected%252Bagainst%252BRNA%252Bdependent%252BRNA%252Bpolymerases%252Bfrom%252Bpositive-sense%252Bviruses%26aulast%3DBhatia%26aufirst%3DSonam%26date%3D2021%26volume%3D8%26spage%3D101005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-Fei  Yang</span>, <span class="hlFld-ContribAuthor ">Chung-Min  Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Norovirus: Clinical Findings and Pharmaceutical Developments. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.5772/intechopen.97091" title="DOI URL">https://doi.org/10.5772/intechopen.97091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5772/intechopen.97091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5772%2Fintechopen.97091%26sid%3Dliteratum%253Aachs%26atitle%3DNorovirus%25253A%252BClinical%252BFindings%252Band%252BPharmaceutical%252BDevelopments%26aulast%3DYang%26aufirst%3DYing-Fei%26date%3D2021%26date%3D2021%26pub%3DIntechOpen%26atitle%3DNorovirus%252B%25255BWorking%252BTitle%25255D%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keivan  Zandi</span>, <span class="hlFld-ContribAuthor ">Franck  Amblard</span>, <span class="hlFld-ContribAuthor ">Sarah  Amichai</span>, <span class="hlFld-ContribAuthor ">Leda  Bassit</span>, <span class="hlFld-ContribAuthor ">Sijia  Tao</span>, <span class="hlFld-ContribAuthor ">Yong  Jiang</span>, <span class="hlFld-ContribAuthor ">Longhu  Zhou</span>, <span class="hlFld-ContribAuthor ">Olivia  Ollinger Russell</span>, <span class="hlFld-ContribAuthor ">Seema  Mengshetti</span>, <span class="hlFld-ContribAuthor ">Raymond F.  Schinazi</span>. </span><span class="cited-content_cbyCitation_article-title">Nucleoside Analogs with Antiviral Activity against Yellow Fever Virus. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2019,</strong> <em>63 </em>
                                    (9)
                                     <a href="https://doi.org/10.1128/AAC.00889-19" title="DOI URL">https://doi.org/10.1128/AAC.00889-19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00889-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00889-19%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DNucleoside%252BAnalogs%252Bwith%252BAntiviral%252BActivity%252Bagainst%252BYellow%252BFever%252BVirus%26aulast%3DZandi%26aufirst%3DKeivan%26date%3D2019%26volume%3D63%26issue%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalie E.  Netzler</span>, <span class="hlFld-ContribAuthor ">Daniel  Enosi Tuipulotu</span>, <span class="hlFld-ContribAuthor ">Peter A.  White</span>. </span><span class="cited-content_cbyCitation_article-title">Norovirus antivirals: Where are we now?. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (3)
                                     , 860-886. <a href="https://doi.org/10.1002/med.21545" title="DOI URL">https://doi.org/10.1002/med.21545</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21545%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DNorovirus%252Bantivirals%25253A%252BWhere%252Bare%252Bwe%252Bnow%25253F%26aulast%3DNetzler%26aufirst%3DNatalie%2BE.%26date%3D2019%26date%3D2018%26volume%3D39%26issue%3D3%26spage%3D860%26epage%3D886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cyril B  Dousson</span>. </span><span class="cited-content_cbyCitation_article-title">Current and future use of nucleo(s)tide prodrugs in the treatment of hepatitis C virus infection. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Chemistry and Chemotherapy</span><span> <strong>2018,</strong> <em>26 </em>, 204020661875643. <a href="https://doi.org/10.1177/2040206618756430" title="DOI URL">https://doi.org/10.1177/2040206618756430</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2040206618756430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2040206618756430%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Chemistry%2520and%2520Chemotherapy%26atitle%3DCurrent%252Band%252Bfuture%252Buse%252Bof%252Bnucleo%252528s%252529tide%252Bprodrugs%252Bin%252Bthe%252Btreatment%252Bof%252Bhepatitis%252BC%252Bvirus%252Binfection%26aulast%3DDousson%26aufirst%3DCyril%2BB%26date%3D2018%26date%3D2018%26volume%3D26%26spage%3D204020661875643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">François-René  Alexandre</span>, <span class="hlFld-ContribAuthor ">Eric  Badaroux</span>, <span class="hlFld-ContribAuthor ">John P.  Bilello</span>, <span class="hlFld-ContribAuthor ">Stéphanie  Bot</span>, <span class="hlFld-ContribAuthor ">Tony  Bouisset</span>, <span class="hlFld-ContribAuthor ">Guillaume  Brandt</span>, <span class="hlFld-ContribAuthor ">Sylvie  Cappelle</span>, <span class="hlFld-ContribAuthor ">Christopher  Chapron</span>, <span class="hlFld-ContribAuthor ">Dominique  Chaves</span>, <span class="hlFld-ContribAuthor ">Thierry  Convard</span>, <span class="hlFld-ContribAuthor ">Clément  Counor</span>, <span class="hlFld-ContribAuthor ">Daniel  Da Costa</span>, <span class="hlFld-ContribAuthor ">David  Dukhan</span>, <span class="hlFld-ContribAuthor ">Marion  Gay</span>, <span class="hlFld-ContribAuthor ">Gilles  Gosselin</span>, <span class="hlFld-ContribAuthor ">Jean-François  Griffon</span>, <span class="hlFld-ContribAuthor ">Kusum  Gupta</span>, <span class="hlFld-ContribAuthor ">Brenda  Hernandez-Santiago</span>, <span class="hlFld-ContribAuthor ">Massimiliano  La Colla</span>, <span class="hlFld-ContribAuthor ">Marie-Pierre  Lioure</span>, <span class="hlFld-ContribAuthor ">Julien  Milhau</span>, <span class="hlFld-ContribAuthor ">Jean-Laurent  Paparin</span>, <span class="hlFld-ContribAuthor ">Jérôme  Peyronnet</span>, <span class="hlFld-ContribAuthor ">Christophe  Parsy</span>, <span class="hlFld-ContribAuthor ">Claire  Pierra Rouvière</span>, <span class="hlFld-ContribAuthor ">Houcine  Rahali</span>, <span class="hlFld-ContribAuthor ">Rachid  Rahali</span>, <span class="hlFld-ContribAuthor ">Aurélien  Salanson</span>, <span class="hlFld-ContribAuthor ">Maria  Seifer</span>, <span class="hlFld-ContribAuthor ">Ilaria  Serra</span>, <span class="hlFld-ContribAuthor ">David  Standring</span>, <span class="hlFld-ContribAuthor ">Dominique  Surleraux</span>, <span class="hlFld-ContribAuthor ">Cyril B.  Dousson</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery of IDX21437: Design, synthesis and antiviral evaluation of 2′-α-chloro-2′-β-C-methyl branched uridine pronucleotides as potent liver-targeted HCV polymerase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (18)
                                     , 4323-4330. <a href="https://doi.org/10.1016/j.bmcl.2017.08.029" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.08.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.08.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdiscovery%252Bof%252BIDX21437%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bantiviral%252Bevaluation%252Bof%252B2%2525E2%252580%2525B2-%2525CE%2525B1-chloro-2%2525E2%252580%2525B2-%2525CE%2525B2-C-methyl%252Bbranched%252Buridine%252Bpronucleotides%252Bas%252Bpotent%252Bliver-targeted%252BHCV%252Bpolymerase%252Binhibitors%26aulast%3DAlexandre%26aufirst%3DFran%25C3%25A7ois-Ren%25C3%25A9%26date%3D2017%26volume%3D27%26issue%3D18%26spage%3D4323%26epage%3D4330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei Zhu  Chen</span>, <span class="hlFld-ContribAuthor ">Hua  Fang</span>, <span class="hlFld-ContribAuthor ">Rui Zao  Yi</span>, <span class="hlFld-ContribAuthor ">Zhuan  Hong</span>, <span class="hlFld-ContribAuthor ">Yu Fen  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Separation of antiviral nucleoside phosphoramidate diastereomers by analytical supercritical fluid chromatography. </span><span class="cited-content_cbyCitation_journal-name">Phosphorus, Sulfur, and Silicon and the Related Elements</span><span> <strong>2016,</strong> <em>191 </em>
                                    (6)
                                     , 913-918. <a href="https://doi.org/10.1080/10426507.2015.1114946" title="DOI URL">https://doi.org/10.1080/10426507.2015.1114946</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10426507.2015.1114946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10426507.2015.1114946%26sid%3Dliteratum%253Aachs%26jtitle%3DPhosphorus%252C%2520Sulfur%252C%2520and%2520Silicon%2520and%2520the%2520Related%2520Elements%26atitle%3DSeparation%252Bof%252Bantiviral%252Bnucleoside%252Bphosphoramidate%252Bdiastereomers%252Bby%252Banalytical%252Bsupercritical%252Bfluid%252Bchromatography%26aulast%3DChen%26aufirst%3DWei%2BZhu%26date%3D2016%26date%3D2016%26volume%3D191%26issue%3D6%26spage%3D913%26epage%3D918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ülkü  Yılmaz</span>, <span class="hlFld-ContribAuthor ">Hasan  Küçükbay</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and characterization of novel phosphoramidates containing benzimidazole moiety. </span><span class="cited-content_cbyCitation_journal-name">Phosphorus, Sulfur, and Silicon and the Related Elements</span><span> <strong>2016,</strong> <em>191 </em>
                                    (1)
                                     , 140-143. <a href="https://doi.org/10.1080/10426507.2015.1067209" title="DOI URL">https://doi.org/10.1080/10426507.2015.1067209</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10426507.2015.1067209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10426507.2015.1067209%26sid%3Dliteratum%253Aachs%26jtitle%3DPhosphorus%252C%2520Sulfur%252C%2520and%2520Silicon%2520and%2520the%2520Related%2520Elements%26atitle%3DSynthesis%252Band%252Bcharacterization%252Bof%252Bnovel%252Bphosphoramidates%252Bcontaining%252Bbenzimidazole%252Bmoiety%26aulast%3DY%25C4%25B1lmaz%26aufirst%3D%25C3%259Clk%25C3%25BC%26date%3D2016%26date%3D2016%26volume%3D191%26issue%3D1%26spage%3D140%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raymond F.  Schinazi</span>, <span class="hlFld-ContribAuthor ">Junxing  Shi</span>, <span class="hlFld-ContribAuthor ">Tony  Whitaker</span>. </span><span class="cited-content_cbyCitation_article-title">Sofosbuvir (Sovaldi): The First-in-Class HCV NS5B Nucleotide Polymerase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 61-80. <a href="https://doi.org/10.1002/9781118819951.ch4" title="DOI URL">https://doi.org/10.1002/9781118819951.ch4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118819951.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118819951.ch4%26sid%3Dliteratum%253Aachs%26atitle%3DSofosbuvir%252B%252528Sovaldi%252529%25253A%252BThe%252BFirst-in-Class%252BHCV%252BNS5B%252BNucleotide%252BPolymerase%252BInhibitor%26aulast%3DSchinazi%26aufirst%3DRaymond%2BF.%26date%3D2015%26date%3D2015%26spage%3D61%26epage%3D80%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DInnovative%252BDrug%252BSynthesis%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2015%26volume%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanchao  Xie</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>, <span class="hlFld-ContribAuthor ">Guanghui  Tian</span>, <span class="hlFld-ContribAuthor ">Mingshuo  Xu</span>, <span class="hlFld-ContribAuthor ">Tianwen  Hu</span>, <span class="hlFld-ContribAuthor ">Xiangrui  Jiang</span>, <span class="hlFld-ContribAuthor ">Jingshan  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">A neighboring group participation strategy: facile synthesis of 3,5-di-O-benzoyl-2-C-methyl-d-arabino-γ-lactone. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2015,</strong> <em>56 </em>
                                    (29)
                                     , 4345-4348. <a href="https://doi.org/10.1016/j.tetlet.2015.05.085" title="DOI URL">https://doi.org/10.1016/j.tetlet.2015.05.085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2015.05.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2015.05.085%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bneighboring%252Bgroup%252Bparticipation%252Bstrategy%25253A%252Bfacile%252Bsynthesis%252Bof%252B3%25252C5-di-O-benzoyl-2-C-methyl-d-arabino-%2525CE%2525B3-lactone%26aulast%3DXie%26aufirst%3DYuanchao%26date%3D2015%26volume%3D56%26issue%3D29%26spage%3D4345%26epage%3D4348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Munmun  Maiti</span>, <span class="hlFld-ContribAuthor ">Mohitosh  Maiti</span>, <span class="hlFld-ContribAuthor ">Jef  Rozenski</span>, <span class="hlFld-ContribAuthor ">Steven  De Jonghe</span>, <span class="hlFld-ContribAuthor ">Piet  Herdewijn</span>. </span><span class="cited-content_cbyCitation_article-title">Aspartic acid based nucleoside phosphoramidate prodrugs as potent inhibitors of hepatitis C virus replication. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2015,</strong> <em>13 </em>
                                    (18)
                                     , 5158-5174. <a href="https://doi.org/10.1039/C5OB00427F" title="DOI URL">https://doi.org/10.1039/C5OB00427F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB00427F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB00427F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DAspartic%252Bacid%252Bbased%252Bnucleoside%252Bphosphoramidate%252Bprodrugs%252Bas%252Bpotent%252Binhibitors%252Bof%252Bhepatitis%252BC%252Bvirus%252Breplication%26aulast%3DMaiti%26aufirst%3DMunmun%26date%3D2015%26date%3D2015%26volume%3D13%26issue%3D18%26spage%3D5158%26epage%3D5174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qun  Dang</span>, <span class="hlFld-ContribAuthor ">Zhibo  Zhang</span>, <span class="hlFld-ContribAuthor ">Bingyu  Tang</span>, <span class="hlFld-ContribAuthor ">Yang  Song</span>, <span class="hlFld-ContribAuthor ">Ling  Wu</span>, <span class="hlFld-ContribAuthor ">Tongqian  Chen</span>, <span class="hlFld-ContribAuthor ">Stephane  Bogen</span>, <span class="hlFld-ContribAuthor ">Vinay  Girijavallabhan</span>, <span class="hlFld-ContribAuthor ">David B.  Olsen</span>, <span class="hlFld-ContribAuthor ">Peter T.  Meinke</span>. </span><span class="cited-content_cbyCitation_article-title">Syntheses of nucleosides with 2′-spirolactam and 2′-spiropyrrolidine moieties as potential inhibitors of hepatitis C virus NS5B polymerase. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2014,</strong> <em>55 </em>
                                    (28)
                                     , 3813-3816. <a href="https://doi.org/10.1016/j.tetlet.2014.05.051" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.05.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.05.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.05.051%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSyntheses%252Bof%252Bnucleosides%252Bwith%252B2%2525E2%252580%2525B2-spirolactam%252Band%252B2%2525E2%252580%2525B2-spiropyrrolidine%252Bmoieties%252Bas%252Bpotential%252Binhibitors%252Bof%252Bhepatitis%252BC%252Bvirus%252BNS5B%252Bpolymerase%26aulast%3DDang%26aufirst%3DQun%26date%3D2014%26volume%3D55%26issue%3D28%26spage%3D3813%26epage%3D3816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stuart S.  Kaufman</span>, <span class="hlFld-ContribAuthor ">Kim Y.  Green</span>, <span class="hlFld-ContribAuthor ">Brent E.  Korba</span>. </span><span class="cited-content_cbyCitation_article-title">Treatment of norovirus infections: Moving antivirals from the bench to the bedside. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2014,</strong> <em>105 </em>, 80-91. <a href="https://doi.org/10.1016/j.antiviral.2014.02.012" title="DOI URL">https://doi.org/10.1016/j.antiviral.2014.02.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2014.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2014.02.012%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DTreatment%252Bof%252Bnorovirus%252Binfections%25253A%252BMoving%252Bantivirals%252Bfrom%252Bthe%252Bbench%252Bto%252Bthe%252Bbedside%26aulast%3DKaufman%26aufirst%3DStuart%2BS.%26date%3D2014%26volume%3D105%26spage%3D80%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew J.  Wiemer</span>, <span class="hlFld-ContribAuthor ">David F.  Wiemer</span>. </span><span class="cited-content_cbyCitation_article-title">Prodrugs of Phosphonates and Phosphates: Crossing the Membrane Barrier. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 115-160. <a href="https://doi.org/10.1007/128_2014_561" title="DOI URL">https://doi.org/10.1007/128_2014_561</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/128_2014_561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F128_2014_561%26sid%3Dliteratum%253Aachs%26atitle%3DProdrugs%252Bof%252BPhosphonates%252Band%252BPhosphates%25253A%252BCrossing%252Bthe%252BMembrane%252BBarrier%26aulast%3DWiemer%26aufirst%3DAndrew%2BJ.%26date%3D2014%26date%3D2014%26spage%3D115%26epage%3D160%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DPhosphorus%252BChemistry%252BI%26aulast%3DMontchamp%26aufirst%3DJean-Luc%26date%3D2015%26volume%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michal  Sobkowski</span>, <span class="hlFld-ContribAuthor ">Adam  Kraszewski</span>, <span class="hlFld-ContribAuthor ">Jacek  Stawinski</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in H-Phosphonate Chemistry. Part 1. H-Phosphonate Esters: Synthesis and Basic Reactions. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 137-177. <a href="https://doi.org/10.1007/128_2014_562" title="DOI URL">https://doi.org/10.1007/128_2014_562</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/128_2014_562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F128_2014_562%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BAdvances%252Bin%252BH-Phosphonate%252BChemistry.%252BPart%252B1.%252BH-Phosphonate%252BEsters%25253A%252BSynthesis%252Band%252BBasic%252BReactions%26aulast%3DSobkowski%26aufirst%3DMichal%26date%3D2014%26date%3D2014%26spage%3D137%26epage%3D177%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DPhosphorus%252BChemistry%252BII%26aulast%3DMontchamp%26aufirst%3DJean-Luc%26date%3D2015%26volume%3D361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabrício M.  Oliveira</span>, <span class="hlFld-ContribAuthor ">Luiz C. A.  Barbosa</span>, <span class="hlFld-ContribAuthor ">Fyaz M. D.  Ismail</span>. </span><span class="cited-content_cbyCitation_article-title">The diverse pharmacology and medicinal chemistry of phosphoramidates – a review. </span><span class="cited-content_cbyCitation_journal-name">RSC Adv.</span><span> <strong>2014,</strong> <em>4 </em>
                                    (36)
                                     , 18998-19012. <a href="https://doi.org/10.1039/C4RA01454E" title="DOI URL">https://doi.org/10.1039/C4RA01454E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA01454E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA01454E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Adv.%26atitle%3DThe%252Bdiverse%252Bpharmacology%252Band%252Bmedicinal%252Bchemistry%252Bof%252Bphosphoramidates%252B%2525E2%252580%252593%252Ba%252Breview%26aulast%3DOliveira%26aufirst%3DFabr%25C3%25ADcio%2BM.%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D36%26spage%3D18998%26epage%3D19012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Jiang</span>, <span class="hlFld-ContribAuthor ">Nagraj  Mani</span>, <span class="hlFld-ContribAuthor ">Chao  Lin</span>, <span class="hlFld-ContribAuthor ">Andrzej  Ardzinski</span>, <span class="hlFld-ContribAuthor ">Michelle  Nelson</span>, <span class="hlFld-ContribAuthor ">Dugan  Reagan</span>, <span class="hlFld-ContribAuthor ">Doug  Bartels</span>, <span class="hlFld-ContribAuthor ">Yi  Zhou</span>, <span class="hlFld-ContribAuthor ">Olivier  Nicolas</span>, <span class="hlFld-ContribAuthor ">B. Govinda  Rao</span>, <span class="hlFld-ContribAuthor ">Ute  Müh</span>, <span class="hlFld-ContribAuthor ">Brian  Hanzelka</span>, <span class="hlFld-ContribAuthor ">Ann  Tigges</span>, <span class="hlFld-ContribAuthor ">Rene  Rijnbrand</span>, <span class="hlFld-ContribAuthor ">Tara L.  Kieffer</span>. </span><span class="cited-content_cbyCitation_article-title">In Vitro
              Phenotypic Characterization of Hepatitis C Virus NS3 Protease Variants Observed in Clinical Studies of Telaprevir. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2013,</strong> <em>57 </em>
                                    (12)
                                     , 6236-6245. <a href="https://doi.org/10.1128/AAC.01578-13" title="DOI URL">https://doi.org/10.1128/AAC.01578-13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.01578-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.01578-13%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DIn%252BVitro%252BPhenotypic%252BCharacterization%252Bof%252BHepatitis%252BC%252BVirus%252BNS3%252BProtease%252BVariants%252BObserved%252Bin%252BClinical%252BStudies%252Bof%252BTelaprevir%26aulast%3DJiang%26aufirst%3DMin%26date%3D2013%26date%3D2013%26volume%3D57%26issue%3D12%26spage%3D6236%26epage%3D6245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael J.  Sofia</span>. </span><span class="cited-content_cbyCitation_article-title">Nucleotide Prodrugs for the Treatment of HCV Infection. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 39-73. <a href="https://doi.org/10.1016/B978-0-12-405880-4.00002-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-405880-4.00002-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-405880-4.00002-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-405880-4.00002-0%26sid%3Dliteratum%253Aachs%26atitle%3DNucleotide%252BProdrugs%252Bfor%252Bthe%252BTreatment%252Bof%252BHCV%252BInfection%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2013%26spage%3D39%26epage%3D73%26pub%3DElsevier%26atitle%3DAntiviral%252BAgents%26date%3D2013%26volume%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karolina  Madela</span>, <span class="hlFld-ContribAuthor ">Christopher  McGuigan</span>. </span><span class="cited-content_cbyCitation_article-title">Progress in the development of anti-hepatitis C virus nucleoside and nucleotide prodrugs. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2012,</strong> <em>4 </em>
                                    (5)
                                     , 625-650. <a href="https://doi.org/10.4155/fmc.12.10" title="DOI URL">https://doi.org/10.4155/fmc.12.10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.12.10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.12.10%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Bin%252Bthe%252Bdevelopment%252Bof%252Banti-hepatitis%252BC%252Bvirus%252Bnucleoside%252Band%252Bnucleotide%252Bprodrugs%26aulast%3DMadela%26aufirst%3DKarolina%26date%3D2012%26volume%3D4%26issue%3D5%26spage%3D625%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wilfried  Hatton</span>, <span class="hlFld-ContribAuthor ">Julie  Hunault</span>, <span class="hlFld-ContribAuthor ">Maxim  Egorov</span>, <span class="hlFld-ContribAuthor ">Christophe  Len</span>, <span class="hlFld-ContribAuthor ">Muriel  Pipelier</span>, <span class="hlFld-ContribAuthor ">Virginie  Blot</span>, <span class="hlFld-ContribAuthor ">Virginie  Silvestre</span>, <span class="hlFld-ContribAuthor ">Valérie  Fargeas</span>, <span class="hlFld-ContribAuthor ">Adjou  Ané</span>, <span class="hlFld-ContribAuthor ">Tami  McBrayer</span>, <span class="hlFld-ContribAuthor ">Mervi  Detorio</span>, <span class="hlFld-ContribAuthor ">Jong-Hyun  Cho</span>, <span class="hlFld-ContribAuthor ">Nathalie  Bourgougnon</span>, <span class="hlFld-ContribAuthor ">Didier  Dubreuil</span>, <span class="hlFld-ContribAuthor ">Raymond F.  Schinazi</span>, <span class="hlFld-ContribAuthor ">Jacques  Lebreton</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of 4′-C,3′-O-Propylene-Linked Bicyclic Nucleosides. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2011,</strong> <em>2011 </em>
                                    (36)
                                     , 7390-7399. <a href="https://doi.org/10.1002/ejoc.201100859" title="DOI URL">https://doi.org/10.1002/ejoc.201100859</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201100859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201100859%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252B4%2525E2%252580%2525B2-C%25252C3%2525E2%252580%2525B2-O-Propylene-Linked%252BBicyclic%252BNucleosides%26aulast%3DHatton%26aufirst%3DWilfried%26date%3D2011%26date%3D2011%26volume%3D2011%26issue%3D36%26spage%3D7390%26epage%3D7399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhengjun  Cheng</span>, <span class="hlFld-ContribAuthor ">Yuntao  Zhang</span>, <span class="hlFld-ContribAuthor ">Changhong  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR Models for Phosphoramidate Prodrugs of 2′-Methylcytidine as Inhibitors of Hepatitis C Virus Based on PSO Boosting. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2011,</strong> <em>78 </em>
                                    (6)
                                     , 948-959. <a href="https://doi.org/10.1111/j.1747-0285.2011.01236.x" title="DOI URL">https://doi.org/10.1111/j.1747-0285.2011.01236.x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/j.1747-0285.2011.01236.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fj.1747-0285.2011.01236.x%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DQSAR%252BModels%252Bfor%252BPhosphoramidate%252BProdrugs%252Bof%252B2%2525E2%252580%2525B2-Methylcytidine%252Bas%252BInhibitors%252Bof%252BHepatitis%252BC%252BVirus%252BBased%252Bon%252BPSO%252BBoosting%26aulast%3DCheng%26aufirst%3DZhengjun%26date%3D2011%26date%3D2011%26volume%3D78%26issue%3D6%26spage%3D948%26epage%3D959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adrian S.  Ray</span>, <span class="hlFld-ContribAuthor ">Karl Y.  Hostetler</span>. </span><span class="cited-content_cbyCitation_article-title">Application of kinase bypass strategies to nucleoside antivirals. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2011,</strong> <em>92 </em>
                                    (2)
                                     , 277-291. <a href="https://doi.org/10.1016/j.antiviral.2011.08.015" title="DOI URL">https://doi.org/10.1016/j.antiviral.2011.08.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2011.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2011.08.015%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DApplication%252Bof%252Bkinase%252Bbypass%252Bstrategies%252Bto%252Bnucleoside%252Bantivirals%26aulast%3DRay%26aufirst%3DAdrian%2BS.%26date%3D2011%26volume%3D92%26issue%3D2%26spage%3D277%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael J  Sofia</span>. </span><span class="cited-content_cbyCitation_article-title">Nucleotide Prodrugs for HCV Therapy. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Chemistry and Chemotherapy</span><span> <strong>2011,</strong> <em>22 </em>
                                    (1)
                                     , 23-49. <a href="https://doi.org/10.3851/IMP1797" title="DOI URL">https://doi.org/10.3851/IMP1797</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3851/IMP1797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3851%2FIMP1797%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Chemistry%2520and%2520Chemotherapy%26atitle%3DNucleotide%252BProdrugs%252Bfor%252BHCV%252BTherapy%26aulast%3DSofia%26aufirst%3DMichael%2BJ%26date%3D2011%26date%3D2011%26volume%3D22%26issue%3D1%26spage%3D23%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-Ting  Lin</span>, <span class="hlFld-ContribAuthor ">Kuo-Jung  Huang</span>, <span class="hlFld-ContribAuthor ">Chin-Kai  Tseng</span>, <span class="hlFld-ContribAuthor ">Kuan-Jen  Chen</span>, <span class="hlFld-ContribAuthor ">Hui-Min  Wang</span>, <span class="hlFld-ContribAuthor ">Jin-Ching  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient
              In Silico
              Assay of Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase by Structure-Based Virtual Screening and
              In Vitro
              Evaluation. </span><span class="cited-content_cbyCitation_journal-name">ASSAY and Drug Development Technologies</span><span> <strong>2011,</strong> <em>9 </em>
                                    (3)
                                     , 290-298. <a href="https://doi.org/10.1089/adt.2010.0341" title="DOI URL">https://doi.org/10.1089/adt.2010.0341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/adt.2010.0341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fadt.2010.0341%26sid%3Dliteratum%253Aachs%26jtitle%3DASSAY%2520and%2520Drug%2520Development%2520Technologies%26atitle%3DEfficient%252BIn%252BSilico%252BAssay%252Bof%252BInhibitors%252Bof%252BHepatitis%252BC%252BVirus%252BRNA-Dependent%252BRNA%252BPolymerase%252Bby%252BStructure-Based%252BVirtual%252BScreening%252Band%252BIn%252BVitro%252BEvaluation%26aulast%3DLin%26aufirst%3DYing-Ting%26date%3D2011%26volume%3D9%26issue%3D3%26spage%3D290%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John H.  Vernachio</span>, <span class="hlFld-ContribAuthor ">Blair  Bleiman</span>, <span class="hlFld-ContribAuthor ">K. Dawn  Bryant</span>, <span class="hlFld-ContribAuthor ">Stanley  Chamberlain</span>, <span class="hlFld-ContribAuthor ">Damound  Hunley</span>, <span class="hlFld-ContribAuthor ">Jeff  Hutchins</span>, <span class="hlFld-ContribAuthor ">Brenda  Ames</span>, <span class="hlFld-ContribAuthor ">Elena  Gorovits</span>, <span class="hlFld-ContribAuthor ">Babita  Ganguly</span>, <span class="hlFld-ContribAuthor ">Andrea  Hall</span>, <span class="hlFld-ContribAuthor ">Alexander  Kolykhalov</span>, <span class="hlFld-ContribAuthor ">Yule  Liu</span>, <span class="hlFld-ContribAuthor ">Jerry  Muhammad</span>, <span class="hlFld-ContribAuthor ">Nicholas  Raja</span>, <span class="hlFld-ContribAuthor ">C. Robin  Walters</span>, <span class="hlFld-ContribAuthor ">Jin  Wang</span>, <span class="hlFld-ContribAuthor ">Karen  Williams</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Patti</span>, <span class="hlFld-ContribAuthor ">Geoffrey  Henson</span>, <span class="hlFld-ContribAuthor ">Karolina  Madela</span>, <span class="hlFld-ContribAuthor ">Mohamed  Aljarah</span>, <span class="hlFld-ContribAuthor ">Arnaud  Gilles</span>, <span class="hlFld-ContribAuthor ">Christopher  McGuigan</span>. </span><span class="cited-content_cbyCitation_article-title">INX-08189, a Phosphoramidate Prodrug of 6-
              O
              -Methyl-2′-
              C
              -Methyl Guanosine, Is a Potent Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic and Pharmacodynamic Properties. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2011,</strong> <em>55 </em>
                                    (5)
                                     , 1843-1851. <a href="https://doi.org/10.1128/AAC.01335-10" title="DOI URL">https://doi.org/10.1128/AAC.01335-10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.01335-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.01335-10%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DINX-08189%25252C%252Ba%252BPhosphoramidate%252BProdrug%252Bof%252B6-%252BO%252B-Methyl-2%2525E2%252580%2525B2-%252BC%252B-Methyl%252BGuanosine%25252C%252BIs%252Ba%252BPotent%252BInhibitor%252Bof%252BHepatitis%252BC%252BVirus%252BReplication%252Bwith%252BExcellent%252BPharmacokinetic%252Band%252BPharmacodynamic%252BProperties%26aulast%3DVernachio%26aufirst%3DJohn%2BH.%26date%3D2011%26date%3D2011%26volume%3D55%26issue%3D5%26spage%3D1843%26epage%3D1851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiang  Gao</span>, <span class="hlFld-ContribAuthor ">Weizhu  Chen</span>, <span class="hlFld-ContribAuthor ">Gangtian  Zhu</span>, <span class="hlFld-ContribAuthor ">Ruizao  Yi</span>, <span class="hlFld-ContribAuthor ">Zhen  Wu</span>, <span class="hlFld-ContribAuthor ">Pengxiang  Xu</span>, <span class="hlFld-ContribAuthor ">Yufen  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Fast separation of antiviral nucleoside phosphoramidate and H-phosphonate diastereoisomers by reversed-phase liquid chromatography. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chromatography A</span><span> <strong>2011,</strong> <em>1218 </em>
                                    (10)
                                     , 1416-1422. <a href="https://doi.org/10.1016/j.chroma.2011.01.046" title="DOI URL">https://doi.org/10.1016/j.chroma.2011.01.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chroma.2011.01.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chroma.2011.01.046%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chromatography%2520A%26atitle%3DFast%252Bseparation%252Bof%252Bantiviral%252Bnucleoside%252Bphosphoramidate%252Band%252BH-phosphonate%252Bdiastereoisomers%252Bby%252Breversed-phase%252Bliquid%252Bchromatography%26aulast%3DGao%26aufirst%3DXiang%26date%3D2011%26volume%3D1218%26issue%3D10%26spage%3D1416%26epage%3D1422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin-Ching  Lee</span>, <span class="hlFld-ContribAuthor ">Wei-Chun  Chen</span>, <span class="hlFld-ContribAuthor ">Shou-Fang  Wu</span>, <span class="hlFld-ContribAuthor ">Chin-kai  Tseng</span>, <span class="hlFld-ContribAuthor ">Ching-Yi  Chiou</span>, <span class="hlFld-ContribAuthor ">Fang-Rong  Chang</span>, <span class="hlFld-ContribAuthor ">Shih-hsien  Hsu</span>, <span class="hlFld-ContribAuthor ">Yang-Chang  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-hepatitis C virus activity of Acacia confusa extract via suppressing cyclooxygenase-2. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2011,</strong> <em>89 </em>
                                    (1)
                                     , 35-42. <a href="https://doi.org/10.1016/j.antiviral.2010.11.003" title="DOI URL">https://doi.org/10.1016/j.antiviral.2010.11.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2010.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2010.11.003%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DAnti-hepatitis%252BC%252Bvirus%252Bactivity%252Bof%252BAcacia%252Bconfusa%252Bextract%252Bvia%252Bsuppressing%252Bcyclooxygenase-2%26aulast%3DLee%26aufirst%3DJin-Ching%26date%3D2011%26volume%3D89%26issue%3D1%26spage%3D35%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Leisvuori</span>, <span class="hlFld-ContribAuthor ">Yuichiro  Aiba</span>, <span class="hlFld-ContribAuthor ">Tuomas  Lönnberg</span>, <span class="hlFld-ContribAuthor ">Päivi  Poijärvi-Virta</span>, <span class="hlFld-ContribAuthor ">Laurence  Blatt</span>, <span class="hlFld-ContribAuthor ">Leo  Beigelman</span>, <span class="hlFld-ContribAuthor ">Harri  Lönnberg</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical and enzymatic stability of amino acid derived phosphoramidates of antiviral nucleoside 5′-monophosphates bearing a biodegradable protecting group. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2010,</strong> <em>8 </em>
                                    (9)
                                     , 2131. <a href="https://doi.org/10.1039/b924321f" title="DOI URL">https://doi.org/10.1039/b924321f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/b924321f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fb924321f%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DChemical%252Band%252Benzymatic%252Bstability%252Bof%252Bamino%252Bacid%252Bderived%252Bphosphoramidates%252Bof%252Bantiviral%252Bnucleoside%252B5%2525E2%252580%2525B2-monophosphates%252Bbearing%252Ba%252Bbiodegradable%252Bprotecting%252Bgroup%26aulast%3DLeisvuori%26aufirst%3DAnna%26date%3D2010%26volume%3D8%26issue%3D9%26spage%3D2131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0004.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0017.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of <b>1</b> (NM283, valopicitabine), <b>2</b> (R7128), and <b>3</b> (R1626).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0018.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of 2′-<i>C</i>-methylcytidine <b>4a</b> (NM107), the corresponding NTP <b>4b</b>, and the targeted aryl phosphoramidate prodrugs <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Pathway for the Synthesis of 2′-<i>C</i>-Methylcytidine Aryloxy Phosphoramidates <b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Et<sub>3</sub>N, DCM; (b) <b>4a</b>, <i>t</i>-BuMgCl, dry THF; (c) acetone, <i>p</i>TsOH, 71−87% yield; (d) <b>8</b>, <i>t</i>-BuMgCl, dry THF; (e) HCOOH 80%, water. For details of the structures <b>5</b>, see Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>−<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0012.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. General Synthetic Pathway for the Synthesis of 2′-<i>C</i>-Methylcytidine Aryloxy Phosphoramidates <b>14a</b>,<b> 14b</b>,<b> 15</b> and Monoester <b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BnOH or FmOH, Py, 0 °C; (b) <b>4a</b>, Py, 0−40 °C, 1 h; (c) <span class="smallcaps smallerCapital">l</span>-AlaCOOEt·HCl, Et<sub>3</sub>N, CCl<sub>4</sub>, <i>i</i>-PrOH, <i>N</i>,<i>N</i>-dimethylacetamide, 10 min, 0 °C; (d) piperidine, DCM.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0013.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of the Metabolic Product <b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Et<sub>3</sub>N/water, yield 54%.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0020.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Multigram Scale Synthesis of Compounds <b>50</b> and <b>51</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (PhO)<sub>2</sub>POH, Py, anhydrous conditions; (b) BnOH; (c) <b>21</b>-<b>I</b> or <b>21</b>-<b>II</b>, Et<sub>3</sub>N, CCl<sub>4</sub>, CH<sub>3</sub>CN, <i>i</i>-PrOH, THF, 50% yield over three steps; (d) TFA−H<sub>2</sub>O (8:2); (e) H<sub>2</sub>, Pd/C 5%, <i>i</i>-PrOH.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Time course of triphosphate formation in HBI10A cells. HBI10A cells were incubated with 100 μM compound <b>1</b> (empty square), compound <b>17b</b> (filled square), and compound <b>35b</b> (triangle). Intracellular NTP was quantified at the indicated time points, considering that 10<sup>6</sup> hepatoma cells is 2 μL in volume. Each point is the mean ± half-range of duplicate determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Kinetics of phosphorylation in primary human hepatocytes. Cryopreserved primary human hepatocytes were incubated with 10 μM compound <b>17b</b> (filled square), compound <b>35b</b> (triangle), and compound <b>1</b> (empty square). The intracellular concentration of NTP is estimated considering that 10<sup>6</sup> hepatocytes is 4 μL in volume. Results are the average ± half-range, <i>n</i> = 2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Time course of triphosphate formation in rat hepatocytes. Rat hepatocytes were incubated with 10 μM compound <b>1</b> (empty symbol) and compound <b>17b</b> (filled symbol), and NTP levels were quantified at the indicated time points. Data are the average ± half-range from duplicate experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Conversion of compound <b>17b</b> (square) to the metabolic product <b>18</b> (rhombus) in rat plasma.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0009.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Disappearance of compound <b>46b</b> in human (rhombus), rat (square), dog (triangle), and hamster (cross) plasma.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0010.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Profile of the liver concentration of NTP <b>4b</b> in hamster, rabbit, and rat after subcutaneous administration of <b>50</b> at 1 mg/kg.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/medium/jm-2009-00447q_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0019.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Profile of liver concentration of NTP <b>4b</b> and plasma concentration of nucleoside <b>4a</b> in hamster and rat after subcutaneous administration of <b>50</b> at 5 and 10 mg/kg, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-17/jm900447q/production/images/large/jm-2009-00447q_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900447q&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i62">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05242" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05242" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 48 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Shepard, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alter, M. J.</span><span> </span><span class="NLM_article-title">Global epidemiology of hepatitis C virus infection</span> <span class="citation_source-journal">Lancet Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">558</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1016%2FS1473-3099%2805%2970216-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=16122679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A280%3ADC%252BD2Mvls1Wlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=558-567&author=C.+W.+Shepardauthor=L.+Finelliauthor=M.+J.+Alter&title=Global+epidemiology+of+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Global epidemiology of hepatitis C virus infection</span></div><div class="casAuthors">Shepard Colin W; Finelli Lyn; Alter Miriam J</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Infectious diseases</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">558-67</span>
        ISSN:<span class="NLM_cas:issn">1473-3099</span>.
    </div><div class="casAbstract">Hepatitis C virus (HCV) is a major cause of liver disease worldwide and a potential cause of substantial morbidity and mortality in the future.  The complexity and uncertainty related to the geographic distribution of HCV infection and chronic hepatitis C, determination of its associated risk factors, and evaluation of cofactors that accelerate its progression, underscore the difficulties in global prevention and control of HCV.  Because there is no vaccine and no post-exposure prophylaxis for HCV, the focus of primary prevention efforts should be safer blood supply in the developing world, safe injection practices in health care and other settings, and decreasing the number of people who initiate injection drug use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQyQ65qEM2alVm8bhe6roZYfW6udTcc2eZZxBlaO_jjn7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mvls1Wlsg%253D%253D&md5=4d5f81fa0c2191b8c32b328e39933fad</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2805%2970216-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252805%252970216-4%26sid%3Dliteratum%253Aachs%26aulast%3DShepard%26aufirst%3DC.%2BW.%26aulast%3DFinelli%26aufirst%3DL.%26aulast%3DAlter%26aufirst%3DM.%2BJ.%26atitle%3DGlobal%2520epidemiology%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2005%26volume%3D5%26spage%3D558%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Hayashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takehara, T.</span><span> </span><span class="NLM_article-title">Antiviral therapy for chronic hepatitis C infection: past, present and future</span> <span class="citation_source-journal">J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1007%2Fs00535-005-1740-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=16501853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A280%3ADC%252BD287hsVaruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=17-27&author=N.+Hayashiauthor=T.+Takehara&title=Antiviral+therapy+for+chronic+hepatitis+C+infection%3A+past%2C+present+and+future"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Antiviral therapy for chronic hepatitis C: past, present, and future</span></div><div class="casAuthors">Hayashi Norio; Takehara Tetsuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of gastroenterology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-27</span>
        ISSN:<span class="NLM_cas:issn">0944-1174</span>.
    </div><div class="casAbstract">Antiviral therapy for chronic hepatitis C has dramatically advanced since the discovery of the hepatitis C virus (HCV) in 1989 and the introduction of interferon (IFN) monotherapy in the early 1990s.  The current standard therapy uses a combination of pegylated IFN and ribavirin.  The duration of therapy and response to therapy are HCV genotype-specific.  Genotype 1 patients require 48 weeks of the combination therapy for 50% successful viral elimination, while genotype 2 patients require 24 weeks of therapy for 80% or 90% viral elimination.  Early viral kinetics after the initiation of therapy is a useful predictor of the sustained virologic response (SVR), which is formally determined at 24 weeks after completion of the treatment.  For example, an early virologic response, which is determined by a 2-log reduction of HCV RNA or viral elimination at 12 weeks after the initiation of therapy, is a strong negative predictor of SVR in genotype 1 patients.  In contrast, a rapid virologic response of HCV RNA-negative at 4 weeks after the initiation of therapy identifies genotype 2 "super-responders," who may require a shorter period of therapy.  Adherence to therapy is one of the most important factors for successful viral clearance.  Hematopoietic growth factors such as epoetin and granulocyte-colony stimulating factor help reduce therapy-mediated cytopenia and improve patient compliance, thereby leading to better viral clearance.  New types of anti-HCV agents such as HCV protease and polymerase inhibitors are needed for those patients that do not respond to combination therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYcPayZzNeEc-crCu0nI_sfW6udTcc2eZZxBlaO_jjn7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD287hsVaruw%253D%253D&md5=d19727776dc8acdeadc3955d8f6261a1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs00535-005-1740-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00535-005-1740-7%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DN.%26aulast%3DTakehara%26aufirst%3DT.%26atitle%3DAntiviral%2520therapy%2520for%2520chronic%2520hepatitis%2520C%2520infection%253A%2520past%252C%2520present%2520and%2520future%26jtitle%3DJ.%2520Gastroenterol.%26date%3D2006%26volume%3D41%26spage%3D17%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Pawlotski, J. M.</span><span> </span><span class="NLM_article-title">Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C</span> <span class="citation_source-journal">Antiviral Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2003&pages=1-11&author=J.+M.+Pawlotski&title=Mechanisms+of+antiviral+treatment+efficacy+and+failure+in+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPawlotski%26aufirst%3DJ.%2BM.%26atitle%3DMechanisms%2520of%2520antiviral%2520treatment%2520efficacy%2520and%2520failure%2520in%2520chronic%2520hepatitis%2520C%26jtitle%3DAntiviral%2520Res.%26date%3D2003%26volume%3D59%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Thompson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tillman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHutchison, J. G.</span><span> </span><span class="NLM_article-title">Directly acting antivirals for the treatment of patients with hepatitis C infection: a clinical development update addressing key future challenges</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1016%2Fj.jhep.2008.10.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=19022518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVCkt77F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=184-194&author=A.+Thompsonauthor=K.+Patelauthor=H.+Tillmanauthor=J.+G.+McHutchison&title=Directly+acting+antivirals+for+the+treatment+of+patients+with+hepatitis+C+infection%3A+a+clinical+development+update+addressing+key+future+challenges"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Directly acting antivirals for the treatment of patients with hepatitis C infection: A clinical development update addressing key future challenges</span></div><div class="casAuthors">Thompson, Alex; Patel, Keyur; Tillman, Hans; McHutchison, John G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">184-194</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Current therapy for chronic hepatitis C virus (HCV) infection is effective in less than 50% of genotype 1-infected patients.  Antiviral agents specifically targeting either the HCV protease or polymerase, or other targets, are now in clin. development.  In general, direct antivirals are potent inhibitors of HCV replication and can result in rapid declines in serum HCV RNA levels.  Yet these agents drive selection pressure for mutant viruses that can reduce susceptibility to any given drug.  Using pegylated interferon (PEG-IFN) and ribavirin (RBV) in combination with direct antivirals can suppress viral breakthrough and increase the likelihood of sustained virol. response.  Direct antivirals also result in adverse events in a proportion of patients, adding to concerns of tolerability that exist with PEG-IFN and RBV.  Direct antivirals are very likely to become an integral part of treatment within the next decade, and already their use in clin. trials has raised important issues related to duration of treatment, early stopping rules, retreatment of previously treated patients, and how or when direct antivirals should be combined.  Here, we provide current information regarding the effectiveness of direct antivirals in treating chronic HCV infection and discuss the key questions and challenges now facing the field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXk6iZ2bv6trVg90H21EOLACvtfcHk0ljzbxBaDWJrbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVCkt77F&md5=4a7040ab882f0dfbc7b441610a4852f6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2008.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2008.10.011%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DTillman%26aufirst%3DH.%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26atitle%3DDirectly%2520acting%2520antivirals%2520for%2520the%2520treatment%2520of%2520patients%2520with%2520hepatitis%2520C%2520infection%253A%2520a%2520clinical%2520development%2520update%2520addressing%2520key%2520future%2520challenges%26jtitle%3DJ.%2520Hepatol.%26date%3D2009%26volume%3D50%26spage%3D184%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span> </span><span class="NLM_article-title">Finger loop inhibitors of the HCV NS5B polymerase: discovery and prospects for new HCV Therapy</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">618</span><span class="NLM_x">–</span> <span class="NLM_lpage">626</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=618-626&author=P.+L.+Beaulieu&title=Finger+loop+inhibitors+of+the+HCV+NS5B+polymerase%3A+discovery+and+prospects+for+new+HCV+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26atitle%3DFinger%2520loop%2520inhibitors%2520of%2520the%2520HCV%2520NS5B%2520polymerase%253A%2520discovery%2520and%2520prospects%2520for%2520new%2520HCV%2520Therapy%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D9%26spage%3D618%26epage%3D626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, G.</span><span> </span><span class="NLM_article-title">Challenges and successes in developing new therapies for hepatitis C</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">953</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=953-960&author=R.+De+Francescoauthor=G.+Migliaccio&title=Challenges+and+successes+in+developing+new+therapies+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DMigliaccio%26aufirst%3DG.%26atitle%3DChallenges%2520and%2520successes%2520in%2520developing%2520new%2520therapies%2520for%2520hepatitis%2520C%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D953%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carfì, A.</span><span> </span><span class="NLM_article-title">Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1242</span><span class="NLM_x">–</span> <span class="NLM_lpage">1262</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2007&pages=1242-1262&author=R.+De+Francescoauthor=A.+Carf%C3%AC&title=Advances+in+the+development+of+new+therapeutic+agents+targeting+the+NS3-4A+serine+protease+or+the+NS5B+RNA-dependent+RNA+polymerase+of+the+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DCarf%25C3%25AC%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520the%2520development%2520of%2520new%2520therapeutic%2520agents%2520targeting%2520the%2520NS3-4A%2520serine%2520protease%2520or%2520the%2520NS5B%2520RNA-dependent%2520RNA%2520polymerase%2520of%2520the%2520hepatitis%2520C%2520virus%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2007%26volume%3D59%26spage%3D1242%26epage%3D1262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span> </span><span class="NLM_article-title">The therapeutic potential of NS3 protease inhibitors in HCV infection</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1129</span><span class="NLM_x">–</span> <span class="NLM_lpage">1144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1517%2F13543784.14.9.1129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=16144497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsleju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=1129-1144&author=N.+Goudreauauthor=M.+Llinas-Brunet&title=The+therapeutic+potential+of+NS3+protease+inhibitors+in+HCV+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic potential of NS3 protease inhibitors in HCV infection</span></div><div class="casAuthors">Goudreau, Nathalie; Llinas-Brunet, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1129-1144</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Hepatitis C virus (HCV) infection is a serious cause of chronic liver disease worldwide and afflicts > 170 million people.  The HCV-encoded NS3 protease is essential for viral replication and has long been recognized as a prime target for antiviral drugs.  However, the peculiar active site structure of this enzyme, a shallow dent on the surface of the protein, has rendered the development of small-mol. inhibitors a highly challenging task.  Nevertheless, perseverance and creativity has led to significant progress in this field over the last few years resulting in three compds. that are reported to enter the clinic.  The impressive redn. of HCV RNA plasma levels obsd. with two of these inhibitors (ciluprevir and VX-950) in clin. trials has undoubtedly illustrated the potential of this viral enzyme-targeted drug discovery approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroso_d0nbjPrVg90H21EOLACvtfcHk0ljzbxBaDWJrbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsleju74%253D&md5=4c719c15a74d6011761e96ea9e0de437</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1517%2F13543784.14.9.1129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.14.9.1129%26sid%3Dliteratum%253Aachs%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26atitle%3DThe%2520therapeutic%2520potential%2520of%2520NS3%2520protease%2520inhibitors%2520in%2520HCV%2520infection%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2005%26volume%3D14%26spage%3D1129%26epage%3D1144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Recent progress in the development of inhibitors of the hepatitis C virus RNA-dependent RNA polymerase</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1302</span><span class="NLM_x">–</span> <span class="NLM_lpage">1329</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.2174%2F156802607781212211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=17627559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1302-1329&author=U.+Kochauthor=F.+Narjes&title=Recent+progress+in+the+development+of+inhibitors+of+the+hepatitis+C+virus+RNA-dependent+RNA+polymerase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of inhibitors of the hepatitis C virus RNA-dependent RNA polymerase</span></div><div class="casAuthors">Koch, Uwe; Narjes, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1302-1329</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The global prevalence of hepatitis C virus (HCV) infection and the serious consequences assocd. with the chronic state of the disease have become a worldwide health problem.  A combination therapy comprising Interferon-alpha and Ribavirin represents the current std. treatment for chronic HCV infection, although it has demonstrated limited success and causes serious side effects.  Promising alternative approaches toward the control of HCV infection include the development of small mol. inhibitors of viral enzymes interfering with the essential steps in the life cycle of the virus.  In this review we will focus on inhibitors of the HCV-encoded NS5B RNA-dependent RNA polymerase (NS5B RdRp) which is essential for viral replication and has been recognized as a prime target for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiFy9xnAKP5rVg90H21EOLACvtfcHk0lgcDhELbLNxFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKqtrvI&md5=02ed6506840e322371e043ce557a31d4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F156802607781212211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607781212211%26sid%3Dliteratum%253Aachs%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DRecent%2520progress%2520in%2520the%2520development%2520of%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520RNA-dependent%2520RNA%2520polymerase%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1302%26epage%3D1329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Pawlotski, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gish, R. G.</span><span> </span><span class="NLM_article-title">Future therapies for hepatitis C</span> <span class="citation_source-journal">Antiviral Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">408</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=397-408&author=J.+M.+Pawlotskiauthor=R.+G.+Gish&title=Future+therapies+for+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPawlotski%26aufirst%3DJ.%2BM.%26aulast%3DGish%26aufirst%3DR.%2BG.%26atitle%3DFuture%2520therapies%2520for%2520hepatitis%2520C%26jtitle%3DAntiviral%2520Ther.%26date%3D2006%26volume%3D11%26spage%3D397%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Gane, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Torres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHutchison, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shulman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symonds, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albanis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berrey, M. M.</span><span> </span><span class="NLM_article-title">Antiviral activity of the HCV nucleoside polymerase inhibitor R7128 in HCV genotype 2 and 3 prior non-responders: interim results of R7128 1500 mg bid with Peg-IFN and ribavirin for 28 days</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1024A</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=1024A&author=E.+J.+Ganeauthor=M.+Rodriguez-Torresauthor=D.+R.+Nelsonauthor=I.+M.+Jacobsonauthor=J.+G.+McHutchisonauthor=L.+Jeffersauthor=A.+Beardauthor=S.+Walkerauthor=N.+Shulmanauthor=W.+Symondsauthor=E.+Albanisauthor=M.+M.+Berrey&title=Antiviral+activity+of+the+HCV+nucleoside+polymerase+inhibitor+R7128+in+HCV+genotype+2+and+3+prior+non-responders%3A+interim+results+of+R7128+1500+mg+bid+with+Peg-IFN+and+ribavirin+for+28+days"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGane%26aufirst%3DE.%2BJ.%26aulast%3DRodriguez-Torres%26aufirst%3DM.%26aulast%3DNelson%26aufirst%3DD.%2BR.%26aulast%3DJacobson%26aufirst%3DI.%2BM.%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26aulast%3DJeffers%26aufirst%3DL.%26aulast%3DBeard%26aufirst%3DA.%26aulast%3DWalker%26aufirst%3DS.%26aulast%3DShulman%26aufirst%3DN.%26aulast%3DSymonds%26aufirst%3DW.%26aulast%3DAlbanis%26aufirst%3DE.%26aulast%3DBerrey%26aufirst%3DM.%2BM.%26atitle%3DAntiviral%2520activity%2520of%2520the%2520HCV%2520nucleoside%2520polymerase%2520inhibitor%2520R7128%2520in%2520HCV%2520genotype%25202%2520and%25203%2520prior%2520non-responders%253A%2520interim%2520results%2520of%2520R7128%25201500%2520mg%2520bid%2520with%2520Peg-IFN%2520and%2520ribavirin%2520for%252028%2520days%26jtitle%3DHepatology%26date%3D2008%26volume%3D48%26spage%3D1024A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span> </span><span class="NLM_article-title">Nucleoside analog inhibitors of hepatitis C virus replication</span> <span class="citation_source-journal">Infect. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.2174%2F187152606776056698" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=16787301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt1Ggu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=17-29&author=S.+S.+Carrollauthor=D.+B.+Olsen&title=Nucleoside+analog+inhibitors+of+hepatitis+C+virus+replication"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleoside analog inhibitors of hepatitis C virus replication</span></div><div class="casAuthors">Carroll, S. S.; Olsen, D. B.</div><div class="citationInfo"><span class="NLM_cas:title">Infectious Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-29</span>CODEN:
                <span class="NLM_cas:coden">IDDTAD</span>;
        ISSN:<span class="NLM_cas:issn">1871-5265</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Of the 30 compds. currently marketed in the United States for treatment of viral infections, 15 are nucleoside analogs, demonstrating the utility of this class of compd. as a source of antiviral drugs.  The success of nucleoside analogs in treating other viral infections provides a compelling rationale for the significant effort that is currently being devoted to the discovery and development of nucleoside analogs to treat infection by hepatitis C virus (HCV) that may lead to improvements in response rates compared to currently available therapies.  Several different approaches were adopted to identify promising analogs, including the use of surrogate viruses in cell culture assays, screening in the cell-based bicistronic HCV replicon assay, and screening nucleoside triphosphates for the ability to inhibit the activity of the HCV RNA-dependent RNA polymerase in vitro.  Several classes of ribonucleoside analogs with modifications of the ribose inhibit HCV replication.  Nucleoside analogs incorporating a 2'-C-Me modification are potent inhibitors in the replicon assay in the absence of cytotoxicity, and appear to exert their inhibition by acting as functional chain terminators of RNA synthesis.  NM283, a prodrug of 2'-C-methylcytidine, has entered clin. trials and demonstrated viral load redns. in subjects infected with genotype 1 HCV, a genotype known to be difficult to treat effectively with currently approved therapies.  Overall, results to date offer encouragement that improved therapies to treat HCV infection including newly developed nucleoside analogs may become available within the next few years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVhFYWU3S1hbVg90H21EOLACvtfcHk0lgcDhELbLNxFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt1Ggu7Y%253D&md5=27a3f74bc6da7bfd4ce02a1266511f5c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F187152606776056698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152606776056698%26sid%3Dliteratum%253Aachs%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26atitle%3DNucleoside%2520analog%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520replication%26jtitle%3DInfect.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2006%26volume%3D6%26spage%3D17%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Ali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philipp, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inocencio, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W. R.</span><span> </span><span class="NLM_article-title">Selected replicon variants with low-level in vitro resistance to the hepatitis C virus NS5B polymerase inhibitor PSI-6130 lack cross-resistance with R1479</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4356</span><span class="NLM_x">–</span> <span class="NLM_lpage">4369</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=4356-4369&author=S.+Aliauthor=V.+Levequeauthor=S.+Le+Pogamauthor=H.+Maauthor=F.+Philippauthor=N.+Inocencioauthor=M.+Smithauthor=A.+Alkerauthor=H.+Kangauthor=I.+Najeraauthor=K.+Klumppauthor=J.+Symonsauthor=N.+Cammackauthor=W.+R.+Jiang&title=Selected+replicon+variants+with+low-level+in+vitro+resistance+to+the+hepatitis+C+virus+NS5B+polymerase+inhibitor+PSI-6130+lack+cross-resistance+with+R1479"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DS.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DPhilipp%26aufirst%3DF.%26aulast%3DInocencio%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DM.%26aulast%3DAlker%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DNajera%26aufirst%3DI.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSymons%26aufirst%3DJ.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DJiang%26aufirst%3DW.%2BR.%26atitle%3DSelected%2520replicon%2520variants%2520with%2520low-level%2520in%2520vitro%2520resistance%2520to%2520the%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%2520inhibitor%2520PSI-6130%2520lack%2520cross-resistance%2520with%2520R1479%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D4356%26epage%3D4369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boots, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simcoe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markel, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobler, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafemina, R. L.</span><span> </span><span class="NLM_article-title">Replication fitness and NS5B drug sensitivity of diverse hepatitis C virus isolates characterized by using a transient replication assay</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">2059</span><span class="NLM_x">–</span> <span class="NLM_lpage">2069</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=2059-2069&author=S.+W.+Ludmererauthor=D.+J.+Grahamauthor=E.+Bootsauthor=E.+M.+Murrayauthor=A.+Simcoeauthor=E.+J.+Markelauthor=J.+A.+Groblerauthor=O.+A.+Floresauthor=D.+B.+Olsenauthor=D.+J.+Hazudaauthor=R.+L.+Lafemina&title=Replication+fitness+and+NS5B+drug+sensitivity+of+diverse+hepatitis+C+virus+isolates+characterized+by+using+a+transient+replication+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DBoots%26aufirst%3DE.%26aulast%3DMurray%26aufirst%3DE.%2BM.%26aulast%3DSimcoe%26aufirst%3DA.%26aulast%3DMarkel%26aufirst%3DE.%2BJ.%26aulast%3DGrobler%26aufirst%3DJ.%2BA.%26aulast%3DFlores%26aufirst%3DO.%2BA.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DLafemina%26aufirst%3DR.%2BL.%26atitle%3DReplication%2520fitness%2520and%2520NS5B%2520drug%2520sensitivity%2520of%2520diverse%2520hepatitis%2520C%2520virus%2520isolates%2520characterized%2520by%2520using%2520a%2520transient%2520replication%2520assay%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26volume%3D49%26spage%3D2059%26epage%3D2069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">McCown, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyaguru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span> </span><span class="NLM_article-title">The hepatitis C virus replicon presents a higher barrier to resistance to nucleoside analogs than to non nucleoside polymerase or protease inhibitors</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1604</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=1604-1612&author=M.+F.+McCownauthor=S.+Rajyaguruauthor=S.+Le+Pogamauthor=S.+Aliauthor=W.+R.+Jiangauthor=H.+Kangauthor=J.+Symonsauthor=N.+Cammackauthor=I.+Najera&title=The+hepatitis+C+virus+replicon+presents+a+higher+barrier+to+resistance+to+nucleoside+analogs+than+to+non+nucleoside+polymerase+or+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcCown%26aufirst%3DM.%2BF.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DAli%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DW.%2BR.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DSymons%26aufirst%3DJ.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DNajera%26aufirst%3DI.%26atitle%3DThe%2520hepatitis%2520C%2520virus%2520replicon%2520presents%2520a%2520higher%2520barrier%2520to%2520resistance%2520to%2520nucleoside%2520analogs%2520than%2520to%2520non%2520nucleoside%2520polymerase%2520or%2520protease%2520inhibitors%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D1604%26epage%3D1612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seshaadri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyaguru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span> </span><span class="NLM_article-title">Existence of hepatitis C virus NS5B variants naturally resistant to non-nucleoside, but not to nucleoside, polymerase inhibitors among untreated patients</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1205</span><span class="NLM_x">–</span> <span class="NLM_lpage">1216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1093%2Fjac%2Fdkn085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=18343801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVajtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2008&pages=1205-1216&author=S.+Le+Pogamauthor=A.+Seshaadriauthor=A.+Kosakaauthor=S.+Chiuauthor=H.+Kangauthor=S.+Huauthor=S.+Rajyaguruauthor=J.+Symonsauthor=N.+Cammackauthor=I.+Najera&title=Existence+of+hepatitis+C+virus+NS5B+variants+naturally+resistant+to+non-nucleoside%2C+but+not+to+nucleoside%2C+polymerase+inhibitors+among+untreated+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Existence of hepatitis C virus NS5B variants naturally resistant to non-nucleoside, but not to nucleoside, polymerase inhibitors among untreated patients</span></div><div class="casAuthors">Le Pogam, Sophie; Seshaadri, Amritha; Kosaka, Alan; Chiu, Sophie; Kang, Hyunsoon; Hu, Steven; Rajyaguru, Sonal; Symons, Julian; Cammack, Nick; Najera, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1205-1216</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">To characterize the effect of hepatitis C virus (HCV) polymerase intrinsic genetic heterogeneity on the inhibitory activity of nucleoside and nonnucleoside HCV polymerase inhibitors.  The sensitivity of genotype (GT) 1 HCV NS5B clin. isolates from treatment-naive patients to nucleoside and nonnucleoside polymerase inhibitors was assessed.  The genetic diversity at the population level, as well as that of their quasispecies, was correlated with the obsd. reduced sensitivity to inhibitors.  R1479 and NM107 (nucleoside analogs that have entered Phase 2 clin. trials as prodrugs R1626 and NM283, resp.) were similarly active across the tested clin. isolates.  Resistance mutations to nucleoside analogs were not obsd. in any of the isolates.  However, the activity of the nonnucleoside thumb II inhibitor NNI-1, palm I inhibitors NNI-2 and NNI-3, and palm II inhibitor HCV-796 was reduced across different isolates.  This redn. in inhibitory activity for nonnucleoside inhibitors (NNIs) was, in most cases, correlated with the existence of known NNI resistance mutations in the NS5B polymerase population of the clin. isolates, as detected by population sequencing.  Resistance mutations to NNIs were also obsd. at a low frequency within the clin. isolates' viral quasispecies that allowed for their rapid selection upon drug selective pressure.  The higher frequency of known NNI resistance mutations or polymorphisms known to affect their antiviral potency when compared with the lack of detection of resistance mutations to the nucleoside analogs suggests a potential for primary reduced responsiveness as well as faster development of clin. significant resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTFPmws2lf_bVg90H21EOLACvtfcHk0lhkEasm25H7VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVajtb4%253D&md5=9ab251b640d8e1c5d0d4b334dc6fe053</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkn085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkn085%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DSeshaadri%26aufirst%3DA.%26aulast%3DKosaka%26aufirst%3DA.%26aulast%3DChiu%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DSymons%26aufirst%3DJ.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DNajera%26aufirst%3DI.%26atitle%3DExistence%2520of%2520hepatitis%2520C%2520virus%2520NS5B%2520variants%2520naturally%2520resistant%2520to%2520non-nucleoside%252C%2520but%2520not%2520to%2520nucleoside%252C%2520polymerase%2520inhibitors%2520among%2520untreated%2520patients%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2008%26volume%3D61%26spage%3D1205%26epage%3D1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNair, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, S.</span><span> </span><span class="NLM_article-title">Recent progress in the development of selected hepatitis C virus NS3-4A protease and NS5B polymerase inhibitors</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1016%2Fj.coph.2008.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=18835365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlaqsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=522-531&author=A.+D.+Kwongauthor=L.+McNairauthor=I.+Jacobsonauthor=S.+George&title=Recent+progress+in+the+development+of+selected+hepatitis+C+virus+NS3-4A+protease+and+NS5B+polymerase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the development of selected hepatitis C virus NS3·4A protease and NS5B polymerase inhibitors</span></div><div class="casAuthors">Kwong, Ann D.; McNair, Lindsay; Jacobson, Ira; George, Shelley</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">522-531</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Chronic hepatitis C virus (HCV) infection is a pressing medical problem worldwide.  Current therapy with pegylated interferon plus ribavirin (Peg-IFN/RBV) is assocd. with a poor risk benefit profile, a long treatment duration (48 wk) and inadequate success rate (∼40-50%) of SVR (sustained viral response) in patients infected with genotype 1 HCV.  This review is focused on recent clin. trial results with specifically targeted antiviral therapy for HCV (STAT-C) protease and polymerase inhibitors.  In the past decade, anti-HCV drug discovery has focused first on targeting host factors required for viral replication and second on multiple HCV antiviral agents.  Owing to the large no. of HCV inhibitors currently in pre-clin. and clin. development today, we have focused on the most advanced compds. in the HCV polymerase and HCV protease inhibitor classes.  Within each class, compds. will be used to illustrate some of the properties assocd. with inhibitors that bind to the active site of HCV polymerase, the active site of HCV protease (macrocyclic and linear ketoamide inhibitors) and allosteric polymerase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb0B_J-gyRGLVg90H21EOLACvtfcHk0lhkEasm25H7VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlaqsLrE&md5=0787600cc6e2a2c28c1240470bf6bf22</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2008.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2008.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DMcNair%26aufirst%3DL.%26aulast%3DJacobson%26aufirst%3DI.%26aulast%3DGeorge%26aufirst%3DS.%26atitle%3DRecent%2520progress%2520in%2520the%2520development%2520of%2520selected%2520hepatitis%2520C%2520virus%2520NS3-4A%2520protease%2520and%2520NS5B%2520polymerase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2008%26volume%3D8%26spage%3D522%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granycome, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laxton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hang, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heindl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrett, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devos, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span> </span><span class="NLM_article-title">The novel nucleoside analog R1479 (4′-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">3793</span><span class="NLM_x">–</span> <span class="NLM_lpage">3799</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=3793-3799&author=K.+Klumppauthor=V.+Levequeauthor=S.+Le+Pogamauthor=H.+Maauthor=W.+R.+Jiangauthor=H.+Kangauthor=C.+Granycomeauthor=M.+Singerauthor=C.+Laxtonauthor=J.+Q.+Hangauthor=K.+Sarmaauthor=D.+B.+Smithauthor=D.+Heindlauthor=C.+J.+Hobbsauthor=J.+H.+Merrettauthor=J.+Symonsauthor=N.+Cammackauthor=J.+A.+Martinauthor=R.+Devosauthor=I.+Najera&title=The+novel+nucleoside+analog+R1479+%284%E2%80%B2-azidocytidine%29+is+a+potent+inhibitor+of+NS5B-dependent+RNA+synthesis+and+hepatitis+C+virus+replication+in+cell+culture"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DW.%2BR.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DGranycome%26aufirst%3DC.%26aulast%3DSinger%26aufirst%3DM.%26aulast%3DLaxton%26aufirst%3DC.%26aulast%3DHang%26aufirst%3DJ.%2BQ.%26aulast%3DSarma%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DHeindl%26aufirst%3DD.%26aulast%3DHobbs%26aufirst%3DC.%2BJ.%26aulast%3DMerrett%26aufirst%3DJ.%2BH.%26aulast%3DSymons%26aufirst%3DJ.%26aulast%3DCammack%26aufirst%3DN.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DDevos%26aufirst%3DR.%26aulast%3DNajera%26aufirst%3DI.%26atitle%3DThe%2520novel%2520nucleoside%2520analog%2520R1479%2520%25284%25E2%2580%25B2-azidocytidine%2529%2520is%2520a%2520potent%2520inhibitor%2520of%2520NS5B-dependent%2520RNA%2520synthesis%2520and%2520hepatitis%2520C%2520virus%2520replication%2520in%2520cell%2520culture%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D3793%26epage%3D3799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Murakami, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramesh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBrayer, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitaker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Micolochik Steyer, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinanzi, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuyver, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obikhod, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otto, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furman, P. A.</span><span> </span><span class="NLM_article-title">Mechanism of activation of β-2′-deoxy-2′-fluoro-2′-<i>C</i>-methylcytidine and inhibition of hepatitis C virus NS5B RNA polymerase</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2007&pages=503&author=E.+Murakamiauthor=H.+Baoauthor=M.+Rameshauthor=T.+R.+McBrayerauthor=T.+Whitakerauthor=H.+M.+Micolochik+Steyerauthor=R.+F.+Schinanziauthor=L.+J.+Stuyverauthor=A.+Obikhodauthor=M.+J.+Ottoauthor=P.+A.+Furman&title=Mechanism+of+activation+of+%CE%B2-2%E2%80%B2-deoxy-2%E2%80%B2-fluoro-2%E2%80%B2-C-methylcytidine+and+inhibition+of+hepatitis+C+virus+NS5B+RNA+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DE.%26aulast%3DBao%26aufirst%3DH.%26aulast%3DRamesh%26aufirst%3DM.%26aulast%3DMcBrayer%26aufirst%3DT.%2BR.%26aulast%3DWhitaker%26aufirst%3DT.%26aulast%3DMicolochik%2BSteyer%26aufirst%3DH.%2BM.%26aulast%3DSchinanzi%26aufirst%3DR.%2BF.%26aulast%3DStuyver%26aufirst%3DL.%2BJ.%26aulast%3DObikhod%26aufirst%3DA.%26aulast%3DOtto%26aufirst%3DM.%2BJ.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26atitle%3DMechanism%2520of%2520activation%2520of%2520%25CE%25B2-2%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-fluoro-2%25E2%2580%25B2-C-methylcytidine%2520and%2520inhibition%2520of%2520hepatitis%2520C%2520virus%2520NS5B%2520RNA%2520polymerase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2007%26volume%3D51%26spage%3D503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Hecker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erion, M. D.</span><span> </span><span class="NLM_article-title">Prodrugs of phosphates and phosphonates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2328</span><span class="NLM_x">–</span> <span class="NLM_lpage">2345</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701260b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2328-2345&author=S.+J.+Heckerauthor=M.+D.+Erion&title=Prodrugs+of+phosphates+and+phosphonates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Prodrugs of Phosphates and Phosphonates</span></div><div class="casAuthors">Hecker, Scott J.; Erion, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2328-2345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The field of prodrugs for phosph(on)ates has evolved considerably in the past decade.  There are now several approaches available to the researcher who finds that a phosphonate moiety achieves the right balance of properties in the lead series, yet needs a prodrug for oral delivery.  The overall best choice in this situation, taking into account stability, byproduct toxicity, avoidance of stereoisomers, and validation in humans, appears to be the diamide class.  Given its relatively recent appearance, there are few examples to date, but it is expected that phosphonic diamides will play an increasingly important role as phosphonate prodrugs going forward.  For drugs given at low to moderate doses, where risks assocd. with the byproduct formaldehyde are low, acyloxyalkyl prodrugs will continue to find application.  If selective targeting to the liver is desired, HepDirect prodrugs are the clear choice, whereas aryl amidates (and possibly diamides) offer the potential for targeting to lymphatic tissue.  The increasing availability of prodrug options should encourage the practicing medicinal chemist to explore phosphonic acids in the course of lead development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrooUagDflp3rVg90H21EOLACvtfcHk0li4wGSGuOFkLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWisbo%253D&md5=62699075f111d09d2ba3f19f089cb7c2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm701260b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701260b%26sid%3Dliteratum%253Aachs%26aulast%3DHecker%26aufirst%3DS.%2BJ.%26aulast%3DErion%26aufirst%3DM.%2BD.%26atitle%3DProdrugs%2520of%2520phosphates%2520and%2520phosphonates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2328%26epage%3D2345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Pierra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amador, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzaria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cretton-Scott, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D'Amours, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moussa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standring, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommadossi, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosselin, G.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacokinetic of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 2′-<i>C</i>-methylcytidine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6614</span><span class="NLM_x">–</span> <span class="NLM_lpage">6620</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0603623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6614-6620&author=C.+Pierraauthor=A.+Amadorauthor=S.+Benzariaauthor=E.+Cretton-Scottauthor=M.+D%27Amoursauthor=J.+Maoauthor=S.+Mathieuauthor=A.+Moussaauthor=E.+G.+Bridgesauthor=D.+N.+Standringauthor=J.-P.+Sommadossiauthor=R.+Storerauthor=G.+Gosselin&title=Synthesis+and+pharmacokinetic+of+valopicitabine+%28NM283%29%2C+an+efficient+prodrug+of+the+potent+anti-HCV+agent+2%E2%80%B2-C-methylcytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm0603623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0603623%26sid%3Dliteratum%253Aachs%26aulast%3DPierra%26aufirst%3DC.%26aulast%3DAmador%26aufirst%3DA.%26aulast%3DBenzaria%26aufirst%3DS.%26aulast%3DCretton-Scott%26aufirst%3DE.%26aulast%3DD%2527Amours%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DMoussa%26aufirst%3DA.%26aulast%3DBridges%26aufirst%3DE.%2BG.%26aulast%3DStandring%26aufirst%3DD.%2BN.%26aulast%3DSommadossi%26aufirst%3DJ.-P.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DGosselin%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520pharmacokinetic%2520of%2520valopicitabine%2520%2528NM283%2529%252C%2520an%2520efficient%2520prodrug%2520of%2520the%2520potent%2520anti-HCV%2520agent%25202%25E2%2580%25B2-C-methylcytidine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6614%26epage%3D6620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Cahard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span> </span><span class="NLM_article-title">Aryloxy phosphoramidate triesters as ProTides</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=371-381&author=D.+Cahardauthor=C.+McGuiganauthor=J.+Balzarini&title=Aryloxy+phosphoramidate+triesters+as+ProTides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCahard%26aufirst%3DD.%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DBalzarini%26aufirst%3DJ.%26atitle%3DAryloxy%2520phosphoramidate%2520triesters%2520as%2520ProTides%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2004%26volume%3D4%26spage%3D371%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Hecker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Poelje, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varkhedkar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujitaki, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linemeyer, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erion, M. D.</span><span> </span><span class="NLM_article-title">Liver-targeted prodrugs of 2′-<i>C</i>-methyladenosine for therapy of hepatitis C virus infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3891</span><span class="NLM_x">–</span> <span class="NLM_lpage">3896</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0701021" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3891-3896&author=S.+J.+Heckerauthor=K.+R.+Reddyauthor=P.+D.+Van+Poeljeauthor=Z.+Sunauthor=W.+Huangauthor=V.+Varkhedkarauthor=M.+V.+Reddyauthor=J.+M.+Fujitakiauthor=D.+B.+Olsenauthor=K.+A.+Koeplingerauthor=S.+H.+Boyerauthor=D.+L.+Linemeyerauthor=M.+MacCossauthor=M.+D.+Erion&title=Liver-targeted+prodrugs+of+2%E2%80%B2-C-methyladenosine+for+therapy+of+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm0701021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0701021%26sid%3Dliteratum%253Aachs%26aulast%3DHecker%26aufirst%3DS.%2BJ.%26aulast%3DReddy%26aufirst%3DK.%2BR.%26aulast%3DVan%2BPoelje%26aufirst%3DP.%2BD.%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DVarkhedkar%26aufirst%3DV.%26aulast%3DReddy%26aufirst%3DM.%2BV.%26aulast%3DFujitaki%26aufirst%3DJ.%2BM.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DBoyer%26aufirst%3DS.%2BH.%26aulast%3DLinemeyer%26aufirst%3DD.%2BL.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DErion%26aufirst%3DM.%2BD.%26atitle%3DLiver-targeted%2520prodrugs%2520of%25202%25E2%2580%25B2-C-methyladenosine%2520for%2520therapy%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3891%26epage%3D3896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Perrone, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luoni, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelleher, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daverio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulready, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congiatu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajyaguru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leveque, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pogam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najera, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuigan, C.</span><span> </span><span class="NLM_article-title">Application of the phosphoramidate ProTide approach to 4′-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1840</span><span class="NLM_x">–</span> <span class="NLM_lpage">1849</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0613370" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1840-1849&author=P.+Perroneauthor=G.+M.+Luoniauthor=M.+R.+Kelleherauthor=F.+Daverioauthor=A.+Angellauthor=S.+Mulreadyauthor=C.+Congiatuauthor=S.+Rajyaguruauthor=J.+A.+Martinauthor=V.+Levequeauthor=S.+Le+Pogamauthor=I.+Najeraauthor=K.+Klumppauthor=D.+B.+Smithauthor=C.+McGuigan&title=Application+of+the+phosphoramidate+ProTide+approach+to+4%E2%80%B2-azidouridine+confers+sub-micromolar+potency+versus+hepatitis+C+virus+on+an+inactive+nucleoside"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm0613370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0613370%26sid%3Dliteratum%253Aachs%26aulast%3DPerrone%26aufirst%3DP.%26aulast%3DLuoni%26aufirst%3DG.%2BM.%26aulast%3DKelleher%26aufirst%3DM.%2BR.%26aulast%3DDaverio%26aufirst%3DF.%26aulast%3DAngell%26aufirst%3DA.%26aulast%3DMulready%26aufirst%3DS.%26aulast%3DCongiatu%26aufirst%3DC.%26aulast%3DRajyaguru%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DLeveque%26aufirst%3DV.%26aulast%3DLe%2BPogam%26aufirst%3DS.%26aulast%3DNajera%26aufirst%3DI.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DD.%2BB.%26aulast%3DMcGuigan%26aufirst%3DC.%26atitle%3DApplication%2520of%2520the%2520phosphoramidate%2520ProTide%2520approach%2520to%25204%25E2%2580%25B2-azidouridine%2520confers%2520sub-micromolar%2520potency%2520versus%2520hepatitis%2520C%2520virus%2520on%2520an%2520inactive%2520nucleoside%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1840%26epage%3D1849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Balzarini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruining, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedgwoog, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannecouque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aquaro, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perno, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naesens, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witvrouw, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heijtink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clerq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuigan, C.</span><span> </span><span class="NLM_article-title">Conversion of 2′,3′-dideoxyadenosine (ddA) and 2′,3′-didehydro-2′,3′-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">410</span><span class="NLM_x">, </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=1997&pages=324-328&author=J.+Balzariniauthor=J.+Kruiningauthor=O.+Wedgwoogauthor=C.+Pannecouqueauthor=S.+Aquaroauthor=C.+F.+Pernoauthor=L.+Naesensauthor=M.+Witvrouwauthor=R.+Heijtinkauthor=E.+De+Clerqauthor=C.+McGuigan&title=Conversion+of+2%E2%80%B2%2C3%E2%80%B2-dideoxyadenosine+%28ddA%29+and+2%E2%80%B2%2C3%E2%80%B2-didehydro-2%E2%80%B2%2C3%E2%80%B2-dideoxyadenosine+%28d4A%29+to+their+corresponding+aryloxyphosphoramidate+derivatives+markedly+potentiates+their+activity+against+human+immunodeficiency+virus+and+hepatitis+B+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DKruining%26aufirst%3DJ.%26aulast%3DWedgwoog%26aufirst%3DO.%26aulast%3DPannecouque%26aufirst%3DC.%26aulast%3DAquaro%26aufirst%3DS.%26aulast%3DPerno%26aufirst%3DC.%2BF.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DWitvrouw%26aufirst%3DM.%26aulast%3DHeijtink%26aufirst%3DR.%26aulast%3DDe%2BClerq%26aufirst%3DE.%26aulast%3DMcGuigan%26aufirst%3DC.%26atitle%3DConversion%2520of%25202%25E2%2580%25B2%252C3%25E2%2580%25B2-dideoxyadenosine%2520%2528ddA%2529%2520and%25202%25E2%2580%25B2%252C3%25E2%2580%25B2-didehydro-2%25E2%2580%25B2%252C3%25E2%2580%25B2-dideoxyadenosine%2520%2528d4A%2529%2520to%2520their%2520corresponding%2520aryloxyphosphoramidate%2520derivatives%2520markedly%2520potentiates%2520their%2520activity%2520against%2520human%2520immunodeficiency%2520virus%2520and%2520hepatitis%2520B%2520virus%26jtitle%3DFEBS%2520Lett.%26date%3D1997%26volume%3D410%26spage%3D324%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheeka, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahmood, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, A.</span><span> </span><span class="NLM_article-title">Phosphate derivatives of d4T as inhibitors of HIV</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1203</span><span class="NLM_x">–</span> <span class="NLM_lpage">1206</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1993&pages=1203-1206&author=C.+McGuiganauthor=H.+M.+Sheekaauthor=N.+Mahmoodauthor=A.+Hay&title=Phosphate+derivatives+of+d4T+as+inhibitors+of+HIV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DSheeka%26aufirst%3DH.%2BM.%26aulast%3DMahmood%26aufirst%3DN.%26aulast%3DHay%26aufirst%3DA.%26atitle%3DPhosphate%2520derivatives%2520of%2520d4T%2520as%2520inhibitors%2520of%2520HIV%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1993%26volume%3D3%26spage%3D1203%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheeka, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clerq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span> </span><span class="NLM_article-title">Arylphosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1748</span><span class="NLM_x">–</span> <span class="NLM_lpage">1753</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm950605j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=1748-1753&author=C.+McGuiganauthor=D.+Cahardauthor=H.+M.+Sheekaauthor=E.+De+Clerqauthor=J.+Balzarini&title=Arylphosphoramidate+derivatives+of+d4T+have+improved+anti-HIV+efficacy+in+tissue+culture+and+may+act+by+the+generation+of+a+novel+intracellular+metabolite"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm950605j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm950605j%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DCahard%26aufirst%3DD.%26aulast%3DSheeka%26aufirst%3DH.%2BM.%26aulast%3DDe%2BClerq%26aufirst%3DE.%26aulast%3DBalzarini%26aufirst%3DJ.%26atitle%3DArylphosphoramidate%2520derivatives%2520of%2520d4T%2520have%2520improved%2520anti-HIV%2520efficacy%2520in%2520tissue%2520culture%2520and%2520may%2520act%2520by%2520the%2520generation%2520of%2520a%2520novel%2520intracellular%2520metabolite%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D1748%26epage%3D1753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassan-Abdallah, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddiqui, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daluge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peckham, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnette, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condreay, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span> </span><span class="NLM_article-title">Application of phosphoramidate protide technology significantly improves antiviral potency of carbocyclic adenosine derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7215</span><span class="NLM_x">–</span> <span class="NLM_lpage">7226</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060776w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFOmtLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7215-7226&author=C.+McGuiganauthor=A.+Hassan-Abdallahauthor=S.+Srinivasanauthor=Y.+Wangauthor=A.+Siddiquiauthor=S.+M.+Dalugeauthor=K.+S.+Gudmundssonauthor=H.+Zhouauthor=E.+W.+McLeanauthor=J.+P.+Peckhamauthor=T.+C.+Burnetteauthor=H.+Marrauthor=R.+Hazenauthor=L.+D.+Condreayauthor=L.+Johnsonauthor=J.+Balzarini&title=Application+of+phosphoramidate+protide+technology+significantly+improves+antiviral+potency+of+carbocyclic+adenosine+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Application of phosphoramidate ProTide technology significantly improves antiviral potency of carbocyclic adenosine derivatives</span></div><div class="casAuthors">McGuigan, Christopher; Hassan-Abdallah, Alshaimaa; Srinivasan, Sheila; Wang, Yikang; Siddiqui, Adam; Daluge, Susan M.; Gudmundsson, Kristjan S.; Zhou, Huiqiang; McLean, Ed W.; Peckham, Jennifer P.; Burnette, Thimysta C.; Marr, Harry; Hazen, Richard; Condreay, Lynn D.; Johnson, Lance; Balzarini, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7215-7226</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the application of phosphoramidate pronucleotide (ProTide) technol. to the antiviral agent carbocyclic L-d4A (L-Cd4A).  The Ph Me alaninyl parent ProTide of L-Cd4A was prepd. by Grignard-mediated phosphorochloridate reaction and resulted in a compd. with significantly improved anti-HIV (2600-fold) and HBV activity.  We describe modifications of the aryl, ester, and amino acid regions of the ProTide and how these changes affect antiviral activity and metabolic stability.  Sep. and distinct SARs were noted for HIV and HBV.  Addnl., ProTides were prepd. from the D-nucleoside D-Cd4A and the dideoxy analogs L-CddA and D-CddA.  These compds. showed more modest potency improvements over the parent drug.  In conclusion, the ProTide approach is highly successful when applied to L-Cd4A with potency improvements in vitro as high as 9000-fold against HIV.  With a view to preclin. candidate selection we carried out metabolic stability studies using cynomolgus monkey liver and intestinal S9 fractions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnYwJaILYt0rVg90H21EOLACvtfcHk0lhLF0v2kN9GlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFOmtLfN&md5=dc7f7592f250c3fb2f63817ecabc89dc</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm060776w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060776w%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DHassan-Abdallah%26aufirst%3DA.%26aulast%3DSrinivasan%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSiddiqui%26aufirst%3DA.%26aulast%3DDaluge%26aufirst%3DS.%2BM.%26aulast%3DGudmundsson%26aufirst%3DK.%2BS.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DMcLean%26aufirst%3DE.%2BW.%26aulast%3DPeckham%26aufirst%3DJ.%2BP.%26aulast%3DBurnette%26aufirst%3DT.%2BC.%26aulast%3DMarr%26aufirst%3DH.%26aulast%3DHazen%26aufirst%3DR.%26aulast%3DCondreay%26aufirst%3DL.%2BD.%26aulast%3DJohnson%26aufirst%3DL.%26aulast%3DBalzarini%26aufirst%3DJ.%26atitle%3DApplication%2520of%2520phosphoramidate%2520protide%2520technology%2520significantly%2520improves%2520antiviral%2520potency%2520of%2520carbocyclic%2520adenosine%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7215%26epage%3D7226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedgwood, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clerq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span> </span><span class="NLM_article-title">Phosphoramidate derivatives of 2′,3′-didehydro-2′,3′-dideoxyadenosine (d4A) have markedly improved anti-HIV potency and selectivity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2359</span><span class="NLM_x">–</span> <span class="NLM_lpage">2362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=2359-2362&author=C.+McGuiganauthor=O.+M.+Wedgwoodauthor=E.+De+Clerqauthor=J.+Balzarini&title=Phosphoramidate+derivatives+of+2%E2%80%B2%2C3%E2%80%B2-didehydro-2%E2%80%B2%2C3%E2%80%B2-dideoxyadenosine+%28d4A%29+have+markedly+improved+anti-HIV+potency+and+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DWedgwood%26aufirst%3DO.%2BM.%26aulast%3DDe%2BClerq%26aufirst%3DE.%26aulast%3DBalzarini%26aufirst%3DJ.%26atitle%3DPhosphoramidate%2520derivatives%2520of%25202%25E2%2580%25B2%252C3%25E2%2580%25B2-didehydro-2%25E2%2580%25B2%252C3%25E2%2580%25B2-dideoxyadenosine%2520%2528d4A%2529%2520have%2520markedly%2520improved%2520anti-HIV%2520potency%2520and%2520selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1996%26volume%3D6%26spage%3D2359%26epage%3D2362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Pierra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benzaria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amador, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moussa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gosselin, G.</span><span> </span><span class="NLM_article-title">NM283, an efficient prodrug of the potent anti-HCV agent 2′-methylcytidine</span> <span class="citation_source-journal">Nucleosides, Nucleotides Nucleic Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">767</span><span class="NLM_x">–</span> <span class="NLM_lpage">770</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1081%2FNCN-200060112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=16248033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFGisbbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=767-770&author=C.+Pierraauthor=S.+Benzariaauthor=A.+Amadorauthor=A.+Moussaauthor=S.+Mathieuauthor=R.+Storerauthor=G.+Gosselin&title=NM283%2C+an+efficient+prodrug+of+the+potent+anti-HCV+agent+2%E2%80%B2-methylcytidine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">NM 283, an efficient prodrug of the potent anti-HCV agent 2'-C-methylcytidine</span></div><div class="casAuthors">Pierra, C.; Benzaria, S.; Amador, A.; Moussa, A.; Mathieu, S.; Storer, R.; Gosselin, G.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5-7</span>),
    <span class="NLM_cas:pages">767-770</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">In order to improve the oral bioavailability of 2'-C-methylcytidine, a potent anti-HCV agent, the corresponding 3'-O-L-valinyl ester deriv. (NM 283) has been synthesized.  Based on its ease of synthesis and its physicochem. properties, NM 283 has emerged as a promising antiviral drug for treatment of chronic HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoafc6FbtvUsrVg90H21EOLACvtfcHk0lifnGc0QIN8PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFGisbbF&md5=50888c7dd06c8d49f1f56204c43f69a0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1081%2FNCN-200060112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FNCN-200060112%26sid%3Dliteratum%253Aachs%26aulast%3DPierra%26aufirst%3DC.%26aulast%3DBenzaria%26aufirst%3DS.%26aulast%3DAmador%26aufirst%3DA.%26aulast%3DMoussa%26aufirst%3DA.%26aulast%3DMathieu%26aufirst%3DS.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DGosselin%26aufirst%3DG.%26atitle%3DNM283%252C%2520an%2520efficient%2520prodrug%2520of%2520the%2520potent%2520anti-HCV%2520agent%25202%25E2%2580%25B2-methylcytidine%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2005%26volume%3D24%26spage%3D767%26epage%3D770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Tang, X.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piccirilli, J. A.</span><span> </span><span class="NLM_article-title">2′-C-Branched ribonucleosides: synthesis of the phosphoramidite derivatives of 2′-<i>C</i>-β-methylcytidine and their incorporation into oligonucleotides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo981329u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1999&pages=747-754&author=X.-Q.+Tangauthor=X.+Liaoauthor=J.+A.+Piccirilli&title=2%E2%80%B2-C-Branched+ribonucleosides%3A+synthesis+of+the+phosphoramidite+derivatives+of+2%E2%80%B2-C-%CE%B2-methylcytidine+and+their+incorporation+into+oligonucleotides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo981329u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo981329u%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DX.-Q.%26aulast%3DLiao%26aufirst%3DX.%26aulast%3DPiccirilli%26aufirst%3DJ.%2BA.%26atitle%3D2%25E2%2580%25B2-C-Branched%2520ribonucleosides%253A%2520synthesis%2520of%2520the%2520phosphoramidite%2520derivatives%2520of%25202%25E2%2580%25B2-C-%25CE%25B2-methylcytidine%2520and%2520their%2520incorporation%2520into%2520oligonucleotides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1999%26volume%3D64%26spage%3D747%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Uchiyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aso, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noyori, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, Y.</span><span> </span><span class="NLM_article-title">O-Selective phosphorylation of nucleosides without N-protection</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00054a020" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1993&pages=373-379&author=M.+Uchiyamaauthor=Y.+Asoauthor=R.+Noyoriauthor=Y.+Hayakawa&title=O-Selective+phosphorylation+of+nucleosides+without+N-protection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjo00054a020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00054a020%26sid%3Dliteratum%253Aachs%26aulast%3DUchiyama%26aufirst%3DM.%26aulast%3DAso%26aufirst%3DY.%26aulast%3DNoyori%26aufirst%3DR.%26aulast%3DHayakawa%26aufirst%3DY.%26atitle%3DO-Selective%2520phosphorylation%2520of%2520nucleosides%2520without%2520N-protection%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1993%26volume%3D58%26spage%3D373%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuyang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yufen, Z.</span><span> </span><span class="NLM_article-title">Convenient and regioselective synthesis of nucleoside phosphoramidate monoesters</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1927</span><span class="NLM_x">–</span> <span class="NLM_lpage">1929</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=1927-1929&author=J.+Zhuauthor=H.+Fuauthor=J.+Yuyangauthor=Z.+Yufen&title=Convenient+and+regioselective+synthesis+of+nucleoside+phosphoramidate+monoesters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DYuyang%26aufirst%3DJ.%26aulast%3DYufen%26aufirst%3DZ.%26atitle%3DConvenient%2520and%2520regioselective%2520synthesis%2520of%2520nucleoside%2520phosphoramidate%2520monoesters%26jtitle%3DSynlett%26date%3D2005%26volume%3D12%26spage%3D1927%26epage%3D1929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daluge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burnette, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condreay, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clerq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span> </span><span class="NLM_article-title">Application of phosphoramidate pronucleotide technology to abacavir leads to a significant enhancement of antiviral potency</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3504</span><span class="NLM_x">–</span> <span class="NLM_lpage">3515</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0491400" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjt1Okuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3504-3515&author=C.+McGuiganauthor=S.+A.+Harrisauthor=S.+M.+Dalugeauthor=K.+S.+Gudmundssonauthor=E.+W.+McLeanauthor=T.+C.+Burnetteauthor=H.+Marrauthor=R.+Hazenauthor=L.+D.+Condreayauthor=L.+Johnsonauthor=E.+De+Clerqauthor=J.+Balzarini&title=Application+of+phosphoramidate+pronucleotide+technology+to+abacavir+leads+to+a+significant+enhancement+of+antiviral+potency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Phosphoramidate Pronucleotide Technology to Abacavir Leads to a Significant Enhancement of Antiviral Potency</span></div><div class="casAuthors">McGuigan, Christopher; Harris, Sarah A.; Daluge, Susan M.; Gudmundsson, Kristjan S.; McLean, Ed W.; Burnette, Thimysta C.; Marr, Harry; Hazen, Richard; Condreay, Lynn D.; Johnson, Lance; De Clercq, Erik; Balzarini, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3504-3515</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the first application of pronucleotide (ProTide) technol. to the antiviral agent abacavir (Ziagen), used for the treatment of HIV infection.  The phenylmethoxyalaninyl phosphoramidate of abacavir was prepd. in good yield in one step.  Also prepd. was the corresponding phosphoramidate of the guanine nucleoside analog "carbovir".  The antiviral profile of each of the parent nucleosides was compared to that of the phosphoramidate ProTides.  A significant (28- to 60-fold) increase in anti-HIV potency was noted for the ProTide of abacavir but not for that of carbovir.  These findings were in agreement with the markedly higher (ca. 37-fold) levels of carbovir triphosphate that are formed in CEM cells upon response to the abacavir ProTide compared with the parent abacavir compd.  In contrast the anti-HBV potency of both abacavir and carbovir were improved (10- and 20-fold, resp.) by ProTide formation.  As in CEM cells, the abacavir ProTide provided significantly enhanced carbovir triphosphate levels in HepG2 2.2.15 cells over that of the parent nucleoside.  On the basis of these data, a series of phosphoramidate analogs with structural variation in the ester and amino acid regions were prepd. and their antiviral profiles described.  In addn., the pharmacokinetic disposition of the abacavir phenylethoxyalaninyl phosphoramidate was evaluated in Cynomolgus monkeys.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3b0LhbMvaULVg90H21EOLACvtfcHk0lhb8fQlr-mxAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjt1Okuro%253D&md5=32ba0bb2d6648f0602f9bad08dd5e482</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm0491400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0491400%26sid%3Dliteratum%253Aachs%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DS.%2BA.%26aulast%3DDaluge%26aufirst%3DS.%2BM.%26aulast%3DGudmundsson%26aufirst%3DK.%2BS.%26aulast%3DMcLean%26aufirst%3DE.%2BW.%26aulast%3DBurnette%26aufirst%3DT.%2BC.%26aulast%3DMarr%26aufirst%3DH.%26aulast%3DHazen%26aufirst%3DR.%26aulast%3DCondreay%26aufirst%3DL.%2BD.%26aulast%3DJohnson%26aufirst%3DL.%26aulast%3DDe%2BClerq%26aufirst%3DE.%26aulast%3DBalzarini%26aufirst%3DJ.%26atitle%3DApplication%2520of%2520phosphoramidate%2520pronucleotide%2520technology%2520to%2520abacavir%2520leads%2520to%2520a%2520significant%2520enhancement%2520of%2520antiviral%2520potency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3504%26epage%3D3515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Congiatu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuigan, C.</span><span> </span><span class="NLM_article-title">Novel potential anticancer naphthyl phosphoramidates of BVdU: separation of diastereoisomers and assignment of the absolute configuration of the phosphorus center</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">452</span><span class="NLM_x">–</span> <span class="NLM_lpage">455</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0509896" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=452-455&author=C.+Congiatuauthor=A.+Brancaleauthor=M.+D.+Masonauthor=W.+G.+Jiangauthor=C.+McGuigan&title=Novel+potential+anticancer+naphthyl+phosphoramidates+of+BVdU%3A+separation+of+diastereoisomers+and+assignment+of+the+absolute+configuration+of+the+phosphorus+center"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm0509896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0509896%26sid%3Dliteratum%253Aachs%26aulast%3DCongiatu%26aufirst%3DC.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DMason%26aufirst%3DM.%2BD.%26aulast%3DJiang%26aufirst%3DW.%2BG.%26aulast%3DMcGuigan%26aufirst%3DC.%26atitle%3DNovel%2520potential%2520anticancer%2520naphthyl%2520phosphoramidates%2520of%2520BVdU%253A%2520separation%2520of%2520diastereoisomers%2520and%2520assignment%2520of%2520the%2520absolute%2520configuration%2520of%2520the%2520phosphorus%2520center%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D452%26epage%3D455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Siddiqui, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuigan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balzarini, J.</span><span> </span><span class="NLM_article-title">Enhancing the aqueous solubility of d4T-based phosphoramidate prodrugs</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=381-384&author=A.+Siddiquiauthor=C.+McGuiganauthor=C.+Ballatoreauthor=S.+Srinivasanauthor=E.+De+Clercqauthor=J.+Balzarini&title=Enhancing+the+aqueous+solubility+of+d4T-based+phosphoramidate+prodrugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqui%26aufirst%3DA.%26aulast%3DMcGuigan%26aufirst%3DC.%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DSrinivasan%26aufirst%3DS.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DBalzarini%26aufirst%3DJ.%26atitle%3DEnhancing%2520the%2520aqueous%2520solubility%2520of%2520d4T-based%2520phosphoramidate%2520prodrugs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D381%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Morton, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iacono, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyatt, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheshire, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danks, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, P. M.</span><span> </span><span class="NLM_article-title">Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">629</span><span class="NLM_x">–</span> <span class="NLM_lpage">636</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1007%2Fs00280-005-1027-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=15918039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKqu7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2005&pages=629-636&author=C.+L.+Mortonauthor=L.+Iaconoauthor=J.+L.+Hyattauthor=K.+R.+Taylorauthor=P.+J.+Cheshireauthor=P.+J.+Houghtonauthor=M.+K.+Danksauthor=C.+F.+Stewartauthor=P.+M.+Potter&title=Activation+and+antitumor+activity+of+CPT-11+in+plasma+esterase-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice</span></div><div class="casAuthors">Morton, Christopher L.; Iacono, Lisa; Hyatt, Janice L.; Taylor, Kody R.; Cheshire, Pamela J.; Houghton, Peter J.; Danks, Mary K.; Stewart, Clinton F.; Potter, Philip M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">629-636</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: To examine the antitumor activity and the pharmacokinetics of CPT-11 (irinotecan, 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxycamptothecin) in a plasma esterase-deficient scid mouse model, bearing human tumor xenografts.  Exptl. design: Plasma carboxylesterase (CE)-deficient mice were bred with scid animals to develop a strain that would allow growth of human tumor xenografts.  Following xenotransplantation, the effect of the plasma esterase on antitumor activity following CPT-11 administration was assessed.  In addn., detailed pharmacokinetic studies examg. plasma and biliary disposition of CPT-11 and its metabolites were performed.  Results: In mice lacking plasma carboxylesterase, the mean SN-38 systemic exposures were approx. fourfold less than that obsd. in control animals.  Consistent with the pharmacokinetic data, four to fivefold more CPT-11 was required to induce regressions in human Rh30 xenografts grown in esterase-deficient scid mice, as opposed to those grown in scid animals.  Addnl., the route of elimination of CPT-11, SN-38, and SN-38 glucuronide (SN-38G) was principally in the bile.  Conclusions: The pharmacokinetic profile for CPT-11 and its metabolites in the esterase-deficient mice more closely reflects that seen in humans.  Hence, these mice may represent a more accurate model for antitumor studies with this drug and other agents metabolized by CEs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosjcaJcbFkKrVg90H21EOLACvtfcHk0lhb8fQlr-mxAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKqu7nF&md5=1144eab9d1cb06d91c75d3e1302c610b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2Fs00280-005-1027-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-005-1027-y%26sid%3Dliteratum%253Aachs%26aulast%3DMorton%26aufirst%3DC.%2BL.%26aulast%3DIacono%26aufirst%3DL.%26aulast%3DHyatt%26aufirst%3DJ.%2BL.%26aulast%3DTaylor%26aufirst%3DK.%2BR.%26aulast%3DCheshire%26aufirst%3DP.%2BJ.%26aulast%3DHoughton%26aufirst%3DP.%2BJ.%26aulast%3DDanks%26aufirst%3DM.%2BK.%26aulast%3DStewart%26aufirst%3DC.%2BF.%26aulast%3DPotter%26aufirst%3DP.%2BM.%26atitle%3DActivation%2520and%2520antitumor%2520activity%2520of%2520CPT-11%2520in%2520plasma%2520esterase-deficient%2520mice%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2005%26volume%3D56%26spage%3D629%26epage%3D636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="note"><p class="first last">The initial concentration of compound <b>46b</b> was 1 μM. The degradation of the substrate was monitored by LC−MS/MS within a 2 h experiment incubating at 37 °C. The monitoring was carried out at the following time points: 0, 5, 10, 30, 60, and 120 min.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Pucci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monteagudo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonelli, F.</span><span> </span><span class="NLM_article-title">HILIC LC−MS for the determination of 2′-<i>C</i>-methyl-cytidine-triphosphate in rat liver</span> <span class="citation_source-journal">J. Sep. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1275</span><span class="NLM_x">–</span> <span class="NLM_lpage">1283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1002%2Fjssc.200800722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=19347863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1Kjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2009&pages=1275-1283&author=V.+Pucciauthor=C.+Giulianoauthor=R.+Zhangauthor=K.+A.+Koeplingerauthor=J.+F.+Leoneauthor=E.+Monteagudoauthor=F.+Bonelli&title=HILIC+LC%E2%88%92MS+for+the+determination+of+2%E2%80%B2-C-methyl-cytidine-triphosphate+in+rat+liver"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">HILIC LC-MS for the determination of 2'-C-methylcytidine-triphosphate in rat liver</span></div><div class="casAuthors">Pucci, Vincenzo; Giuliano, Claudio; Zhang, Rena; Koeplinger, Kenneth Alan; Leone, Joseph F.; Monteagudo, Edith; Bonelli, Fabio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Separation Science</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1275-1283</span>CODEN:
                <span class="NLM_cas:coden">JSSCCJ</span>;
        ISSN:<span class="NLM_cas:issn">1615-9306</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A very accurate and selective LC-MS/MS method was developed and validated for the quantification of 2'-C-modified nucleoside triphosphate in liver tissue samples.  An efficient pretreatment procedure of liver tissue samples was developed, using a fully automated SPE procedure with 96-well SPE plate (weak anion exchange sorbent, 30 mg).  Nucleotide hydrophilic interaction chromatog. has been performed on an aminopropyl column (100 mm × 2.0 mm, 3 μm) using a gradient mixt. of ACN and ACN/water (5:95 vol./vol.) with 20 mM ammonium acetate at pH 9.45 as mobile phase at 300 μL/min flow rate.  The 2'-C-modified nucleoside triphosphate was detected in the neg. ESI mode in multiple reaction monitoring (MRM) mode.  Calibration curve was linear over the 0.05-50 μM concn. range.  Satisfying results, confirming the high reliability of the established LC-MS/MS method, were obtained for intraday precision (CV = 2.5-9.1%) and accuracy (92.6-94.8%) and interday precision (CV = 9.6-11.5%) and accuracy (94.4-102.4%) as well as for recovery (82.0-112.6%) and selectivity.  The method has been successfully applied for pharmacokinetic studies of 2'-C-methyl-cytidine-triphosphate in liver tissue samples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomFTcxsRh_vLVg90H21EOLACvtfcHk0lhb8fQlr-mxAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1Kjsrc%253D&md5=290a9d8a04b8dd890efc16499e6d79ac</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fjssc.200800722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjssc.200800722%26sid%3Dliteratum%253Aachs%26aulast%3DPucci%26aufirst%3DV.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DLeone%26aufirst%3DJ.%2BF.%26aulast%3DMonteagudo%26aufirst%3DE.%26aulast%3DBonelli%26aufirst%3DF.%26atitle%3DHILIC%2520LC%25E2%2588%2592MS%2520for%2520the%2520determination%2520of%25202%25E2%2580%25B2-C-methyl-cytidine-triphosphate%2520in%2520rat%2520liver%26jtitle%3DJ.%2520Sep.%2520Sci.%26date%3D2009%26volume%3D32%26spage%3D1275%26epage%3D1283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span>Composition for 1 L in water: NaCl (2.0 g), pepsin (3.2 g), HCl (7 mL). Final pH of 1.2.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Composition+for+1+L+in+water%3A+NaCl+%282.0+g%29%2C+pepsin+%283.2+g%29%2C+HCl+%287+mL%29.+Final+pH+of+1.2."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span>Toxicological Profile for Phenol; 1-205; Agency for Toxic Substances and Disease Registry, U.S. Department of Health and Human Services: Atlanta, GA,<span class="NLM_x"> </span><span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Toxicological+Profile+for+Phenol%3B+1-205%3B+Agency+for+Toxic+Substances+and+Disease+Registry%2C+U.S.+Department+of+Health+and+Human+Services%3A+Atlanta%2C+GA%2C+1998."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Abraham, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntee, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidhya, V. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinazi, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, C. R.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity and decomposition studies of amino acid phosphomonoester amidates of Aciclovir</span> <span class="citation_source-journal">Nucleosides, Nucleotides Nucleic Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2079</span><span class="NLM_x">–</span> <span class="NLM_lpage">2092</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1080%2F07328319708002557" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADyaK2sXotVCqtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=2079-2092&author=T.+W.+Abrahamauthor=E.+J.+McInteeauthor=V.+I.+Vidhyaauthor=R.+F.+Schinaziauthor=C.+R.+Wagner&title=Synthesis+and+biological+activity+and+decomposition+studies+of+amino+acid+phosphomonoester+amidates+of+Aciclovir"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, biological activity and decomposition studies of amino acid phosphomonoester amidates of acyclovir</span></div><div class="casAuthors">Abraham, Timothy W.; Mcintee, Edward J.; Iyer, Vidhya V.; Schinazi, Raymond F.; Wagner, Carston R.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides & Nucleotides</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10 & 11</span>),
    <span class="NLM_cas:pages">2079-2092</span>CODEN:
                <span class="NLM_cas:coden">NUNUD5</span>;
        ISSN:<span class="NLM_cas:issn">0732-8311</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">Highly stable and water sol. amino acid phosphomonoester amidates of acyclovir (ACV) were synthesized and shown to function predominantly as prodrugs of ACV and not acyclovir monophosphate (ACV-MP) with activities within two fold of the amino acid prodrug of ACV, valaciclovir (VACV).  Metab. studies revealed that incubation of cell-free exts. of Vero cells with the L-leucine phosphomonoester amidate of ACV (3c), resulted in a burst of ACV-MP prodn. followed by the rapid generation of ACV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUk5K6LuI0ArVg90H21EOLACvtfcHk0liOJAgsizd1xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXotVCqtr8%253D&md5=61e0af839cfd823edc2ed8b3454c7f20</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1080%2F07328319708002557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07328319708002557%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DT.%2BW.%26aulast%3DMcIntee%26aufirst%3DE.%2BJ.%26aulast%3DVidhya%26aufirst%3DV.%2BI.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26aulast%3DWagner%26aufirst%3DC.%2BR.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520and%2520decomposition%2520studies%2520of%2520amino%2520acid%2520phosphomonoester%2520amidates%2520of%2520Aciclovir%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D1997%26volume%3D16%26spage%3D2079%26epage%3D2092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Chang, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griesgraber, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southern, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, C. R.</span><span> </span><span class="NLM_article-title">Amino acid phosphoramidate monoesters of 3′-azido-3′-deoxy-thymidine: relationship between antiviral potency and intracellular metabolism</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000260r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=223-231&author=S.+L.+Changauthor=G.+W.+Griesgraberauthor=P.+J.+Southernauthor=C.+R.+Wagner&title=Amino+acid+phosphoramidate+monoesters+of+3%E2%80%B2-azido-3%E2%80%B2-deoxy-thymidine%3A+relationship+between+antiviral+potency+and+intracellular+metabolism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm000260r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000260r%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DS.%2BL.%26aulast%3DGriesgraber%26aufirst%3DG.%2BW.%26aulast%3DSouthern%26aufirst%3DP.%2BJ.%26aulast%3DWagner%26aufirst%3DC.%2BR.%26atitle%3DAmino%2520acid%2520phosphoramidate%2520monoesters%2520of%25203%25E2%2580%25B2-azido-3%25E2%2580%25B2-deoxy-thymidine%253A%2520relationship%2520between%2520antiviral%2520potency%2520and%2520intracellular%2520metabolism%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D223%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Chang, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griesgraber, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, C. R.</span><span> </span><span class="NLM_article-title">Comparison of the antiviral activity of hydrophobic amino acid phosphoramidate monoesters of 2′,3′-dideoxyadenosine (DDA) and 3′-azido-3′-deoxythymidine (AZT)</span> <span class="citation_source-journal">Nucleosides, Nucleotides Nucleic Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1571</span><span class="NLM_x">–</span> <span class="NLM_lpage">1582</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1081%2FNCN-100105248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=11554546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmsFOht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=1571-1582&author=S.+L.+Changauthor=G.+W.+Griesgraberauthor=C.+R.+Wagner&title=Comparison+of+the+antiviral+activity+of+hydrophobic+amino+acid+phosphoramidate+monoesters+of+2%E2%80%B2%2C3%E2%80%B2-dideoxyadenosine+%28DDA%29+and+3%E2%80%B2-azido-3%E2%80%B2-deoxythymidine+%28AZT%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the antiviral activity of hydrophobic amino acid phosphoramidate monoesters of 2',3'-dideoxyadenosine (DDA) and 3'-azido-3'-deoxythymidine (AZT)</span></div><div class="casAuthors">Chang, Shu-Ling; Griesgraber, George; Wagner, Carston R.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1571-1582</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">A series of hydrophobic, water sol. and non-toxic amino acid phosphoramidate monoesters of dideoxyadenosine (ddA) and 3'-azido-3'-deoxythymidine were shown to inhibit the replication of HIV-1 in human peripheral blood mononuclear cells (PBMC) from two donors.  The tryptophan Me ester phosphoramidates of AZT and ddA were equally potent (EC50S = 0.3-0.4 μM), while the Ph Me ester of ddA was 40- and 100- fold more potent than the AZT derivs.  The alaninyl Me ester of AZT was found to be 70- fold more potent than the ddA deriv.  The Me amide derivs. were found to be 5-20 fold less active than the Me esters for the ddA series, while for AZT the derivs. were found to be of similar potency or 60- to 166-fold more potent than the Me esters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjOMTnDH_qMbVg90H21EOLACvtfcHk0liOJAgsizd1xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmsFOht7k%253D&md5=81b5a13436fa2e24160eb320fe31f152</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1081%2FNCN-100105248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FNCN-100105248%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DS.%2BL.%26aulast%3DGriesgraber%26aufirst%3DG.%2BW.%26aulast%3DWagner%26aufirst%3DC.%2BR.%26atitle%3DComparison%2520of%2520the%2520antiviral%2520activity%2520of%2520hydrophobic%2520amino%2520acid%2520phosphoramidate%2520monoesters%2520of%25202%25E2%2580%25B2%252C3%25E2%2580%25B2-dideoxyadenosine%2520%2528DDA%2529%2520and%25203%25E2%2580%25B2-azido-3%25E2%2580%25B2-deoxythymidine%2520%2528AZT%2529%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2001%26volume%3D20%26spage%3D1571%26epage%3D1582" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">McIntee, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remmel, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schinazi, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, C. R.</span><span> </span><span class="NLM_article-title">Probing the mechanism of action and decomposition of amino acid phosphomonoester amidates of antiviral nucleoside prodrugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">3323</span><span class="NLM_x">–</span> <span class="NLM_lpage">3331</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm960694f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=3323-3331&author=E.+J.+McInteeauthor=R.+P.+Remmelauthor=R.+F.+Schinaziauthor=T.+W.+Abrahamauthor=C.+R.+Wagner&title=Probing+the+mechanism+of+action+and+decomposition+of+amino+acid+phosphomonoester+amidates+of+antiviral+nucleoside+prodrugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm960694f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960694f%26sid%3Dliteratum%253Aachs%26aulast%3DMcIntee%26aufirst%3DE.%2BJ.%26aulast%3DRemmel%26aufirst%3DR.%2BP.%26aulast%3DSchinazi%26aufirst%3DR.%2BF.%26aulast%3DAbraham%26aufirst%3DT.%2BW.%26aulast%3DWagner%26aufirst%3DC.%2BR.%26atitle%3DProbing%2520the%2520mechanism%2520of%2520action%2520and%2520decomposition%2520of%2520amino%2520acid%2520phosphomonoester%2520amidates%2520of%2520antiviral%2520nucleoside%2520prodrugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D3323%26epage%3D3331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Wagner, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntee, E. J.</span><span> </span><span class="NLM_article-title">Pronucleotides: toward the in vivo delivery of antiviral and anticancer nucleotides</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm900447q&amp;key=10.1002%2F1098-1128%28200011%2920%3A6%3C417%3A%3AAID-MED1%3E3.0.CO%3B2-Z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm900447q&amp;key=11058891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm900447q&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotVOiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=417-451&author=C.+R.+Wagnerauthor=V.+V.+Iyerauthor=E.+J.+McIntee&title=Pronucleotides%3A+toward+the+in+vivo+delivery+of+antiviral+and+anticancer+nucleotides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Pronucleotides: Toward the in vivo delivery of antiviral and anticancer nucleotides</span></div><div class="casAuthors">Wagner, Carston R.; Iyer, Vidhya V.; McIntee, Edward J.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">417-451</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review with 168 refs.  To overcome the many hurdles preventing the use of antiviral and anticancer nucleosides as therapeutics, the development of a prodrug methodol. (i.e., pronucleotide) for the in vivo delivery of nucleotides has been proposed as a soln.  The ideal pronucleotide should be non-toxic, stable in plasma and blood, capable of being i.v. and/or orally dosed, and intracellularly convertible to the corresponding nucleotide.  Although this goal has yet to be achieved, many clever and imaginative pronucleotide approaches have been developed, which are likely to be important pharmacol. tools.  This review will discuss the major advances and future directions of the emerging field of antiviral and anticancer pronucleotide design and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSvddFrhBi07Vg90H21EOLACvtfcHk0lhXOYcMsHevJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotVOiurc%253D&md5=02a724f8be792902e021385c76371e63</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2F1098-1128%28200011%2920%3A6%3C417%3A%3AAID-MED1%3E3.0.CO%3B2-Z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1098-1128%2528200011%252920%253A6%253C417%253A%253AAID-MED1%253E3.0.CO%253B2-Z%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DC.%2BR.%26aulast%3DIyer%26aufirst%3DV.%2BV.%26aulast%3DMcIntee%26aufirst%3DE.%2BJ.%26atitle%3DPronucleotides%253A%2520toward%2520the%2520in%2520vivo%2520delivery%2520of%2520antiviral%2520and%2520anticancer%2520nucleotides%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2000%26volume%3D20%26spage%3D417%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Meppen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bazzo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeplinger, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Paz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span> </span><span class="NLM_article-title">Cyclic phosphoramidates as prodrugs of 2′-<i>C</i>-methylcytidine</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3765</span><span class="NLM_x">–</span> <span class="NLM_lpage">3770</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=3765-3770&author=M.+Meppenauthor=B.+Paciniauthor=R.+Bazzoauthor=U.+Kochauthor=J.+F.+Leoneauthor=K.+A.+Koeplingerauthor=M.+Rowleyauthor=S.+Altamuraauthor=A.+Di+Marcoauthor=F.+Fioreauthor=C.+Giulianoauthor=O.+Gonzalez-Pazauthor=R.+Lauferauthor=V.+Pucciauthor=F.+Narjesauthor=C.+Gardelli&title=Cyclic+phosphoramidates+as+prodrugs+of+2%E2%80%B2-C-methylcytidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeppen%26aufirst%3DM.%26aulast%3DPacini%26aufirst%3DB.%26aulast%3DBazzo%26aufirst%3DR.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DLeone%26aufirst%3DJ.%2BF.%26aulast%3DKoeplinger%26aufirst%3DK.%2BA.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DDi%2BMarco%26aufirst%3DA.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DGonzalez-Paz%26aufirst%3DO.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DPucci%26aufirst%3DV.%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DGardelli%26aufirst%3DC.%26atitle%3DCyclic%2520phosphoramidates%2520as%2520prodrugs%2520of%25202%25E2%2580%25B2-C-methylcytidine%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D3765%26epage%3D3770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Donghi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attenni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiore, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, F.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of novel phosphoramidate prodrugs of 2′-methyl cytidine as inhibitors of hepatitis C virus NS5B polymerase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1392</span><span class="NLM_x">–</span> <span class="NLM_lpage">1395</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1392-1395&author=M.+Donghiauthor=B.+Attenniauthor=C.+Gardelliauthor=A.+Di+Marcoauthor=F.+Fioreauthor=C.+Giulianoauthor=R.+Lauferauthor=J.+F.+Leoneauthor=V.+Pucciauthor=M.+Rowleyauthor=F.+Narjes&title=Synthesis+and+evaluation+of+novel+phosphoramidate+prodrugs+of+2%E2%80%B2-methyl+cytidine+as+inhibitors+of+hepatitis+C+virus+NS5B+polymerase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDonghi%26aufirst%3DM.%26aulast%3DAttenni%26aufirst%3DB.%26aulast%3DGardelli%26aufirst%3DC.%26aulast%3DDi%2BMarco%26aufirst%3DA.%26aulast%3DFiore%26aufirst%3DF.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DLeone%26aufirst%3DJ.%2BF.%26aulast%3DPucci%26aufirst%3DV.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%2520phosphoramidate%2520prodrugs%2520of%25202%25E2%2580%25B2-methyl%2520cytidine%2520as%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%2520NS5B%2520polymerase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1392%26epage%3D1395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i61"><a href="/doi/suppl/10.1021/jm900447q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_16254"></div></div></div></div></div><hr /></hr><p class="last">Analytical data for target compounds and biological data for the first eluting diastereoisomers. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm900447q/suppl_file/jm900447q_si_001.pdf">jm900447q_si_001.pdf (63.95 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm900447q&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-17%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm900447q%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm900447q" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b640d9803cfa","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
